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Abstract
A lot of attention has been paid to trace amounts of pharmaceuticals and personal
care products (PPCPs) and endocrine disrupting compounds (EDCs) in drinking water
supplies. Current water and wastewater treatment techniques, such as coagulation,
flocculation, and sedimentation for water treatment and the conventional activated sludge
process for wastewater treatment, have shown only limited success in their removal.
Although there is a lack of evidence linking these emerging microconstituents to adverse
human health effects, not a lot is known about the effects of long term exposure to these
compounds and more research is still needed. This study examined advanced wastewater
treatment processes, such as membrane bioreactors (MBRs), along with processes that
are not normally used for treating wastewater to remove these emerging contaminants.

vii

The processes include oxidation with ozone coupled with biological active filtration
(BAF) to increase the removal efficiencies of these compounds.
A pilot scale membrane bioreactor (MBR) was set up at the Albuquerque
Bernalillo County Water Utility Authority (ABCWUA) Southside Water Reclamation
Plant (SWRP). The MBR was continuously fed primary treated wastewater. The MBR
effluent was used to feed an ozone contactor, which then fed a BAF column. The MBR
was operated at an SRT of 10 days throughout the duration of the experiments. Three
ozone doses where examined. The applied ozone doses were 2, 4, and 8 mg/L, which
correspond to a ratio of 0.5, 1, and 2 mg ozone/mg TOC. After ozone treatment, the
water was pumped to the BAF column. The BAF column used anthracite media that was
seeded with MLSS and soaked in MBR feedwater for a week to establish a bio-growth
prior to the experiments. The system was run for at least one week between sampling
events to establish steady state conditions at each new ozone dose. To determine steady
state conditions, TOC, UV254, SUVA, and BDOC removal were evaluated. This study
also investigated the removal of microconstituents using a reverse osmosis (RO) system
that ran concurrent to the Ozone/BAF treatment train for two of the ozone doses. The
concentrations of the compounds of interest were tested in the effluents of the MBR,
ozone, BAF, and RO.
Significant removal of the selected compounds was observed at all selected ozone
doses. Although removal of microconstituents increased with increasing ozone dose,
little additional removal occurred at ozone concentrations greater than 4 mg/L. The
change in percent removal of both organics and microconstituents was larger going from
an ozone dose of 2 to 4 mg/L than going from 4 to 8 mg/L. The BAF column did not
dramatically decrease the concentrations of these compounds after the initial decrease
due to ozonation, although additional TOC removal was achieved. This can be
contributed to oxidation breaking the compounds down to smaller, more biodegradable
compounds. Bulk organic analysis such as TOC, UV254 absorbance, SUVA, and BDOC
show that organic compounds are not mineralized to CO2 and H2O by ozonation alone.
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However, the data also shows that additional destruction of TOC occurred in the BAF
column following ozonation. Although the organic analyses do not indicate the fate of
individual microconstituents, the microconstituents can be expected to have the same fate
as other organics.
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Chapter 1: Introduction
Of the many problems our country, and indeed the world, is facing today, a clean,
safe, and abundant water supply is one that often gets little attention despite its
importance to both the economy and quality of life. Of recent concern is the presence of
pharmaceuticals and personal care products (PPCPs) and endocrine disrupting
compounds (EDCs) that are being found in trace amounts in the nation’s water supply.
These microconstituents enter the water supply through many sources, although one of
the most important is thought to be through wastewater treatment plants (WWTPs) [1, 2].
A large portion of these microconstituents enter the wastewater stream as human
excretions of unmetabolized or partly metabolized pharmaceuticals [2, 3]. Conventional
processes used in both wastewater treatment plants (WWTPs) [4] and drinking water
treatment plants [5] have been found to be either ineffective at removing many
microconstituents, or have large drawbacks to them.
Removing microconstituents in a wastewater treatment plant can be important in
many ways. The effluent from WWTPs are usually discharged into surface waters, such
as rivers. Contaminants from the treated wastewater have been shown to adversely affect
surrounding wildlife and the aquatic environment [6, 7]. In addition, wastewater effluent
has been shown to be a major source of pharmaceuticals and EDCs for water supplies
that are downstream of these plants. Currently no evidence links PPCPs/EDCs to adverse
human health problems at the concentrations being found in drinking water [7], but there
is a lack of knowledge about the effects these microconstituents have on human health at
these low levels. Until more research on the effect of these compounds is known, the
precautionary principle should be applied and steps should be taken to decrease the
amount of these compounds released into the environment.
Currently a lot of research has been focused on removing micropollutants from
both drinking water and wastewater. Some of the more promising processes for
removing microconstituents are oxidation, adsorption, and reverse osmosis. While these
processes can remove many of these compounds to a relatively high degree, there are
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drawbacks to these processes, especially in trying to incorporate them into wastewater
treatment.
Oxidation can remove many compounds to a high degree although the oxidant
dose and contact time required can be higher than that needed for disinfection. In the
case of ozone, which is the most powerful oxidant used in water and wastewater
treatment, the higher dose would require more energy than that required for disinfection,
and may create higher concentrations of disinfection by-products (DBPs).
Adsorption processes, using granular activated carbon (GAC) and powdered
activated carbon (PAC), can remove many micropollutants well although these processes
also have drawbacks. Research has shown that hydrophilic compounds reach
breakthrough in a column much faster than hydrophobic compounds [8, 9]. In addition,
the presence of NOM can greatly reduce the removal efficiency of the carbon as well as
exhaust the carbon faster. For wastewater treatment, which is expected to have much
higher concentrations of NOM than most source waters, the activated carbon would have
to be replaced or regenerated more often, which leads to higher operating costs.
Current research has shown that reverse osmosis (RO) is a very promising
treatment technique that can remove most micropollutants to a high degree [8]. Although
RO will remove these micropollutants, there are many drawbacks to using RO both in
water and wastewater treatment. The RO process uses a lot of energy and also creates a
concentrated wastestream that must be managed [8]. The RO process also wastes a
portion of the water treated. This amount varies depending on the quality of the influent
and the quality of the effluent desired. This loss of water can be a particular problem in
places like New Mexico where sources of potable water are limited.
Some utilities treating wastewater for indirect potable water reuse are taking it
upon themselves to remove as many of the emerging microconstituents as they can from
the wastewater. This is due to not only the concern about future regulations regarding
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these newly emerging compounds, but also because of the public perception of having
microconstituents in the water.
Currently there are at least two communities in New Mexico that are looking to
supplement their current water supplies through planned indirect potable water reuse.
The village of Cloudcroft, New Mexico is currently constructing a state of the art water
and wastewater treatment plant to deal with its ongoing water shortage problems.
Cloudcroft will treat its wastewater using a membrane bioreactor (MBR), followed by
RO, and advanced oxidation. The highly treated water will then be blended and stored in
a reservoir for a period of time before it undergoes further water treatment to bring it to
potable standards. These treatments include ultrafiltration followed by granular activated
carbon and disinfection before the water is sent to the water distribution system.
The other community looking to supplement its current water supply is Rio
Rancho, New Mexico. Currently a pilot scale system is investigating planned indirect
potable water reuse using a different treatment train than the one in Cloudcroft. This
pilot also involves the use of a MBR, but unlike the Cloudcroft facility, does not use
reverse osmosis. Instead, the pilot study is examining the use of the advanced oxidation
process (AOP) of ozone and H2O2 followed by GAC. Following this, the community
plans to use the treated wastewater for aquifer storage and recovery where it will be
removed in several years as potable water. One of the important parameters being
monitored is the presence and removal of endocrine disrupting compounds (EDCs) and
pharmaceuticals and personal care products (PPCPs). This treatment train has the
potential to remove micropollutants to a high degree without the loss of water and high
energy consumption associated with RO.
Because of the ongoing scarcity of water and the limitations of treatment
processes like RO, this study examined the use of a combination of water treatment
techniques to try to achieve a high degree of PPCP/EDC removal with no loss of water,
minimal use of energy, and at the lowest cost possible. To gather the best possible data
for the size and scope of this project, a pilot system was continuously operated at the
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Albuquerque Bernalillo County Water Utility Authority (ABCWUA) Southside Water
Reclamation Plant (SWRP). The pilot system consisted of an MBR, ozone contact
chamber, and BAF column. The MBR received primary treated wastewater and operated
at a flowrate of approximately 200 mL/min at an SRT of 10 days. The MBR effluent fed
an ozone contactor at a flowrate of 100 mL/min. The effluent from the ozone contactor
fed a biologically active filter composed of anthracite with an EBCT of approximately 20
minutes.
Due to the cost of the PPCP/EDC analysis, only three ozone doses were tested.
To find the most effective ozone doses, the project was divided into two phases. In Phase
1 of the project, a series of analyses were done to examine the effects of various ozone
doses on different organic parameters. The bulk organic analysis consisted of total
organic carbon (TOC), UV254 absorbance, specific UV absorbance (SUVA), and
biodegradable dissolved organic carbon (BDOC). These parameters were measured at
varying ozone doses ranging from 0 to approximately 12 mg/L. It was determined that
the widest array of data could be gathered by examining PPCP/EDC removal at ozone
doses of 2, 4, and 8 mg/L.
Phase 2 of this research was also divided into two parts. Phase 2 examined both
the removal of organics and the removal of microconstituents at the 3 applied ozone
doses determined in Phase 1. TOC, UV254 absorbance, SUVA, and TOC removal were
measured daily to establish steady state conditions and to predict PPCP/EDC removal.
BDOC was measured 3 times for each applied ozone dose. The other part of Phase 2
examined the removal of microconstituents at the 3 applied ozone doses determined in
Phase 1. A total of 16 samples were collected and analyzed for PPCPs/EDCs.
The purpose of this project was to evaluate the removal of these emerging
contaminants from wastewater by a combination of these water treatment techniques.
The average TOC concentration of the MBR effluent was approximately 4 mg/L, which
corresponds to an ozone to TOC ratio of 0.5, 1.0, and 2.0 mg ozone/mg TOC. A
concurrent RO process was also examined for PPCP/EDC removal and a field blank was
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collected to establish confidence in the sampling process. Organic parameters were also
collected and analyzed to determine if there is a correlation between the removal of
organics and microconstituents.
The hypothesis in this research was that the combination of water treatment
techniques employed in this study would be able to effectively remove a wide variety of
compounds. Each of the treatment techniques employed is able to remove different
compounds to various degrees due to the different properties of both the treatment
techniques and the compounds to be removed. The various organic parameters should
correlate to the degree of PPCP/EDC removal at the various ozone doses examined.

Objectives
The main objective of Phase 1 was to:
•

Determine the three most effective ozone doses to examine the removal of
PPCP/EDCs.
o The ozone doses should give the widest array of removal data
without being redundant

The main objectives of Phase 2 were to:
•

Examine the removal of organics at the three ozone doses selected in
Phase 1

•

Examine the removal of PPCPs/EDCs at the three ozone doses selected in
Phase 1

•

Determine if there is a correlation between the removal of organics and
PPCPs/EDCs
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•

Determine the effectiveness of the MBR-ozone contactor-BAF column
treatment train and compare it to the effectiveness of the MBR-RO
treatment train in removing PPCPs/EDCs from wastewater

Previous research has shown that MBRs have the ability to remove
microconstituents as good as or better than the conventional activated sludge process
used in many treatment facilities today [7, 10-12]. Because the MBR is a biological
process, it is assumed that most biodegradable organics will be removed by this process.
By using ozone, the nonbiodegradable portion that remains, can be oxidized into more
biodegradable compounds. Following oxidation, the biological activity in the BAF
column can use these newly formed, more biodegradable compounds as food and break
them down even more. This combination of processes has the advantage of being able to
remove microconstituents to a high degree without the high energy cost, loss of water,
and production of a separate wastestream that is associated with using RO.
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Chapter 2: Background and Literature Review
Throughout the world there is increasing demand for high quality potable water to
support economic and population growth. As a result, indirect potable water reuse is of
increasing interest to communities, particularly those in areas where water supplies are
fully appropriated. Indirect potable water reuse can be planned or unplanned. Unplanned
indirect potable water reuse occurs whenever wastewater effluent is discharged to a water
body that is a source of supply for a downstream community. The city of Albuquerque,
NM has recently begun using unplanned indirect potable water reuse with the opening of
its new, state of the art, water treatment facility that treats water from the Rio Grande
River. Planned indirect potable water reuse involves treating wastewater to a point where
it can be used as a raw water supply, which is then further treated to potable standards
[13]. Planned indirect potable water reuse has been practiced in the US since the 1970s
[13]. This practice can be economically feasible for communities with limited water
supplies, but several issues must be considered. These include:
•

The treated water must be of high quality and must meet, state, and federal drinking
water regulations.

•

The water and wastewater treatment techniques must be reliable.

•

The system must be economically feasible.

•

An environmental barrier such as a reservoir or aquifer must be part of the system.

•

The treated water must be acceptable to the public. A system may produce the
cleanest, safest drinking water in the world but if no one trusts the water or if public
sentiment towards the treated water is negative, then there is still a problem.

This last point, public acceptability, may ultimately be the factor that controls
whether it is possible to implement a planned indirect potable water reuse system. Public
perception may be sufficiently negative to restrict water reuse options even if health and
treatment information suggests that a particular reuse strategy will be protective of human
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health. For instance, an associated press story was published in early 2008 reporting that
the drinking water supplies for at least 41 million Americans was found to have
pharmaceuticals in them [14]. The story raised public awareness about the presence of
pharmaceuticals and personal care products (PPCPs) and endocrine disrupting
compounds (EDCs) in the nation’s water supply, and may generate public sentiment to
regulate the removals of PPCPs and EDCs from drinking water.
PPCPs and EDCs are present in water at very low concentrations and therefore are
frequently referred to collectively as microconstituents. PPCPs include but are not
limited to fragrances, antibiotics, analgesics, insect repellants, lipid regulators, and
antiepileptics. Many PPCPs are also EDCs, which are compounds that can disrupt an
organism’s endocrine system, often resulting in changes to its hormonal balance [15].
People have been aware of EDCs since the 1930s and they have been detected in surface
and even treated drinking waters since the 1960s and 1970s [16]. There are three general
classes of EDCs: estrogenic or anti-estrogenic (female sex hormones), androgenic or antiandrogenic (male sex hormones), and thyroidal compounds (hormones that control
metabolism and many other systems in the body) [5, 6]. Although there is currently no
comprehensive list of EDCs, efforts are underway to develop one. One problem in
forming this list is that a huge number of chemicals are in use in commerce today and
most of these chemicals have not been screened for endocrine function.
Pharmaceuticals have also been found in treated wastewater for decades. The
first such report on the subject was released by the U.S. EPA in 1976 [17]. Although
there are many different avenues by which EDCs and PPCPs can enter surface waters, the
effluent from municipal WWTPs has been found to be a major source [6, 15, 17, 18].
EDCs can come from such sources as cleaning products, pesticides, plastics, household
chemicals, and even hormones excreted by humans that end up in WWTP receiving
waters [17]. Pharmaceuticals enter wastewater as human excretions of unmetabolized or
partly metabolized pharmaceuticals and their metabolites as well as unused medications
that are disposed of through the sink or toilet [3, 17, 19]. Personal care products can
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enter the wastestream during rinsing while bathing or washing [17]. Other sources for
EDCs and PPCPs include septic systems, combined sewer overflows, and untreated storm
water flows to name a few. Current wastewater treatment processes, such as activated
sludge, have shown to be inadequate at removing many microconstituents [4].
Much of the concern over microconstituents is fueled by the improved ability to
detect them at very low concentrations. Current analytical methods can detect many
organic compounds at concentration levels as low as 1 ng/L or 1 part per trillion (ppt)
[16]. If these compounds had a detection limit in the µg/L range, or parts per billion
(ppb), then few, if any microconstituents would be detected in water supplies [20].
Because it is very difficult to study the effects of these compounds on human health and
the environment at these concentrations, there is limited data on the effects of long term
exposure to these compounds with no concrete evidence thus far that there is a risk to
human health, although more research is needed [17]. Even so, the precautionary
principle should be used and more research should be done into investigating options for
removing these micropollutants.

Treatment processes for PPCP/EDC Removal
To evaluate the overall effectiveness of a treatment process for removing
microconstituents from wastewater, criteria, in addition to just removal efficiency, should
be considered. First, any treatment train used to remove micropollutants from wastewater
must meet all other regulatory guidelines including parameters such as total suspended
solids (TSS), total organic carbon (TOC), ammonium, and chemical oxygen demand
(COD). The treatment techniques should also be affordable, not just in the initial design
and construction, but from an operational standpoint as well. In addition, the treatment
processes should be as energy efficient as possible and avoid creating a separate waste
stream. More energy consumption means more pollution, which in a way defeats the
purpose. The last criterion for considering a process to remove microconstituents from
wastewater is that the process should not waste water. This is especially important in
regions where water is scarce.
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The following sections examine the use of five different treatment processes for
the removal of microconstituents from wastewater. These include MBRs (biological),
RO, oxidation, activated carbon (adsorption), and biological filtration. Each process has
benefits and drawbacks in removing microconstituents from wastewater, although some
seem to work better than others. These five processes are examined due to their potential
for advanced wastewater treatment or due to their frequent occurrence in the literature as
processes being researched for removing microconstituents from wastewater.

Membrane Bioreactors
Membrane bioreactors are a relatively new technology with commercial use
starting in the early 1970’s [21]. With the increased use and reliability of these systems
and the cost of the membranes and membrane processes decreasing, the use of this
technology has become an increasingly attractive alternative to traditional processes like
conventional activated sludge (CAS) [10, 21]. Stricter environmental regulations are
making the MBR systems an even more attractive alternative due to their increased
performance and cleaner effluent that is produced compared to conventional systems.
Although the MBR process is very similar to the CAS process, there is a significant
difference between the two processes.
Many WWTPs use the CAS process to treat wastewater. The CAS process is a
biological process that involves aerobic biodegradation of suspended and dissolved
organics in wastewater. The process involves developing a mixed culture of suspended
microorganisms in an aeration basin. The microorganisms are separated from the treated
wastewater by gravity settling and recycled back to the aeration basin. The supernatant
from the clarifier becomes the treated wastewater effluent. The CAS process is highly
effective at removing organic constituents; a well-operated plant will remove greater than
90 percent of both the suspended and dissolved material in the influent wastewater.
Typical effluent limits on a CAS plant consist of maximum concentrations of 30 mg/L for
both 5-day biochemical oxygen demand (BOD5) and total suspended solids (TSS).
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A membrane bioreactor combines the processes of biological treatment and
membrane separation [21]. The MBR process is a variation of the activated sludge
process that utilizes membrane filtration to separate biological solids from the treated
effluent rather than gravity settling. This modification produces a much higher quality
effluent because the concentration of suspended solids is near zero [22]. The BOD5
concentration of an MBR plant is also low because much of the effluent BOD5 from a
CAS plant is due to suspended solids. Diagrams of a CAS and an MBR plant are shown
in Figures 2-1 and 2-2, respectively.

Aeration
Basin

Secondary
Clarifier

Treated
Effluent

Air
Sludge Rec ycle

Waste Sludge
Figure 2-1: Flow diagram of the conventional activated sludge (CAS) process.

Membrane
Microfilters

Membrane
Microfilters
Treated
Effluent

Aeration
Basin

Waste Sludge
Air

Aeration
Basin
Air
Sludge Rec ycle

Treated
Effluent

Waste Sludge

(B)
(A)
Figure 2-2: Flow diagram of the membrane bioreactor (MBR) process with (A) membrane
microfilters located in the aeration basin and (B) membrane microfilters located outside of
the aeration basin.

In an MBR plant, the membranes can be configured inside the aeration basin or
externally [21]. Since solids separation does not depend on the settling characteristics of
the biomass, separation with a membrane allows for higher concentration of biomass in
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the aeration basin, which can reduce the size of treatment plant. The process can also be
operated with a much longer solids retention time (SRT) which, in the CAS process,
results in poor solids settling.

Mechanisms for microconstituent removal by biological processes
The removal of microconstituents by biological processes can be attributed
primarily to two mechanisms, sorption and degradation [7, 10, 22]. Sorption is a term that
includes adsorption, absorption, and ion exchange and is used when it is not clear which
is occurring [23]. For the MBR process, sorption is the transfer of microconstituents from
the water to either the sludge or the membrane [7, 24]. Biological solids in CAS and
MBRs have large specific sorption capacities that can be attributed to the high specific
surface area of the suspended microbial population [7]. Despite the large sorption
capacity, current research is showing that the removal of many microconstituents by the
MBR process is mainly due to biodegradation/biotransformation. Better
biodegradation/biotransformation of compounds is due to the low concentration of TOC
in a slow growing culture with long SRT. This forces organisms to develop degradation
pathways for slowly degradable compounds in order to continue to recover energy to
sustain microbial growth. Although there has been some contradicting research about the
effect of SRT on some compounds [7], many reports have shown that a higher SRT
increases biodegradation and therefore increases removal [7, 10, 22, 24]. The ability of
MBRs to operate at long SRT values is one advantage of this process over CAS systems.
Some of the findings concerning MBRs and how well they perform in both
traditional parameters as well as their ability to remove microconstituents are listed
below. Many of the investigations studied only a small number of target
microconstituents, in part because of the analytical challenges associated with measuring
these compounds. Although many of the studies reviewed have varying ranges of
compounds studied, some trends are evident in the findings. These include:
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1.

The studies confirm that MBRs achieved comparable or better removal of

microconstituents than the CAS process. A couple studies found only slightly better
performance [1, 22] while other studies reported much better removal for many more
compounds [7, 10-12]. The conclusion of most of the investigations was that the MBR
process can remove some microconstituents well but other compounds are left
unaffected. Only a few microconstituents were removed to below the method reporting
limit (MRL) [1, 4, 5, 7, 8, 10, 22].
2.

The investigations confirm that longer SRTs in the MBR process produce a more

diverse microbial population that enhances nitrification and removal of poorly degradable
compounds [1, 7, 8, 21, 24].
3.

Biodegradation and sorption to the sludge and membrane [24] were the main

removal mechanisms for microconstituent removal by the MBR process [10, 22].
Although both of these mechanisms can remove microconstituents, biodegradation was
found to be the most effective mechanism for microconstituent removal [7, 8, 15].
4.

MBRs do an exceptional job of removing traditional wastewater parameters

including TOC, TSS, ammonium, and COD [10, 21].
MBRs did not effectively remove some compounds. Several studies found that
the antiepileptic medication carbamazepine is especially persistent with both the MBR
and CAS process providing little to no removal [5, 10, 12, 22, 25]. Seven compounds
that had no removal by at least one research group included carbamazepine, DEET,
diclofenac, EDTA, hydrocodone, TCEP, and trimethoprim.
Indirect potable water reuse requires water to be treated to a particularly high
quality because of public perception and concern about possible long-term health effects.
Many researchers have agreed that a multi-barrier approach is the best way to achieve
this and an MBR system can be a good first process. Although the MBR process is not
effective at removing all microconstituents, they can provide subsequent systems with a
high quality feed water that has low TSS and DOC. This will improve the performance
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of subsequent advanced treatment by processes such as adsorption, advanced oxidation,
or RO.

Reverse Osmosis
Reverse osmosis is a membrane-based treatment process that separates
contaminants from water by forcing water through the membrane under pressure.
Dissolved contaminants are separated from the water as the water passes through the
membrane. The primary treatment mechanism in reverse osmosis is the physical
separation of micropollutants from water because of differences in physicochemical
properties that allow permeation through the membrane at substantially different rates.
RO can effectively remove most microconstituents. Like the MBR process, removal
depend on properties of the feedwater, membranes, and compounds to be removed [24].
Unlike the MBR process though, the RO feedwater must be of high quality to prevent
fouling. In particular, this means that the feedwater for an RO system must be nearly free
of solids.

Mechanisms for microconstituent removal by reverse osmosis
Many factors influence the removal mechanisms of microconstituents by the RO
process. Because reverse osmosis is a diffusion-controlled process, solute separation
occurs when constituents diffuse across the membrane slower than water does.
Diffusion, and therefore removal efficiency is influenced by:

•

Physical-chemical properties of the compound: These include the molecular weight,
size, diameter, solubility, diffusivity, polarity, hydrophobicity, charge, and
protonization of the compound [26, 27].

•

Membrane properties: These include the membrane’s surface charge, molecular
weight cut off (MWCO), pore size, hydrophobicity, and surface roughness [26, 27].

15

•

Membrane operating conditions: These include such parameters as flux,
transmembrane pressure, and the fraction of water to be recovered [26, 27].

•

Feedwater characteristics: The composition of the feedwater can play an important
role in rejection efficiencies. These parameters include a feedwater’s temperature,
ionic strength, pH, hardness, concentration of microconstituents, and total organic
matter concentration [26].

Conventional understanding of reverse osmosis dictates that removal efficiency will
increase as the physicochemical properties of the micropollutant deviate from those of
water. Drewes et al. (2006) developed the diagram shown in Figure 2-3 to estimate
rejection of microconstituents by RO membranes [26, 28]. The objective of the diagram
is to correlate removal efficiencies with solute and membrane properties. Although the
diagram can be useful in the design of water treatment systems to remove certain
microconstituents, the accuracy of this diagram has not been confirmed [26]. Figure 2-3
summarizes many types of interactions between the membrane, compound, and source
water.
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Figure 2-3: Rejection diagram for microconstituents using membrane processes as
functions of both solute and membrane properties [26, 28].

Molecular size has been shown to be a major mechanism for solute rejection by
RO and NF membranes [3, 8, 29, 30]. The density and molecular weight cut-off
(MWCO) of the membrane greatly affect removal due to size exclusion, for both ionized
and non-ionized compounds and is especially important for solutes that are not charged.
Some studies have shown that the RO process removes uncharged organic compounds
primarily through size exclusion [3, 29]. Compounds with a molecular weight greater
than 200-300 Daltons (Da) are effectively rejected by RO/NF membranes although some
larger compounds can still be detected in the permeate [27, 29]. For example, Kimura et
al. (2004) reported the EDC, 17β-estradiol (MW: 279 Da), was found in RO permeate,
although at very low concentrations [18].
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Another important removal mechanism employed by the RO process is charge
repulsion or electrostatic exclusion. This mechanism is explained by the repulsion
between the negatively charged membrane surface and negatively charged solutes.
Experimental results have shown that negatively charged compounds could achieve high
rejection due to electrostatic exclusion [27, 31]. This was found to be true regardless of
other physicochemical properties.
The concentration of microconstituents may also have an effect on how well they
are rejected. Kimura et al. suggests that rejection efficiencies decrease with lower feed
concentrations although they suggest further research should be done to determine its
effects [27].
One factor that is not a property of either the membrane or solute but can still
have a large effect on microconstituent removal is the fractional feed water recovery.
Factors that can limit recovery are osmotic pressure, concentration polarization, and the
solubility of sparingly soluble salts [23]. Higher recovery will result in increased
permeate volume but will decrease its quality [23]. This can be important when trying to
remove microconstituents. Verliefde et al. showed that at a recovery of 10 percent, a NF
membrane was able to remove >75% of all target compounds with most achieving >90
percent removal and a few compounds being removed at >99 percent [28]. At 80%
recovery, the same compounds were removed less effectively with one compound
dropping to ~10 percent removal.

Membrane selection
Because solute removal efficiencies are closely linked to the chemical and
physical properties of the membranes, material selection for RO membranes is important.
A good RO membrane must meet many characteristics [23]. Ideally, an RO membrane
material will produce a high flux that will not clog or foul easily while still maintaining
high solute removal efficiency. The material should be affordable while being durable
and stable. No commercial RO membrane can completely reject all solutes [26].
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Membrane manufacturers have focused their efforts on developing membrane materials
that achieve a high solute rejection while producing the highest fluxes at the lowest
transmembrane pressures [26].
The two most popular materials used in RO membranes are cellulose acetate and
polyamide. Although both materials have benefits and drawbacks, the polyamide seems
to be better suited for many RO applications including the removal of microconstituents.
One of the drawbacks of a polyamide membrane is that chlorine and other disinfectants
will damage the membrane. Care must be taken in designing these systems to maintain
feed water with proper disinfection while maintaining the integrity of the membrane.
Besides the membrane material, the decision to use either a NF or RO membrane
can have important implications on different parameters. The classification of different
membranes can be somewhat arbitrary. NF membranes can selectively remove divalent
cations (hardness) and anions (e.g. sulfate) and NOM while leaving higher concentrations
of the monovalent ions in the permeate. While traditionally many RO membranes
removed ions indiscriminately, newer RO membranes have been developed that have
similar selectivity.
Although RO membranes will achieve higher removal of microconstituents than
NF membranes due to their tighter, denser material, NF membranes have some
advantages. The RO process requires much higher pressures and is therefore more
energy intensive [23]. NF membranes can be operated at lower pressures than RO,
resulting in lower operating costs [29]. NF membranes are less susceptible to chemical
and biological fouling and can be operated at higher fractional feed water recovery
values.
Even though the RO process has shown to be very effective in the removal of
microconstituents, there are several drawbacks to the process that make it an undesirable
alternative in wastewater applications. As suggested earlier when considering criteria for
selecting a wastewater treatment process for removing microconstituents, the process
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should be relatively energy efficient. Although NF membranes can be more energy
efficient that RO membranes, they still both consume a lot of energy. In addition, both
RO and NF membranes create a separate, more concentrated waste stream that must be
dealt with. Along with the concentrate from this stream is the water that cannot be
recovered, which as mentioned earlier can be a very large drawback in areas where clean
water is scarce. In addition, fouling of the RO membrane can be a serious problem,
especially in wastewater applications.

Oxidation and Advanced Oxidation Processes
Oxidation and advanced oxidation processes (AOPs) achieve removal by
chemical destruction rather than by separating chemicals from solution [23]. The most
desirable outcome would be the complete oxidation of organic compounds to carbon
dioxide, water, and mineral acids, but as this section will examine, few oxidants or AOPs
achieve total mineralization of the constituents.

The Oxidation Process
A variety of water quality problems is amenable to treatment by chemical
oxidation. These include disinfection, taste and odor control, and the removal of
hydrogen sulfide, color, iron, and manganese, to name a few [23]. Oxidation processes
have also been used to oxidize organic compounds.
The driving force behind all oxidation processes is the exchange of electrons
between constituents and the corresponding decrease in the overall electrical potential
[23]. Conventional oxidation processes use oxidants such as chlorine gas (Cl2) and its
dissolution products hypochlorous acid (HOCl) and hypochlorite (OCl-), ozone (O3),
hydrogen peroxide (H2O2), permanganate (KMnO4), and chlorine dioxide (ClO2). In
conventional oxidation processes, the oxidants are generally selective regarding which
compounds they degrade. Although the use of oxidants such as chlorine is common in
drinking water treatment, there are disadvantages. One of the largest concerns is the
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production of disinfection by-products such as trihalomethanes (THMs) and haloacetic
acids (HAAs).
Advanced oxidation processes combine a chemical oxidant with UV radiation or
sometimes use combinations of oxidants to increase the rate of the oxidation process.
Advanced oxidation processes include various combinations of H2O2, Ozone, UV, TiO2,
and other oxidants. Common AOPs include UV-ozone, UV-peroxide, UV-titanium
dioxide (TiO2), and Fenton’s reagent (H2O2 and an iron salt). Other processes such as
wet air oxidation, super-critical oxidation, and catalytic oxidation require large amounts
of energy in the form of high temperature and pressures. Because contaminant
concentrations in drinking water are so low and the daily volume of water to be treated is
so large, these processes are not used for drinking water treatment.
Although most AOPs that have commercial applications are actually a
combination of two or more other processes, ozone is sometimes considered an AOP due
to its ability to form hydroxyl radicals [23]. Ozone forms a variety of free radical species
through a sequential decay cycle in water. Ozone also forms hydroxyl radicals when it
reacts with NOM. This reaction is considered an important mechanism in destroying
target compounds. At high pH (> 8.3) free radical scavengers such as carbonate ions
(CO32-) compete for these radicals with organic compounds, thus the effectiveness of
ozonation processes diminishes at high pH.
Oxidation may occur through direct chemical oxidation of susceptible bonds in
the target molecule or through generation of highly reactive free radicals such as the
hydroxyl radical (OH•). AOPs, such as UV/O3, UV/H2O2, UV/TiO2, and Fenton’s
reagent are especially effective at generating free radicals which is the principal
mechanisms responsible for their enhanced performance [30]. Hydroxyl radicals are
reactive electrophiles that react with almost all electron-rich organic compounds [23].
For most compounds, their reaction rates are orders of magnitude faster than
conventional oxidants.
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The effectiveness of disinfection by oxidation processes is determined by a
number of factors including the concentration of the oxidant or intensity of UV radiation,
the reaction time, temperature, and the presence of competing reactants or free radical
scavengers. For most oxidation reactions, there is a direct trade-off between oxidant
concentration and reaction time. In other words, similar destruction can be achieved
using a high oxidant concentration and short reaction time, or low oxidant concentration
and long reaction time. Thus, design of disinfection processes are usually based on the
parameter CT where CT is:
CT = Oxidant Concentration x Time
CT usually has units of mg-min/L. The equivalent dose for UV oxidation is the
product of light intensity (watts/m2) and time (seconds) to give an exposure measured in
Joules/m2. Note that the energy of light is inversely proportional to its wavelength so that
short wavelength light (i.e. ultra violet light) has more energy than visible light.
Chemical reactions are accelerated by higher temperatures, hence better oxidation
or disinfection is achieved in warmer water. However, because of the large volume of
water processed in a treatment plant it is not possible to control the temperature of water
in a disinfection of oxidation process. Instead, the CT product is increased for lower
temperatures to give similar removal.
Most AOPs are not specific to particular solutes and will react with any
oxidizable compound in solution. This includes suspended solids as well as dissolved
organic carbon, whether these compounds are natural or not. Therefore, it is important
that the feed water have as low a concentration of TOC as possible to maximize
destruction of microconstituents. Further, because suspended solids absorb light, it is
important that the suspended solids concentration be as low as possible for oxidation
processes that utilize UV light.
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Summary of Oxidation Process Effectiveness for Microconstituent Removal
Water utilities have begun looking at oxidation and AOPs as a way to remove
micropollutants due to the success of these processes in disinfecting drinking water [31].
Recently, significant advances in the understanding of the aquatic photochemistry of
certain single compounds or classes of pharmaceuticals has been made, although specific
data in this area is still needed [32].
Although most conventional oxidation processes work well for disinfection, they
are not very effective at removing many micropollutants [33]. This is largely because
lower oxidant concentrations and less powerful oxidants are needed to achieve
disinfection than are needed to destroy trace concentrations of microconstituents. As a
result, most studies have found relatively poor micropollutant removal by oxidation
processes designed to achieve disinfection. In contrast, AOPs rely on higher oxidant
doses, longer reaction times, and employ processes that maximize the production of
highly reactive free radical compounds that will attack a wide variety of chemical bonds
to destroy nearly all organic compounds [43, 44].
Although UV light irradiation has been shown to be an effective tool in drinking
water disinfection, it achieves limited degradation of many micropollutants [7, 24, 34, 40,
42, 45], especially at doses used for disinfection (120-400 mJ/cm2) [40, 43] (although one
source cited typical disinfection doses of <5-30 mJ/cm2 [6]). Either much longer
exposure times or higher intensity UV light is required to destroy micropollutants than is
required for disinfection [7, 34, 36, 43]. One author cited that the UV dose required for
treating micropollutants would be orders of magnitude higher than that needed for
disinfection [6], while another author cited the appropriate dose is about five times higher
[34].
The combination of peroxide and UV light has been shown to be quite effective at
degrading many micropollutants [37, 38, 41, 43, 44, 46]. This is believed to be due to
enhanced production of free radical compounds. The studies by Muller and Jekel (2001)
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and Muller, et al. (2001), found that the UV/H2O2 process had the highest degradation for
atrazine (up to 99%), but it also used a lot of energy [36, 39].
Ozone and ozone-based AOPs are effective at removing many micropollutants [7,
46]. Ozonation by itself can reduce both the concentration and number of compounds
detected after treatment [34, 44]. For example, Okuda, et al. (2008) found that ozone
coupled with a biological activated carbon process reduced all residual pharmaceuticals
to below quantification limits [33]. Although O3 oxidation of microconstituents is highly
effective, special considerations are needed for source waters with high bromide
concentration to limit formation of brominated compounds [23, 34]. In addition, O3
oxidation of microconstituents requires longer contact times and/or higher doses than that
used for disinfection, which increase process costs [44].
Muller et al. (2001) found that the H2O2/O3 process produced the best
microconstituent removal in terms of energy use [35]. The energy used for this process
was an order of magnitude lower than the UV based processes (UV/H2O2 and UV/O3).
Kim, et al. (2008) found this process to be very promising but did not pursue a full scale
version due to the high bromide concentration in the source water [34]. Instead, the plant
was built using the UV/H2O2 process. This system has been operating since 2004 and
provides good destruction of both organic micropollutants and microorganisms.
Few AOPs have been built solely for removal of microconstituents; most have
been designed solely to provide disinfection. One benefit to using an ozone or UV/H2O2
system is that they are widely used, have a high level of technical development in
industrial applications, and their effectiveness is well established [36]. Ozone and
UV/H2O2 have shown that they can destroy microconstituents and appear to be promising
techniques although, like other oxidation processes, longer treatment is required for
micropollutant removal than for disinfection [37].
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Problem Compounds and Special Considerations
Ozone, ozone-based, and UV-based AOPs can effectively degrade most
microconstituents but researchers have found some compounds are slowly oxidized. One
study found that 2-QCA, DEET, and cyclophosphamide were poorly removed by these
processes [38]. One study found that Ciprofloxacin was the most persistent target
compound with only 16% degradation by ozone [9]. Carbamazepine [37, 38] and
naproxen [39] were found to be poorly degraded with UV. UV/H2O2 showed better
removal of these compounds [37, 38]. A couple studies found that clofibric acid was
poorly removed by ozonation even at higher doses [10, 33].
Although oxidation processes can degrade many organic compounds, it is
important to recognize that the products may not be not fully mineralized to H2O and
CO2. The objective of an oxidation processes is to change the compound so that it is no
longer biologically active [9]. While an oxidation process may destroy the parent
compound, it may produce degradation products with unknown biological activity [9].
More research is still needed in determining the degradation products produced by
oxidation and into the toxicity these compounds may have.
Although oxidation processes are not likely to completely mineralize organic
compounds in water, considerable research has shown that partial oxidation of many
recalcitrant compounds will substantially increase their biodegradability This principle
is increasingly used in water and wastewater treatment plants where an oxidation step
immediately precedes a biological process to facilitate removal of resistant compounds.
A good example is the drinking water treatment plant recently completed by the
Albuquerque Bernalillo County Water Utility Authority. This plant provides ozonation
immediately prior to biological filters that contain granular activated carbon. Preozonation achieves partial oxidation of refractory compounds that allows rapid
biodegradation by organisms attached to the GAC surface.
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Activated Carbon
This section examines the adsorption of microconstituents by granular activated
carbon (GAC) and powdered activated carbon (PAC). Activated carbon is an effective
adsorbent that is used for removing many dissolved compounds from water. GAC is
used in a fixed-bed process like granular media filtration whereas PAC is added to water
as a suspension, allowed to adsorb constituents from water, and then separated from the
finished water. Activated carbon can be used at several scales, ranging from as large as
full-scale municipal treatment systems to as small as water filters that can attach to the
end of a plastic bottle or faucet. GAC is most commonly incorporated in water treatment
facilities for (1) removal of trace contaminants and (2) removal of dissolved organic
carbon (DOC) [23]. Activated carbon will effectively remove many organic compounds
and the USEPA has designated GAC as a best available technology (BAT) for the
treatment of many regulated organic pollutants [40].

Mechanisms for microconstituent removal by adsorption
Activated carbon removes dissolved constituents from solution by adsorption.
Adsorption is a process in which compounds in the liquid phase accumulate on a solid
surface [23]. The adsorption process is used in drinking water treatment to remove
synthetic organic compounds (SOCs), disinfection by product (DBP) precursors, taste
and odor-causing compounds, and some inorganic compounds. The process involves the
adsorbate, the dissolved compound that undergoes adsorption, being transported via
diffusion into the porous absorbent, the solid onto which the adsorbate adsorbs. The
solute is attached to the absorbent surface thru either chemical bonds (chemisorption) or
physical attraction (physical adsorption).
Adsorption is dependent on time and the amount of surface area (capacity)
available for adsorption. Adsorption is an equilibrium process, so micropollutants in
water will partition between the water and carbon surface until the two are in equilibrium
with each other. Thus, presence of micropollutants on the carbon surface will also
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indicate micropollutants remaining in the water, although in many cases the remaining
micropollutant concentration in the water will be too low to measure.
Adsorption of microconstituents to activated carbon depends on properties of the
water, activated carbon, and the microconstituents [23]. Physicochemical properties
controlling adsorption are similar to those that control removal in reverse osmosis,
although with the opposite effect in some uses. More nonpolar, more hydrophobic, and
lower solubility compounds should be removed efficiently by carbon adsorption. For
activated carbon, lower MW compounds are more efficiently removed because of
increased accessibility to inner pores of the carbon, which is the opposite of reverse
osmosis. In addition, uncharged molecules are more efficiently removed by adsorption
(again, the opposite of reverse osmosis), because of the increased aqueous solubility of
charged compounds. The pH of the solution affects adsorption for ionic solutes for
several reasons. First, the charge on activated carbon is affected by pH. Generally,
activated carbon has a negative charge above pH of about 5, and is neutral between a pH
of 4 and 5. Adsorption of anionic constituents is thus greater below pH 4, but from an
operational standpoint, is not practical. The pH is also an important parameter for the
removal of acids and bases where the pH affects the charge of the solute.
Activated carbon has a nonpolar surface at a neutral pH [23]. Because water is a
polar liquid, nonpolar organics are more hydrophobic and have lower aqueous solubility.
Therefore, neutral hydrophobic compounds will have the strongest affinity to carbon
surface, and organic compounds that are polar, hydrophilic, or charged will not be
adsorbed as strongly due to strong water-adsorbate forces.
An implication of this removal mechanism is that compounds are not degraded or
destroyed, just transferred to the activated carbon surface. If carbon were regenerated,
compounds would then be destroyed during the regeneration process. If however, the
carbon is just discarded when it reaches capacity, PPCPs could be released to the
environment from the surface of the carbon.
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A second mechanism for micropollutant removal by activated carbon is
biodegradation by microorganisms living on the carbon surface. Ozone followed by
activated carbon can be an effective removal strategy because the ozone chemically
degrades compounds and makes them more biodegradable, and then the microorganisms
living in the carbon bed complete the degradation process. This process is commonly
called biofiltration.
Although activated carbon does have the potential to remove many
microconstituents to a relatively high degree, it does come with some drawbacks. One of
the drawbacks is that GAC must be regularly replaced or regenerated once breakthrough
has occurred. Studies have found that for hydrophilic compounds, breakthrough can
occur much more rapidly than in hydrophobic compounds [6, 34]. Vieno, et al. found
that the hydrophobic compound, carbamazepine, could be effectively removed by GAC
even after treatment of >70,000 bed volumes of water [34]. The same study found that
the more hydrophilic compounds could pass GAC treatment after only 2,000 to 3,000 bed
volumes of water. The regular regeneration or replacement of GAC could be quite
expensive, especially if the breakthrough of hydrophilic compounds is a concern.
Another concern with using GAC in treating wastewater is the amount of NOM in
the water. The presence of NOM can greatly reduce the removal efficiency of
microconstituents by activated carbon due to competition for adsorption sites [8]. This is
especially true for using GAC to treat wastewater due to the higher concentrations of
NOM in wastewater as compared to many other surface water sources.
One of the concerns in developing the processes used in this research was in
trying to develop a process that would both remove microconstituents well and be
affordable and easy to maintain. The regular regeneration or replacement of the GAC in
the process train would mean much more expense and maintenance. This goes against
the initial criteria used in developing a treatment process. Another drawback to using
GAC in the biofilter for this research project is in trying to account for which mechanism
is contributing to microconstituent removal in the biofilter. This is because
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biodegradation and adsorption are both present in the BAC column and it is difficult to
account for the degree of removal of microconstituents by each mechanism [41].

Biological Filtration
Biologically active filters use microorganisms attached to the filter media in a
column reactor to treat water. Biofiltration has shown that it can reduce chlorinated
DBPs, bacterial regrowth, and chlorine demand as well as control other compounds of
concern [42].
Biologically active filtration (BAF) is often follows an AOP such as ozonation to
improve the biodegradability of recalcitrant compounds [42]. This process uses ozone to
oxidize non-biodegradable organics into a biodegradable form that the active biomass on
the filter media use as an energy and carbon source. The non-biodegradable organics are
usually larger in MW. Ozone has the ability to oxidize and break down these larger
organics into smaller, more biodegradable compounds. Although there are many
different types of biological filters, this research is focused on single stage biological
filtration [42]. This process incorporates both particulate and biodegradable organic
matter removal into the same filter unit.
Because biologically active filters are a combination of two different processes,
several factors can contribute to their effectiveness. The first factor is the ozone dose.
Although it has been shown that a larger ozone dose will achieve a higher removal of
microconstituents, there are problems associated with using an increased ozone dose.
One problem is that most compounds do not exhibit a linear correlation between ozone
dose and compound removal. A 2006 study by Snyder et al. shows that for many
compounds additional removal was achieved with higher ozone doses, but the change in
percent removal decreased at the highest dose for many of the compounds [43]. Higher
ozone doses require more energy, which increases operating costs. Higher ozone doses
also produce more ozonation by-products, which is especially a problem in bromide-rich
waters. These disadvantages are examined further in the oxidation section.
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Another factor that can contribute to the effectiveness of a biologically active
filter in removing microconstituents is the type of filter media used. One of the most
common biofilter media used is GAC. GAC has shown that it can remove many
emerging micropollutants to a high degree, although as discussed in the section on
activated carbon, there are drawbacks to using GAC in a wastewater application. One of
the objectives of this research was to develop a process that can be operated for long
periods with little maintenance and low costs. Another goal was to properly account for
the microconstituent removal. In order to do this anthracite was used for the BAF media.
Anthracite is considered a non-adsorptive filter media [42]. It is frequently used
in granular media filtration for water and wastewater treatment [23]. While GAC and
anthracite are nominally the same material (pure carbon), the surface are of GAC is
orders of magnitude higher than anthracite, which leads to orders of magnitude more
adsorption capacity.
Both GAC and anthracite are used as biofilter media. Although GAC has a much
greater surface area per unit volume than anthracite, it is thought that little biomass
growth can occur inside the micropores of the GAC [42]. This makes the two medias
much more evenly matched in growing a biomass. The GAC does have the advantage of
being able to adsorb compounds; although once the adsorption capacity of the GAC is
exhausted it cannot simply be backwashed. The GAC must be regenerated or replaced to
regain its ability to adsorb compounds.
Another advantage of GAC is that it can quickly destroy any residual ozone. An
ozone residual can quickly compromise the biological performance of BAF using
anthracite. Because a GAC column quickly reduces the ozone residual, much of the
biological activity in the column remains unaffected. This is why care should be taken in
operating a BAF with anthracite to ensure that any ozone residual is removed before
entering the column.
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Although there are advantages to using GAC over anthracite, anthracite was used
as the media in the BAF column for this research. This is due to the cost implications
associated with using GAC and the ability to examine the contributions of biodegradation
in removing microconstituents from wastewater. By eliminating adsorption as a
contaminant removal mechanism, the project focus was on oxidation and biodegradation
processes.
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Chapter 3: Experimental Methods
A pilot system, consisting of an MBR, ozone contact chamber, RO system, and
BAF column, was continuously operated at the ABCWUA Southside Wastewater
Reclamation Plant (SWRP). The process flow diagram for the pilot system is shown in
Figure 3-1. The system was used to examine the removal of PPCPs/EDCs from
wastewater using two different treatment trains. One of the treatment trains consisted of
an MBR that fed an ozone contactor that then fed the BAF column. The other consisted
of the MBR followed by RO.
The MBR system was continuously fed primary treated wastewater throughout
the duration of the experiments and operated at an SRT of approximately 10 days. The
MBR produced an average of 175 mL/min of effluent, of which 100 mL/min was used to
feed the ozone contactor. The ozone contactor consisted of three chambers with each
chamber providing 5 minutes of contact time. The ozone contactor fed the BAF column,
which had an EBCT of 20 minutes. From here the water was stored in a reservoir with an
overflow. The reservoir was used to store enough water to backwash the BAF column
for 10 minutes at a flowrate of 1.6 L/min.
Due to the cost of each PPCP/EDC analysis, only 16 samples were analyzed. The
first PPCP/EDC sample was an MBR effluent sample collected on 8/18/09 that was used
to determine what compounds were in the wastewater. It was determined that 3 ozone
doses could be examined for PPCP/EDC removal. Each ozone dose sampling event
tested for PPCPs/EDCs in the MBR, ozone, and BAF effluents. Two of the three
sampling events also included samples from the RO effluent. A field blank and duplicate
samples of the MBR, ozone, and BAF effluents were collected for quality assurance
purposes. MWH laboratories performed the PPCP/EDC analysis, which included 83
compounds. In order to determine the ozone doses to analyze PPCP/EDC removal at, the
project was divided into two phases.
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Phase 1 of the project determined the ozone doses used to examine the removal of
PPCPs/EDCs. A series of analyses were done to examine the effects of various ozone
doses on different organic parameters. The bulk organic analysis consisted of TOC,
UV254 absorbance, SUVA, and BDOC. These parameters were measured at varying
ozone doses ranging from 0 to approximately 12 mg/L. Phase 2 of the project examined
the removal of both organics and PPCPs/EDCs. The bulk organic analysis in Phase 2
was used to both determine steady state conditions and to monitor organic removal at the
various ozone doses. At least one week was allowed for the BAF column to come to
steady state. The RO system was run for at least one day to allow the system to achieve
steady state conditions.
Besides the bulk organic and PPCP/EDC analysis, several other parameters were
monitored to ensure proper performance of all systems. Mixed liquor suspended solids
(MLSS) and mixed liquor volatile suspended solids (MLVSS) samples were collected
throughout the duration of the experiments to ensure proper MBR performance.
Dissolved oxygen (DO) measurements were taken daily to ensure proper performance of
both the MBR and the BAF column. Other system parameters were measured daily to
ensure proper performance of all the systems including pH, conductivity, temperature,
flowrates, and pressure. The indigo method, described in Standard Methods for the
Examination of Water and Wastewater (APHA, 2005), was used to measure both the
ozone dose and ozone residual, which were measured daily to ensure proper operation of
the ozone contactor. Detailed descriptions of each analysis can be found later in this
chapter. A full description of the design of each treatment process is given in the
following sections.

Process Design
For this research project, four pilot scale treatment processes were designed and
built from scratch. These processes consisted of a membrane bioreactor, an ozone
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contactor, a biologically active filter, and a reverse osmosis system. Initially, the project
was used by another graduate student and was further modified to meet the research goals
of this project. A schematic of the modified system used in this research can be found in
Figure 3-1.

Figure 3-1: Schematic of project setup for pilot system at the ABCWUA SWRP

The system was set up at the SWRP. The MBR effluent was split with 100
ml/min feeding the ozone contactor and BAF systems and the rest feeding into an RO
feed tank which then fed an RO system. The advantages of operating the system this way
is that it allowed for a side-by-side comparison of the oxidation/biofiltration process and
the RO process. Splitting the flow from one MBR ensures that both columns are
receiving a similar water quality and that the concentrations of the selected compounds
are similar for both effluents. Further detail about the design and operation of each of the
systems is described below.

34

MBR System Design
The MBR unit was first constructed and tested in the environmental engineering
lab at the University of New Mexico. The microfiltration units were constructed and
donated by Koch and consist of hollow fiber microfilter tubes. The membranes are
designed for submerged use with outside-in flow. The Koch microfilter was equipped
with an air feed that allowed for both air scrubbing of the membrane and proper aeration
of the tank. A Pondmaster model AP-40 that delivered approximately 1350 L/min was
used to provide air to the Koch microfilter. Due to insufficient aeration of the tank, a
second air pump was needed. A Pondmaster model AP-100 with a flow of 4300 L/min
was used to supply air to a system of fine air diffusers that kept the DO in the tank at
around 6 mg/L. Figure 3-2 shows a picture of the supplemental air delivery system.
Peristaltic pumps were used for both the MBR effluent and the wasting lines. The
flow rates were calibrated with a graduated cylinder and stopwatch as described in the
flowrates method and procedures section. The system used a ChronTrol-XT table top
timer to shut off the peristaltic pump for the effluent. The pump was shut off every 10
minutes for one minute in order to relax the membrane and keep pressure from building
up. This allowed the membrane to maintain a higher flux for longer periods of time
between cleanings. To measure the pressure and calculate the flux through the
membrane, a pressure gauge and transducer were used. The pressure transducer was
monitored by a LabView data collection system, which also monitored the RO feed
pressure, and temperature.
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Figure 3-2: Photo of supplemental air supply system for MBR tank

The MBR influent flow was controlled by a float valve that kept the volume of
wastewater in the tanks constant. A second float valve was installed to ensure that if the
first one clogged, the system could keep running. Due to problems with high pressure
and solids in the influent feed, a standpipe was used to keep the influent flowing into the
tank consistent and stable. A low flow switch was installed in the tank just above the top
of the membrane. If the water level in the tank became too low, the low flow switch
would shut off the pump, which would keep the membrane from drying out. The volume
of the tank, as well as the effluent and wasting flow rates used to establish the solids
retention time (SRT) and hydraulic retention time (HRT) can be found in Table 3-1
below.
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Table 3-1: MBR design parameters

Design Parameter

Value

SRT
HRT
Effective Tank Volume

10.0 days
9.0 hours
23.2 gallons (87.9 L)
16.1 ft2 (1.5m2)

MF surface area

Flowrates
Waste
Influent
Effluent

0.0016 gpm (6 mL/min)
0.048 gpm (181 mL/min)
0.046 gpm (175 mL/min)

A wasting tank was used to collect all overflow and final effluent streams from
the system as well as the wasting flow from the MBR tank. From the wasting tank the
flow was diverted through a hose, down to a sump. Prior attempts to waste streams
separately through hoses failed due to clogging of the hoses. The wasting tank provided
an easy and reliable way to collect and waste the various sources of water.
In order to maintain a constant and accurate flow to the ozone contactor a
standpipe was installed after the MBR effluent pump. From the standpipe a peristaltic
pump fed the ozone contactor at 100 mL/min and the overflow fed the RO feed tank.
This configuration kept the flow to the ozone contactor steady, even when the MBR
effluent pump was shut off to relax the membrane.

Ozone Contactor Design
The ozone contactor consisted of three columns. This system is similar in design
to the one used by Huber et al. (2005) [44]. A schematic of the system is presented in
Figure 3-3. Effluent from the MBR is pumped into the top of the first column where it
runs countercurrent to the ozone being bubbled in at the bottom through a glass diffuser.
The ozone is generated with an Ozone Lab OL80W ozone generator that uses
compressed USP oxygen to create the ozone.
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Figure 3-3: Diagram of ozone contactor

The water then flows up the second column for additional contact time. From
here, the water flows into the top of the third column while air is being diffused into the
bottom of the column in a countercurrent direction. The air is supplied by an
Aquaculture 20-60 gallon aquarium air pump and is provided to strip off any residual
ozone still in the water. This is important because the ozone could inactivate microbes in
the BAC column. The column diameter, height, and total volume give a total hydraulic
detention time of 5 minutes for each column. The parameters for this design can be
found in Table 3-2.
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Table 3-2: Ozone contactor design parameters

Design Parameter
Flowrate
HRT
Column Height
Column diameter
Column area
Column Volume

Value
100 mL/min (0.026 gpm)
5 min
0.44 m (1.44 ft)
0.038 m (0.125 ft)
0.0011 m2 (0.0123 ft2)
0.0005 m3 (0.0177 ft3)

All components used in the ozone contactor were composed of glass, stainless
steel, or other ozone resistant materials. This precaution is necessary because ozone is
very corrosive to many materials. This can not only corrode any non ozone resistant
materials, but also contaminate the water with ozone byproducts caused by interactions
between the ozone and the components.
The Ozone Lab OL80W ozone generator has an adjustable gas rotameter and a 10
turn, high precision, ozone output regulator that allowed for more precise control of the
amount of ozone produced. The flow of oxygen was controlled by an oxygen flow
regulator with a CGA 540 connection from Responsive Respiratory Inc. Since the
rotameter was found to be inaccurate, ozone production was controlled by measuring the
flow of air and adjusting the ozone output regulator.
This design offers a simple yet effective way to introduce ozone into the system.
The three different sampling ports at the end of each column allow for ozone residual
measurements at 5, 10, and 15 minute intervals, as well as TOC and microconstituent
sampling. The three way valves in the off gas allow minimal interruption to the ozone
gas flow while measuring the applied ozone dose.
The effluent from the ozone contactor flowed into a small reservoir where it was
pumped to the top of the BAF column using a peristaltic pump. The reservoir and pump
were required because the top of the BAF column was much higher than the ozone
contactor. The flowrate on the peristaltic pump was set slightly higher than the 100
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mL/min going into the reservoir. This was done to ensure that all of the water leaving the
ozone contact chamber would be sent to the BAF column. As a precaution, an overflow
was built into the reservoir that fed directly into the wasting tank so if the flow from the
reservoir dropped below 100 mL/min, the system would not back up.

Biologically Active Filter Design
Following the ozone contactor, the water was pumped to the top of the BAF
column, which was the last process in the treatment train. The media in the BAF column
consisted of anthracite that was first seeded with MLSS and soaked in MBR feedwater
for a week to establish a bio-growth prior to the experiments. The system was run for at
least one week between sampling events to establish steady state conditions at each new
ozone dose.
The BAF column consisted of a 2” diameter, clear PVC pipe. In order to get an
EBCT of 20 minutes the height of the anthracite media was 3.24 feet (0.99 m) for a total
volume of 0.071 ft3 (0.002 m3). An EBCT of 20 minutes was chosen to allow for the
maximum amount of biodegradation by the BAF column, which is comparable to that in
the GAC-biological filters used in the ABCWUA’s San Juan Chama drinking water
treatment plant. The dimensions and parameters for the BAF column are listed in Table
3-3 below.
Table 3-3: BAF column design parameters

Design Parameter
Flowrate
Carbon Height
Column diameter

Value
100 ml/min (0.026 gpm)
0.99 m (3.24 ft)
0.051m (0.167 ft)

Column area

0.002 m2 (0.022 ft2)

Carbon Volume
EBCT

0.002 m3 (0.071 ft3)
20 min

Column loading rate
Backwash flow rate

2.96 m/hr (1.12 gpm/ft2)
1.6 L/min (0.42 gpm)

Backwash loading rate

47.4 m/hr (19.4 gpm/ft2)
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A standpipe was used to ensure the BAF media was constantly submerged. The
flow from the BAF column would enter the bottom of the standpipe. The flow would
exit the top of the standpipe which was situated a couple of inches higher than the
anthracite media ensuring the media stayed submerged. This can be seen in the
schematic of the BAF column found in Figure 3-4. After exiting the standpipe, the water
would flow to a 12-gallon reservoir to store treated water for backwashing the column.

Figure 3-4: Schematic of BAF system
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The column was backwashed between each ozone dose to maintain performance.
Prior to the first two backwashes, the head on the column was over 30 inches, which was
almost to the overflow near the top of the column. To reduce the head the column was
backwashed with a peristaltic pump using water stored in the final effluent reservoir.
Using the average values for anthracite and the design equations found in Water
Treatment Principles and Design, Crittenden et al. (2005), a backwash flowrate of 1.6
L/min, which corresponds to a backwash loading rate of 47.4 m/hr (19.4 gpm/ft2), was
used to achieve 50% bed expansion during backwashing. The backwash was done for 10
minutes, which reduced the head to between 8 and 9 inches above the anthracite media.
One of the major obstacles in using a BAF column for research purposes is
ensuring the column is at steady state. Toor et al. (2007) tried to validate that the BAC
columns operated under steady state conditions through a heterotrophic plate count
(HPC) and visual inspections of bacterial colonies [45]. Similar methods were used by
Liang et al. (2003) [41]. The decision was made not to use these methods but instead to
examine the TOC, UV254 absorbance, SUVA, and TOC removal of each process. The
results for these parameters are found in the Results section. It was decided that the HPC
method was too vague, and that there were too many variables to account for, even while
following the procedures in Standard Methods.

Reverse Osmosis
The alternative process train to the MBR-ozone-BAF column was the MBR-RO
treatment train. Literature has shown the RO process to be very effective in removing
most micropollutants to a high degree although there are a few compounds that are still
present in the RO effluent at highly reduced concentrations. A better understanding of
how well the proposed process treatment train effectively removes microconstituents can
be achieved through a side-by-side analysis with a process that the literature has shown to
be effective in removing microconstituents from wastewater.
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The RO unit was designed by Dr. Kerry Howe and constructed in the machine
shop in the Physics department at the University of New Mexico. A picture of the unit is
shown in Figure 3-5. The unit consists of six machined plates where up to five flat sheet
RO membranes could be run in series. Osmonics AG RO membranes (proprietary
polyamide thin film membranes) were cut to size and fitted between the plates. The unit
was designed so that the system could run with as many as five and as few as one
membrane. For this project, the RO unit was operated with 3 membranes.

Figure 3-5: Picture of the RO Unit

For this research project, feedwater from the RO feedtank was pumped into the
bottom RO cell where it flowed across the membranes. Permeate passed through the
membrane at an average rate of 3.2 mL/min per membrane for a total unit permeate flow
of 9.5 mL/min. The concentrate passed through the series of plates until it is recycled
back into the RO feed tank. Due to the low flux of permeate across the membranes, the
system recycles concentrate into the feed tank allowing for the water to become more
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concentrated which simulates conditions associated with higher recovery. Design
parameters for the RO unit are found in Table 3-4. All parameters except permeate flow
and recovery are actually average values taken by Elizabeth Field during her master’s
thesis research.

Table 3-4: Table of RO parameters

Design Parameter
RO membrane length
RO Membrane width
Channel depth
Effective membrane area

Value
0.200 m
0.080 m
0.000508 m
0.016 m2

Feed channel cross sectional area
Feed flow velocity

4.06E-5 m2
0.015 m/s

Permeate flux
Feed flow
Permeate flow (average per
membrane)
Concentrate flow
Average Recovery
Flow to feed tank
Average system recovery

20 (L/m2-hr)
0.366 L/min
0.0032 L/min
.356 L/min
78.7%
0.075 L/min
21.3%

The RO unit was turned on the day before microconstituent samples were taken.
The day before that the RO feed tank was filled by diverting the overflow from the
standpipe feeding the ozone contactor. The RO feedtank filled at an average flowrate of
75 mL/min.

Sampling and Analysis Procedures
With any research, one of the most important aspects is ensuring that sampling,
analysis, and system operations are performed consistently and properly throughout the
experimental process. This research called for most parameters to be measured daily
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including system parameters such as flowrates, DO, and pH, and lab analysis such as
TOC and UV254. A list of these parameters along with testing frequency and location are
found in Table 3-5.

Table 3-5: System parameters, testing frequency and location, and data use
Parameter

Frequency

pH

Everyday

DO

Everyday

Temperature

Everyday

EC

Everyday

Pressure
Flow
MLSS
MLVSS
TOC
BDOC
Ozone dose
Ozone
residual

Continuously
Everyday
3 times per
sampling event
3 times per
sampling event

Location

Data use

MBR, Ozone, BAF, and RO
effluent
MBR, Ozone, BAF, and RO
effluent
MBR, Ozone, BAF, and RO
effluent
MBR, Ozone, BAF, and RO
effluent

Ozone contactor

Proper system
operation
Proper system
operation
Proper system
operation
Proper system
operation
Proper system
operation
Proper system
operation
Proper system
operation
Proper system
operation
Analysis of
treatment train
Analysis of
treatment train
Proper system
operation
Proper system
operation

MBR, Ozone, BAF, and RO
effluent
MBR, Ozone, BAF, and RO
effluent

Analysis of
treatment train
Analysis of
treatment train

MBR effluent and RO feed
MBR, Ozone, BAF, and RO
effluent
MBR tank

Everyday
3 times per set
ozone dose

MBR tank
MBR, Ozone, BAF, and RO
effluent
MBR, Ozone and BAF
effluent

Everyday

Ozone contactor

Everyday
3 times (once at
PPCP/EDC
end of every ozone
concentrations
dose)
UV254
absorbance
Everyday
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Sampling and Cleaning Procedures
To achieve the most accurate and reliable results possible, extreme care was taken
to ensure all lab and sampling equipment was as clean as possible. This was achieved by
adhering to the methods and procedures described in Standard Methods for the
Examination of Water and Wastewater (APHA, 2005). A list of procedures, instruments,
and parameters is shown in Table 3-6.
Table 3-6: Measured parameters, instruments, and procedures

Parameter
pH
EC
Temperature
DO
Ozone dose
Ozone residual
TOC
BDOC
MLSS/MLVSS
UV254 absorbance

Instrument
Oakton pH/CON 10 Series
Meter
HACH HQ40d DO Meter
HACH DR 890 Colorimeter
Tekmar Dohrmann Phoenix
8000
NA
Varian Cary 50 Conc UV/Vis
Spectrophotometer

Procedure
SM 4500-H+ B
SM 2510 B
SM 2550 B
SM 4500-O G
See Ozone procedure
SM 4500-O3 B
SM 5310 C
See BDOC procedure
2540 G
5910 B

Sampling was done with plasticware that was thoroughly washed with soap and
water. The plasticware was then rinsed with DI water and inverted while drying to
ensure dust did not collect in the container. The glassware cleaning procedure includes
the same procedure for the plasticware with an additional soak in a 10% nitric acid bath
for at least one hour. The TOC vials followed the same procedure except they were
soaked for 24 hours in the acid bath and then capped with aluminum foil. The vials were
then baked at 550 ºC for an hour and wrapped in foil to keep them from being
contaminated. The TOC vial cleaning procedure follows Standard Methods 5310 B.1d
except that the vials are baked at 550 ºC instead of 400ºC.
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TOC Sampling and Analysis Procedure
The TOC data gathered for this research was used for many different reasons and
ended up being one of the most important parameters examined. The TOC data was used
to not only check the performance of the MBR system, but was also used to ensure the
system was at steady state, measure BDOC, and to examine the amount of degradation of
organics in each process. Because of this, the methods and procedures for sampling and
analyzing TOC follow those in Standard Methods and care was used to ensure consistent,
accurate data.
Sampling for TOC was done every day at several different locations in the
treatment train. These locations can be found in Table 3-5. Grab samples were collected
with clean plasticware and brought back to the lab for filtering and pH adjustment shortly
following sampling. The samples were vacuum filtered through a 0.7 μm binder-free
glass fiber filter (GF/F Whatman). Samples of 250 mL were collected every day except
on days that included a BDOC analysis. In that case, 500 mL samples were collected
instead. All samples were analyzed within 6 days of collection with most being analyzed
in 3 days or less.
TOC analysis was done in accordance with Standard Method 5310 C (persulfateultraviolet oxidation method) using a Tekmar-Dohrmann Phoenix 8000 TOC analyzer.
To ensure accuracy, two sets of standards (2 mg/L and 10 mg/L TOC) were run at the
beginning and end of each set of analysis. Due to slight discrepancies in these standards
before the experiments began, a new calibration curve was developed using KHP in
concentrations of 0, 2, 6, 10, and 20 mg/L TOC.

UV254 Sampling and Procedures
Another important parameter examined in this research was UV254 absorbance.
Like TOC, UV254 absorbance is often used as a surrogate for the concentration of NOM
[23]. In addition, a recent study by Bahr et al. (2007) concluded that there is a good
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correlation with UV254 absorbance between the specific ozone consumption and the
removal of micropollutants [46]. The analysis for UV254 absorbance for this project
followed the procedures in Standard Methods 5910-B using a Varian Cary 50 UV/Vis
spectrophotometer. Sampling for UV254 absorbance was taken every day for the MBR,
ozone, and BAF effluents as well as for the days the RO system was operating. For the
RO system, samples were collected in the RO tank and permeate effluent. All samples
were collected in clean TOC vials and tested within hours of collection.

SUVA
The specific UV absorbance (SUVA) parameter is the ratio of the UV254
absorbance to the TOC concentration. The formula is given by Equation 1:
SUVA = 100 * UV254/TOC

[1]

The SUVA parameter was used to determine how well a treatment process may
work in removing NOM [23].

SUVA can be used to measure how easily degradable

organics are. Because of these factors, the SUVA parameter was found to be very
important for many aspects of this research including its use in determining steady state
conditions, how well the system treated TOC, and in predicting the removal of
micropollutants based on the applied ozone dose.

BDOC Procedure
Unlike many of the other parameters used in this research the BDOC procedure is
not listed in Standard Methods. Biodegradable dissolved organic carbon (BDOC) is a
parameter that is widely used to quantify biodegradable organic matter (BOM) in
drinking water [47]. In 1998, Khan et al. (1998) developed a modified batch procedure
for determining BDOC in wastewater [47, 48]. The development of this procedure
allowed BDOC analysis to be done on municipal water reclamation and secondary treated
wastewaters with relatively low DOC concentrations. Although this procedure reduces
variability and increases precision compared to BOD and COD, the 28-day incubation
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period required can be a large drawback, especially if results are needed much sooner. In
1999, Khan et al. (1999) described a modified method so that the procedure could be
done in just 5 days and included both ozonated and non ozonated secondary effluent
samples [47]. This refined procedure was used in these experiments to determine the
BDOC for the MBR, ozone, and BAF effluents, although further modifications were
made.
The refined procedure in Khan et al. (1999) calls for the concurrent determination
of SBOD5 with BDOC. It was determined that the SBOD5 parameter was not needed.
Because of this, modifications to the procedure could be further made to ensure better
accuracy and consistency. Instead of using 300 mL BOD bottles that were water sealed,
glass bottles of at least 500 mL of volume were used. In addition, the modified bottles
were only filled with 250 mL of undiluted sample. This was to ensure that there was
enough oxygen in the bottles to allow for maximum biodegradation. Initial tests that
followed the original method described by Khan et al. (1999), showed that after 5 days
most of the samples, including those diluted by a factor of 4:1, were below the final
dissolved oxygen concentration limit of 1 mg/L. This means that biodegradation of the
organics could have been incomplete due to a lack of oxygen. Further testing showed
that reliable BDOC measurements could be achieved using the 500 mL bottles with no
dilution and 250 mL of sample.

BDOC Equipment
•

500 mL bottles, preferably with airtight lids or glass stoppers

•

0.7 µm glass-fiber filter (GF/F Whatman, Whatman International Ltd.)

•

DI water (containing less than 0.20 mg/L TOC)

•

Incubator at 37 ºC

•

Clean 500 mL and 250 mL plasticware for sampling
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•

TOC vials and TOC analyzer

•

Freshly collected MLSS (used as inoculum)

•

Pipettes with wide mouthed tip

Methodology
The modified BDOC procedure used in this study is based on the method described in
“Method development for measuring biodegradable DOC in reclaimed and treated
wastewater” by Khan et al. (1998) [48]. Included is the refinements made in “Factors
influencing biodegradable dissolved organic carbon measurement” by Khan et al (1999)
[48] as well as the in house modifications mentioned above.
The cleaning method for all TOC vials, plasticware, and glassware used in this
procedure can be found in the section on sampling and cleaning procedures. All
glassware was thoroughly washed with soap and water, rinsed with DI water, soaked for
at least 1 hour in a 10% nitric acid bath, and then rinsed again with DI water. The step by
step procedure is as follows:
•

Rinse a 0.7 μm glass fiber filter (GF/F Whatman) with 300 mL DI water,
containing a TOC content of <0.2 mg/L.

•

Filter sample through a 0.7 μm glass fiber filter (GF/F Whatman)
o Waste first 50 mL of sample.

•

Place samples in a washed glassware with at least 20% gas volume.

•

Saturate the sample with DO by shaking.

•

After shaking, collect two, 40 mL samples in clean TOC vials and measure TOC.
o Record as TOCi.

•

Next, place mixture in washed glassware that is at least 500 mL in volume.

•

Add 2 mL of unfiltered inoculum (2 mL of MLSS). This is part of the modified
version by Khan et al. (1999). The MLSS should be used, without pre-rinsing,
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within 24 hours. The well mixed inoculum should be added with a wide tipped
pipette.
•

Incubate in the dark for 5 days at 37° C.
o Note: The original procedure calls for 28 days at 20° C, but the modified
version from Khan et al. (1999) gives these variations.

•

The samples are then filtered through GF/F filters and two, 40 mL samples
collected and measured as DOCf.

•

A seed control, sample b, was prepared in the same way except that the 2 mL seed
was added to 250 mL of DI water (TOC <0.2 mg/L) with no sample and the
values were recorded as DOCbi and DOCbf. The DOCbi measurement does not
include the 2 mL of MLSS.

•

The BDOC can then be found using Equation 2 below.

BDOC (mg/L) = [(DOCi- DOCf) –(DOCbi –DOCbf)]

[2]

Ozone Residual and Applied Dose Procedure
One of the challenging aspects of this research was to develop an accurate,
reliable, and inexpensive procedure to measure both the applied dose of the ozone and the
residual ozone at different points in the ozone contactor columns. One of the
complicating aspects was that the ozone measurements needed to be done in the field.
This means that any apparatus used would have to be not only portable, but also able to
hold up to the harsh environment at the pilot system set up at the SWRP. After reviewing
Standard Methods, as well as several journal articles, a technique was found and further
developed that meets all the criteria stated above.
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A HACH DR 890 colorimeter was purchased and tested in the lab to ensure its
accuracy. This instrument was chosen because it could accurately measure ozone and
was portable, reliable, and affordable.
One of the key elements in developing a procedure to measure ozone was that it
had to measure ozone in the feed gas and off gas as well as in the ozone contactor
effluent. There are a couple of different methods that could have been used to measure
the ozone residual in the chambers. One of them included using HACH AccuVac ampuls
and a calibration curve that was preprogrammed into the HACH DR 890 Colorimeter.
The problem with this method is that it could not be used to measure ozone
concentrations in the gas. The other method involved programming a calibration curve
into the instrument and following Standard Methods 4500-O3 B, the indigo colorimetric
method. This method was chosen because it could be further modified to measure ozone
concentrations in the off gas.

Equipment
The following equipment was used to measure ozone in the off gas as well as
residual concentrations in the water.
•

5 mm Precision Seal® rubber septa cap

•

1” piece of ozone resistant tubing with 5 mm ID

•

3 way, luer lock valve (Kynar or other ozone resistant material)

•

5 ml Gastight®, Hamilton syringe with 22 gauge, noncoring needle

•

Indigo Reagent II (SM 4500 O3 B)

•

Glass 50 mL graduated cylinder

•

5 mL pipette
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•

Parafilm

•

Two, 25 mL HACH sample vials

•

Two, 100 mL volumetric flasks

•

50 mL, Erlenmeyer flask

Before using the HACH DR 890 series colorimeter, a calibration curve was made and
entered as a program into the instrument. To ensure the accuracy of this program and the
procedure used to measure the ozone in both the residual and off gas, side-by-side
analyses were done in the lab with procedures and instruments known to be accurate.
Confidence in both procedures was established before using them in the field.
For ozone residual measurements, the ozone concentrations produced by the HACH
instrument were compared to analysis done following Standard Methods 4500 O3 B using
a Varian Cary Conc UV/Visible Spectrophotometer. The procedure developed closely
follows the indigo colorimetric method in Standard Methods and is described in detail
below.
For gaseous ozone, concentrations were measured in the lab using the Varian Cary 50
Conc UV/Visible Spectrophotometer. A molar absorptivity of E = 2950 M/cm was
assumed and the absorbance was measured at 258 nm, as suggested in Standard Methods
4500 O3 B. The data was then compared to the measurements taken by the HACH DR
890 Colorimeter using the method described below. A 1:1 stoichiometric ratio is
assumed for the reaction between the ozone and the indigo for both the residual and off
gas measurements [49].

Ozone Residual Procedure
To measure the ozone concentration in the residual, two 100 mL volumetric flasks
were prepared with 10 mL each of indigo reagent II added with a clean pipette. The first
volumetric flask is then filled to the mark with DI water. This blank can be used
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repeatedly for up to four hours. The volumetric flask for the residual sample may need to
be diluted with DI water depending on the concentration of the residual ozone in the
sample. This dilution is factored into equation 3, which is used to calculate the
concentration of ozone in the residual. After adding the correct amount of DI for
dilution, the volumetric flask was filled to the line with sample water, being careful not to
let the sample run down the side of the flask. The top of the flask was quickly covered
with parafilm and inverted repeatedly for 30 seconds. Next, the blank sample was added
to a clean 25 mL HACH sample vial. The vial was pre-rinsed with a small amount of the
sample first. After that, at least 10 mL of the sample is added. After ensuring the vial
was free of air bubbles, dust, or any other material, an accurate absorbance reading was
taken. This procedure was repeated with another 25 mL HACH sample vial for the
residual sample. The HACH instrument was turned on and set to the user-entered
program. The sample vial was inserted into the HACH DR 890 colorimeter, and the cap
closed to ensure there was no light interference. The “Blank” button on the control panel
was then pressed. Note: Because the ozone bleaches the indigo solution, the actual
sample was read as the blank. The sample was then taken out and replaced with the
blank, again ensuring the cap was on correctly. The “Read” on the instrument panel was
then pressed. An ozone concentration, CH, was taken and used in equation 3 to find the
ozone residual, COR.
COR = CH*VT/VS
Where:
COR = Concentration of ozone residual (mg/L)
CH = Concentration of ozone reported by the HACH instrument
VT = Total volume of sample with DI water, usually 90 mL (mL)
VS = Volume of sample added (mL)

[3]
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This measurement was taken twice and averaged for each chamber in the ozone
contactor, except when there was no ozone in the preceding chamber. Then the chamber
was assumed to have zero residual, although occasional measurements were taken to
ensure this was true.

Ozone feed and off gas procedure
Measuring the concentrations of ozone in the feed gas and off gas was used to
find the applied ozone dose, the mass of ozone per volume applied to the reaction
chamber. Some of the methods described in an article by Chiou et al. (1995) were used
to develop ozone gas concentration measurements used in this research [49]. This
measurement uses the same user-entered calibration curve used to measure the ozone
residual. A ratio of 9:1 of DI water to indigo was used. This means that if 2 mL of
indigo solution was used, 18 mL of DI water was also added. This was done to ensure all
ozone gas measurements were consistent and so that the same calibration curve used to
measure residual ozone could be used. The same 9:1 ratio was used in measuring the
residual ozone.
The first step in measuring the ozone gas concentration was to prepare the
syringe. A clean 5 ml Gastight® Hamilton syringe was first prepared by adding the
proper amount of indigo solution. The amount of indigo solution varied by 0.5 mL
increments and was chosen so that the ozone measurement with the HACH colorimeter
read between 0.1 and 0.5 mg/L with optimal readings at the higher end. Initial test results
in the lab showed readings greater than 0.5 mg/L were not reliable due to the indigo
solution becoming too bleached for the HACH colorimeter to reliably measure.
Next, the proper amount of DI water was measured in a clean 50 mL graduated
cylinder and added to a 50 mL Erlenmeyer flask. As mentioned earlier, a 9:1 ratio of DI
water to indigo solution was used. After this was complete, the ozone gas was ready for
sampling. The syringe was inserted into the septa to where the tip of the syringe is just
visible past the luer lock connection. After that, the tubing with syringe was attached to
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the 3-way valve via the luer locks. A picture of the tubing, syringe, and three-way valve
are shown in Figure 3-6. Next, the 3-way valve was quickly and smoothly turned to
where the ozone gas was open to all 3 ports. At the same time, the syringe was inserted
as far as it would go. As soon as this happened, gas was immediately pulled through the
syringe. Care was taken to do this in a smooth motion and as quickly as possible. The
syringe was then filled with the predetermined amount of gas. Care was also taken in this
step since being off by as little as 0.1 mL can mean a difference of up to 20% for some
measurements. Next, the syringe was carefully pulled out of the septa and gently shaken
for one minute. At the same time, the 3-way valve was switched back to its original
position and the tubing with the septa was detached. After the minute of shaking, the
contents of the syringe were injected into the Erlenmeyer flask with the predetermined
amount of DI in it. The flask was then covered with parafilm and inverted several times
to ensure the sample was properly mixed and diluted. Next, the 25 mL HACH sample
vials were prepared the same way as when measuring the ozone residual. The vials were
pre-rinsed with a small amount of sample. Then, at least 10 mL of sample was added to
the vials and the ozone concentration measured. Equation 4 was used to get the true
ozone off gas concentration, Y. The same procedure was used to measure the ozone
concentration in both the feed gas and off gas.
Y = VDI*CH/Vg

[4]

Where:
Y = Concentration of ozone measured in the gas (mg/L)
VDI = Volume of DI water (mL)
CH = Concentration of ozone reported by the HACH instrument
Vg = Volume of off gas added
To find the applied ozone dose, a mass balance was done around the first ozone
contact chamber. This can be seen in Figure 3-7. The volumetric water flowrate was
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measured daily and the volumetric flow rate for the gas was measured at least every other
day to ensure accuracy. The procedures for measuring the flow rates can be found below
in the section on flowrate method and procedures. The applied ozone dose is given by
Equation 5.
Cf = Qg/Qw*(Yi-Yf)
Where:
Qg = Volumetric flow of gas (L/min)
Qw = Volumetric flow of water (L/min)
Cf = Applied ozone dose (mg/L)
Ci = Initial ozone concentration in water = 0 (mg/L)
Yi = Initial ozone gas concentration (mg/L)
Yf = Final ozone gas concentration (mg/L)

[5]
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Figure 3-6: Picture of gas tight tubing with syringe and 3 way valve

To ensure accuracy, both the feed gas and off gas were measured three times and
the average of the three measurements was used for each. This was done for several
reasons. As described below, several small measurements must be taken in order to
calculate the concentration of the off gas. These include measuring out the amount of DI
water, indigo solution, and ozonated gas. Although the errors in each one of these is
quite small, they can add up. In addition, the precision of the HACH DR890 colorimeter
is less than that of the UV/Vis spectrophotometer. The HACH instrument is precise to 2
significant digits while the UV/Vis spectrophotometer in the lab reports 4 significant
digits. This difference alone can cause inaccuracies of a few percent. The initial lab
results showed that a more reliable and accurate value is achieved by averaging the ozone
gas concentrations measured with the HACH instrument.
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Figure 3-7: Schematic of mass balance around the first ozone contact chamber

Flowrate method and procedures
For this project, measuring and recording accurate flow rates was crucial in
providing proper system operation. Accurate flow rate measurements are vital to
calculating the SRT, HRT, and applied ozone dose. This ensures the data collected for
this research project is both reliable and reproducible and that the system is running
properly.
Because of the harsh environment at the pilot system, the initial flow meters used
to monitor the MBR effluent flow did not last long. In addition, the flow rates
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established by the peristaltic pumps and used to measure the wasting and MBR effluent
flows were found to be inconsistent and unreliable over time. Because of this, it was
established early on that the flow rates would have to be measured by hand with a
stopwatch and graduated cylinder.
The flow rates for the MBR, ozone, and BAF effluents were established with a
stopwatch and 100 ml graduated cylinder. This can be found in Equation 6. For the
wasting flow rate, the volume was measured after 3 minutes of wasting flow into a 50 mL
graduated cylinder. The flow rate for the RO permeate was measured using a calibration
column were the initial and final volumes were measured over time using a stopwatch.
Q = V/t

[6]

Where:
Q = Volumetric flow rate
V = Volume
t = Time measured with stopwatch

The flow rate for the volumetric gas flow was found by diverting the flow of gas
from the ozone generator to the ozone contact chamber. The diverted flow was used to
fill an inverted 100 mL graduated cylinder that was full of water. The air would fill up
the cylinder over time and a flow rate could be established. The flow rate was measured
twice and the results averaged. Because the results for this method varied little from day
to day, this flowrate was occasionally measured every other day although most of the
time this measurement, along with the other volumetric flowrates listed in this section,
were taken daily. This is because small changes in either the volumetric gas or water
flowrate could change the applied ozone dose by a few percent.
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PPCP/EDC sampling
Due to the extremely small concentrations of microconstituents and the
complexity of the treated wastewater, the PPCP/EDC analysis was done by an outside
lab. MWH labs was contracted to do the PPCP/EDC analysis for sixteen samples
including one field blank and one initial sample from the MBR effluent used to determine
what compounds might be found in future sampling events. The sampling schedule,
including sampling locations, can be found in Table 3-7.

Table 3-7: Sampling schedule for PPCP/EDC analysis

Date

Sample Location

Data Use

# Samples

18-Aug-09

MBR effluent

Initial sample

1

29-Oct-09

MBR, BAF, and ozone
effluent and the field
blank

Samples for 8 mg/L
ozone dose

4

Samples for 4 mg/L
ozone dose

7

Samples for 2 mg/L
ozone dose

4

6-Nov-09

13-Nov-09

Duplicates for MBR,
BAF, and ozone effluents
and 1 sample for RO
effluent
MBR, BAF, RO, and
ozone effluents

The analysis done by MWH labs uses LC-MS-MS by electrospray positive and
negative modes to analyze 83 microconstituents using samples of less than 40 mL. Most
of the compounds can be quantified in concentrations of 5 ng/L. A list of the compounds
tested for and their detection limits can be found in Table 3-8.
Samples were shipped to MWH labs via next day air. The samples were grab
samples collected in 40 mL vials sent by MWH labs. The sample vials came ready to use
with the preservatives already inside. For each sample, two vials were filled. Before
taking the samples, hands were thoroughly cleaned with soap and water. Gloves could
not be worn while sampling and special precautions such as not wearing fragrances, or
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smoking were done to prevent contamination. The vials were wrapped in protective
plastic and put in a cooler with pre-frozen cooling packs to keep the samples preserved
while shipping.

Table 3-8: PPCPs and EDCs analyzed by MWH laboratories
Analyte
1,7-Dimethylxanthine
4-Nonylphenol
4-tert-Octylphenol
Acetaminophen

Detection
Limit (ng/L)

Analyte

Detection
Limit (ng/L)

Analyte

Detection
Limit (ng/L)

20 Progesterone
10 Propylparaben
5 Sucralose
5 Sulfachloropyridazine

Albuterol
Amoxicillin
Andorostenedione
Atenolol
Bendroflumethiazide
Bezafibrate
BPA
Butalbital
Butylparaben
Caffeine
Carbadox
Carbamazepine
Carisoprodol
Chloramphenicol

5 Dilantin
10 Erythromycin
10 Estradiol
5 Estrone
Ethinyl Estradiol 5 17 alpha
20 Ethylparaben
5 Flumeqine
5 Furosimide
5 Gemfibrozil
5 Ibuprofen
10 Iohexal
5 Iopromide
5 Isobutylparaben
10 Ketoprofen
5 Ketorolac
5 Lidocaine
5 Lincomycin
10 Lopressor

Chloridazon
Cimetidine
Cotinine
DACT

5 Meclofenamic Acid
5 Meprobamate
10 Metazachlor
5 Methylparaben

5 Propazine
5 Chlorotoluron
5 Atrazine
20 Cyanazine

5
5
5
5
5

5 Sulfadiazine
20 Sulfadimethoxine
10 Sulfamerazine
10 Sulfamethazine
5 Sulfamethizole
10 Sulfamethoxazole
10 Sulfathiazole
5 TCEP
5 Theobromine
5 Theophylline
5 Triclosan
5 Trimethoprim
10 Warfarin
20 Simazine

DEA

5 Naproxen

10 Bromacil

DEET
Dehydronifedipine
DIA
Diazepam
Diclofenac

2 Nifedipine
5 Norethisterone
5 Oxolinic acid
5 Pentoxifylline
5 Primidone

20 Diuron
5 Linuron
5 Isoproturon
5 2,4-D
5

5
5
100
5
5
5
5
5
5
10
5
5
5
10
10
10
5
5

5
5
20
5
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A field blank was used to ensure proper sampling, preservation, and shipping
protocol. The field blank procedure was the same as the sampling procedure except that
instead of taking a sample, water provided by MWH labs was poured into the sample
vials. The field blank water was free of any of the compounds being tested for and
showed if there was a source of contamination in the sampling procedure.
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Chapter 4: Experimental Results
To determine which applied ozone doses to evaluate PPCP/EDC removal at, the
project was divided into two phases. Phase 1 analyses examined the effects of ozone
dose on several organic parameters. The bulk organic analysis were TOC, percent TOC
removal, UV254 absorption, SUVA, and BDOC with the applied ozone dose ranging from
0 to approximately 12 mg/L. Due to the cost of each PPCP/EDC analysis and the limited
budget for testing, only three applied ozone doses could be examined for PPCP/EDC
removal. Phase 1 examined the bulk organic analysis at varying ozone doses to
determine the most effective ozone doses for microconstituent removal.
Phase 2 examined the removal of microconstituents at the 3 different applied
ozone doses determined in Phase 1. In addition, some samples were collected and
analyzed for PPCPs/EDCs for quality assurance purposes. Because the detection limits
for PPCPs/EDCs are low (5 ng/L for most compounds), and the wastewater matrix so
complex, there is inherent variability expected in the detection of these compounds. To
increase confidence in the sampling procedures and PPCP/EDC analysis, some of the
samples were used for quality assurances purposes. The quality assurance samples
included one set of duplicates for the MBR, ozone, and BAF effluent, as well as a field
blank to insure contamination was not an issue.

Phase 1: Evaluation of selected parameters at varying ozone doses
In Phase 1, MBR effluent was fed to the ozone contactor at a flowrate of 100
mL/min. Bulk organic analyses were performed at 13 applied ozone doses ranging from
1.3-11.9 mg/L. The bulk organic analysis included TOC, percent TOC removal, UV254,
SUVA, and BDOC. These parameters were examined to establish applied ozone doses
for micropollutant removal.
To generate different ozone doses an oxygen flow rate and a power setting on the
ozone generator was set. Once a day, before the ozone generator was turned on, the air
and water flow rates were measured, as detailed in the flowrate method and procedures
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section. The ozone generator was then turned on and allowed to run for at least half an
hour to allow both the ozone generator to establish 100% output and to allow steady state
conditions to develop in all the chambers.
Once the system came to steady state, measurements were taken for the influent
gas concentration and the off gas ozone concentration. Several attempts were needed to
establish the correct amount of indigo solution and gas volume to ensure accurate gas
measurements of ozone. The average of three measurements for both the influent and off
gas ozone concentrations was used to establish an applied ozone dose as described in the
ozone procedure. The next step was to measure the residual ozone at different points in
the ozone contactor.
The procedure for measuring the ozone residual is described in the ozone residual
procedure section. To ensure the system was at steady state, the system was allowed to
run uninterrupted for twenty minutes after the last ozone gas measurement. This was
because opening and closing the three-way valve, when measuring ozone gas, could
affect the ozone residual measurements because of the potential interruption of the ozone
gas flow. In addition, the ozone residuals were measured from back to front, with the
third chamber being measured first. This was done to ensure there was no interruption of
flow to the chambers that had yet to be measured. Residual measurements were usually
taken twice and averaged, except when no residual was detected. Residual data can be
seen in Figure 4-1.
The instantaneous ozone demand of the treated wastewater occurred at an ozone
dose of 2.6 mg/L. This is the ozone dose above which an ozone residual was first
detected in chamber 1. An ozone residual was not detected in chamber 2 until an ozone
dose of 5.8 mg/L. No residual ozone was detected in chamber 3, even at an ozone dose
of almost 12 mg/L. The lack of detection of an ozone residual in chamber 3 showed the
effectiveness of bubbling air into the bottom of chamber 3 any remove the residual
ozone. The R2 values of 0.95 and 0.76 for chambers 1 and 2, show a linear relationship
between the ozone dose and residual ozone, although it is not a one-to-one relationship.
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The slope for chamber 1 is 0.3. This shows that after the ozone demand is met, a 0.3
mg/L ozone residual is formed for every 1 mg/L of ozone added. The slope for chamber
2 is 0.16. An average of 1 mg/L of ozone is added for every 0.16 mg/L of ozone residual
detected in chamber 2. This shows that ozone is being consumed as it goes through
chambers.
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Figure 4-1: Residual ozone dose as a function of applied ozone dose in columns 1 and 2

After residual measurements were taken, 500 mL samples were collected from the
ozone and MBR effluents for bulk organic analysis. The dial on the ozone generator was
changed and the next set of measurements and samples were taken. Two or three
different ozone doses were examined each day. After collecting the samples, a bulk
organic analysis was done to find the most effective ozone dose based on TOC, % TOC
removal, BDOC, UV254, and SUVA.

TOC
TOC was analyzed at varying applied ozone doses to evaluate the effectiveness of
ozone in removing TOC. The TOC samples collected for the ozone contactor were taken
from the end of the third chamber. TOC removal by ozone is due to the complete
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mineralization of organics to CO2 and H2O. Figure 4-2 shows that little to no organic
removal is achieved through ozonation alone. The 11 samples analyzed for TOC removal
ranged from +8% to -8% removal, with an overall average removal of -0.03%. The
negative removals in Figure 4-2 may be the result of three possible causes. First, if no
removal is occurring, the TOC measured in the ozone contactor effluent may be slightly
different from the influent measurements because of instrument variability. A higher
measurement in the ozone contactor effluent would cause negative removal. Second, it is
possible that extremely recalcitrant compounds are not oxidized by the persulfateultraviolet oxidation method used by the TOC analyzer, and therefore not measured as
TOC in the ozone influent. Ozone may be able to partially degrade the recalcitrant
compounds to a point to where they can be mineralized and measured by the TOC
analyzer. The third reason is that there may have been variability in influent TOC over
time, so a particular sample of the effluent may not be paired with an influent sample that
represents the actual influent the column received at the time. As mentioned earlier there
were 2 or 3 different applied ozone doses examined each day during Phase 1. Each
applied ozone dose took between 2 to 3 hours to measure and sample. Only one MBR
effluent sample was taken per day and the concentration of TOC in the MBR effluent
could have shifted between examined ozone doses.
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Figure 4-2: Percent of TOC removed as a function of applied ozone dose for Phase 1

UV254 Absorbance and SUVA
UV254 absorbance is often used as a surrogate for NOM. UV Absorbance at this
wavelength is attributed to double bonded carbon groups in unsaturated and aromatic
organics. These compounds tend to be more hydrophobic and recalcitrant. Increasing
the applied ozone dose decreases the UV254 absorbance, although there is a limit as
illustrated in Figure 4-3. The UV254 absorbance begins to level off at an applied ozone
dose of around 8 mg/L. This is also seen in the SUVA data illustrated in Figure 4-4.
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Figure 4-3: UV254 absorption as a function of applied ozone dose for Phase 1
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Figure 4-4: SUVA values for initial samples
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The SUVA parameter is an indicator of the hydrophobicity of organics in water.
SUVA is the ratio of UV254 absorbance to the TOC concentration and is calculated
according to Equation 1. The SUVA values decrease with increasing applied ozone
doses as seen in Figure 4-4. This suggests that as the applied ozone dose increases, the
aromatic fraction is oxidized to more biodegradable forms. As with the UV254
absorbance measurements, the SUVA values begin to level off at around 8 mg/L, which
leads to the conclusion that higher applied ozone doses have little to no effect on
converting non-biodegradable organics into biodegradable forms.

BDOC
The last of the bulk organic analysis analyzed in Phase 1 was BDOC. BDOC is a
parameter that measures the fraction of biodegradable organics present in water. Because
the wastewater is being treated by a biological process prior to being ozonated, almost all
the biodegradable organics are consumed. Only a small amount of biodegradable
material is left in the MBR effluent when it enters the ozone contact chamber. The
remaining organics consist of larger, recalcitrant compounds. As seen in the TOC, UV254
absorbance, and SUVA data, the non-biodegradable organics are not completely
mineralized by the ozone, but are instead oxidized enough to increase the fraction of
biodegradable organic matter. The fraction of biodegradable organics increases with
increased ozonation as seen in Figure 4-5. Although, the initial concentration of TOC in
the BDOC test varies over the range of samples taken (the initial TOC concentration is
the total height of each column in Figure 4-5), the fraction of non-biodegradable
dissolved organic carbon (NBDOC) in the BDOC test (which is indicative of the
recalcitrant organic carbon) appears to level off at around 8 mg/L. This can be clearly
seen in Figure 4-6, which plots the NBDOC as a function of ozone dose. This also
suggests that the effectiveness of the ozone to covert non-biodegradable organics into a
more biodegradable form is limited.
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Selection of Ozone Doses for Microconstituent Removal
Due to the expense of analyzing these samples, the ozone doses were selected to
give the widest set of experimental conditions used in the project. Three different ozone
doses were examined for their effectiveness in removing PPCPs and EDCs. The organic
analyses in Phase 1 were done to determine the most effective ozone doses to use. The
preliminary data showed that any ozone dose higher than 8 mg/L would not convert
additional non-biodegradable organics into biodegradable forms. This dose was chosen
as the maximum ozone dose to be examined. It was expected that any ozone dose higher
than 8 mg/L would not achieve any additional microconstituent removal and so this was
considered the best-case scenario for what this process could accomplish. The minimum
ozone dose was correlated with the instantaneous ozone demand of the MBR treated
water. An ozone residual in the first ozone chamber first starts to appear at an applied
ozone dose of around 2.6 mg/L, as seen in Figure 4-1. Another consideration is in
examining an ozone dose that oxidizes recalcitrant compounds the most efficiently. The
largest percent decrease in UV254 absorbance occurs in the ozone dose range between
approximately 1 to 4 mg/L as seen in Figure 4-7. Although absorbance still decreases at
higher ozone doses, the effects are not nearly as pronounced. Because ozone doses of 3
and 4 mg/L might have only marginal differences in PPCP removal, ozone doses of 2 and
4 mg/L were selected. Since the MBR effluent TOC was around 4 mg/L, these ozone
doses also give an approximate applied ozone dose to TOC ratio of 0.5, 1.0, and 2.0 mg
ozone/mg TOC for ozone doses of 2, 4, and 8 mg/L.
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Figure 4-7: Percent decrease of UV254 absorbance with increasing applied ozone doses

TOC Removal in the BAF without Ozonation
As seen in the Phase 1 organic analysis, organic matter is not completely removed
by the ozone process; however, the fraction of biodegradable organics is increased. To
remove this fraction from the water, the BAF column uses biodegradation by microbes
growing on the anthracite media in the column. Initially, GAC was used as the media in
the BAF column, but as discussed earlier, was changed to anthracite. This was done in
part because the adsorption capacity of the GAC could not be exhausted. To measure the
amount of adsorption occurring in the column, TOC concentrations were measured in the
influent and effluent of the column of GAC. The influent to the column was MBR
effluent, which after having just undergone a biological process, should consist of mostly
non-biodegradable organics. Therefore, any additional TOC removal is attributed to the
adsorption process. The TOC concentrations for the GAC influent and effluent, as well
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as the TOC percent removal are shown in Table 4-1. The results show that adsorption by
the GAC removed from 30-65% of the TOC. To ensure that adsorption was not
occurring in the BAF column, the media was changed to anthracite.
After the initial seeding of the anthracite, the media was put in the BAF column
fed MBR effluent for a week prior to beginning the experiments. The anthracite was
used in part because the mechanism for the removal of microconstituents is
biodegradation whereas biologically activated carbon (BAC) uses both biodegradation
and adsorption. To ensure there was no contribution of organic removal by adsorption in
the BAF column, TOC was measured several times before starting Phase II. The MBR
fed the BAF column, without ozonation, and TOC was measured in the BAF influent and
effluent to ensure that the concentrations of TOC did not change as it passed through the
column. The data in Table 4-1 shows little change in TOC as it passes through the BAF
column, demonstrating that adsorption is not a mechanism in removing organics in the
BAF column.

Table 4-1: TOC results for preliminary analysis of BAF column

Date
23-Aug
30-Aug
6-Sep
23-Sep
26-Sep
27-Sep
17-Oct
19-Oct
21-Oct

MBR effluent TOC,
mg/L

BAF effluent TOC,
mg/L

BAF Column Using GAC as Media Filter
4.43
2.34
4.70
3.28
4.38
2.95
3.81
1.33
3.67
2.12
3.65
1.73
BAF Column Using Anthracite as Media Filter
4.04
3.97
4.09
3.75

4.05
3.96

Percent
Removal
47%
30%
33%
65%
42%
53%
1.6%
1.0%
-5.6%
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Phase 2: PPCP and EDC Removal by Ozone/BAF
After analyzing the Phase 1 results from the MBR and ozone processes and
determining the effect of ozone doses on microconstituent removal, Phase 2 of the project
was begun. Just like Phase 1, the MBR effluent was fed to the ozone contactor at a
flowrate of 100 mL/min. The applied ozone dose was set to one of the three doses
determined in Phase 1. For Phase 2, the effluent from the ozone contactor was fed to the
BAF column, which completed the treatment process. The system was operated
continuously at the predetermined ozone dose until steady state in the BAF column had
been established, which took between 7 and 8 days. At this point, samples were collected
for PPCP/EDC analysis. The BAF column was backwashed, a new ozone dose was set,
and the process was repeated until steady state in the BAF column was reached again.

MBR Performance
The MBR used in these experiments had been operating at an SRT of
approximately 10 days for approximately 50 days prior to the initiation of these
experiments, and was maintained throughout the duration of these experiments. Several
other MBR parameters were monitored to ensure that the MBR process was functioning
properly. These include the effluent and wasting flowrates, MLSS/MLVSS, pH, DO, and
EC. MBR effluent parameters, such as TOC, UV254, and SUVA were analyzed to
provide a basis for comparison of the subsequent treatment processes. These parameters
were also examined as possible surrogates for prediction of removal efficiencies of
microconstituents and to analyze organic removal by each process.
During the Phase 2 experiments, large fluctuations in TOC, UV254 absorption, and
SUVA were observed for all processes. Two large drops in TOC concentration occurred
during Phase 2 on October 22nd and November 1st, as seen in Figure 4-8. These large
decreases are also seen in the UV254 absorption and to a lesser degree in the SUVA data
as illustrated in Figures 4-9 and 4-10 respectively. These sharp decreases in TOC and
SUVA correspond to a sharp increase in conductivity and a drop in pH, as illustrated in
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Figures 4-11 and 4-12 respectively. Because SUVA is a ratio of UV254 absorption to
TOC and the values for both decreased, the SUVA values on these dates are not nearly as
pronounced.
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Figure 4-8: Phase 2 TOC values for MBR, ozone, and BAF effluent at applied ozone doses
of 2, 4, and 8 mg/L

Even with the large changes to the MBR feedwater, the MBR still produced
effluent with TOC concentrations less than 5 mg/L throughout Phase 2 of the
experiments, as seen in Figure 4-8. Because MBRs can be resilient to such shock
loadings, the measured parameters stabilized within a couple of days. Even with these
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changes, TOC, UV254, and SUVA rebounded quickly and steady state conditions were
observed in each of these parameters before PPCP/EDC sampling. This will be explored
in more detail later.
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Figure 4-9: Phase 2 UV254 data for MBR, ozone, and BAF effluent at applied ozone doses of
2, 4, and 8 mg/L

The fluctuations in these parameters can be attributed to unstable conditions in the
feedwater from the SWRP. Total suspended solids (TSS) and carbonaceous biochemical
oxygen demand (CBOD) data from the SWRP primary effluent pump house sampling
station, which sampled the same water used to feed the MBR, is shown in Figures 4-13
and 4-14 respectively. The data shows TSS for the MBR influent is much greater than
the normal range of values typically observed by plant operators (90–150 mg/L) for the
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entire duration of Phase 2. At one point, the TSS is over an order of magnitude higher
than the normal maximum value. The CBOD data also shows several instances where
the values are well above the normal range (90-130 mg/L) as illustrated in Figure 4-14.
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Figure 4-10: Phase 2 SUVA values for MBR, ozone, and BAF effluent at ozone doses of 2,
4, and 8 mg/L

According to plant operators, one or more of the primary settling basins that fed
though the pump house where the pilot system operated, was continuously
malfunctioning over the duration of Phase 2 of the experiments. The settling basins
would then have to be drained, the problem repaired, and the basins filled again. As soon
as the basin would fill up, another problem occurred that would take it off line again.
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The basin would again have to be drained, repaired, and filled. The high TSS and CBOD
values shown in Figures 4-13 and 4-14, are the result of the malfunctioning settling
basins.
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Figure 4-11: Conductivity values for all processes for Phase 2

Even though there is a clear connection between the quality of the wastewater
being fed to the MBR, and the sharp spikes or drops in the parameters measured, the
large spikes in TSS and CBOD do not quite match the spikes in TOC and conductivity
and drops in pH, UV254 absorbance, and SUVA. The changes in water quality observed
on October 22nd and November 1st, do not correlate with any sharp increases in the TSS
and BDOC data shown in Figures 4-13 and 4-14 respectively. This could be due to a
couple of possible causes. First there could be a change in the makeup of the feedwater
that is not accounted for in any of the parameters measured. The events on October 22nd
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and November 1st could also be attributed to a build up of solids over several days instead
of being caused by one single event. The TSS values are consistently many times the
typical values observed by plant operators throughout the duration of the Phase 2
experiments. Instead of the Events on October 22nd and November 1st being caused by
one single large event, the changes in water quality could be due to a build up of solids
over several days.
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Figure 4-12: pH values for all processes for Phase 2

This build up of solids can be seen in the MLSS/MLVSS data shown in Figure 415. The figure shows MLSS/MLVSS data from September 10th to November 11th, 2009.
During this period of time, the MBR was running at steady state with an SRT of 10 days.
Up until October 14th, one week prior to the start of Phase 2, the average MLSS and
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MLVSS for the system was approximately 6,000 and 4,000 mg/L respectively. By the
start of Phase 2 on October 21st, the MLSS and MLVSS had spiked to 10,700 and 7,315
mg/L respectively. By November 3rd, the values had gradually tapered off to 8,205 mg/L
for MLSS and 5,670 mg/L for MLVSS. Over the next 8 days, though, the values more
than double. On November 11th, the MLSS was at 17,520 mg/L and the MLVSS was at
12,125 mg/L.
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Figure 4-13: Pump House data for TSS from October 15 to November 15, 2009. Data used
as influent MBR TSS

The MLSS/MLVSS data does correlate well with the TSS data. The TSS data
shows values of over 550 mg/L starting on the 15th of October as shown in Figure 4-14.
There is a sharp spike in TSS on the 19th and 20th of October with TSS measured at 1,296
and 1,276 mg/L respectively. This correlates well to the first spike in MLSS/MLVSS
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that peaked on the 21st of October. After the spike in TSS the values fall sharply but are
still well above the typical range. On November 3rd the TSS values spike again with a
measurement of 1,900 mg/L. The values fall for a few days after this but jump to 1,250
mg/l on November 7th where they stay above 1,000 mg/L for the duration of the
experiments. This correlates to what is seen in the MLSS/MLVSS data, and helps to
explain the large drop in DO in the MBR effluent observed over the last few days of
Phase 2 as shown in Figure 4-16.
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Figure 4-14: Pump House data for CBOD from October 15 to November 15, 2009. Data
used as influent MBR CBOD

Unlike the other parameters, the DO remained constant through much of Phase 2
with average values between 5 and 7 mg/L in the MBR effluent as illustrated in Figure 4-
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16. The values dramatically drop though during the last three days of Phase 2
experiments. The DO values on the 11th, 12th, and 13th of November are 4.99, 3.87, and
2.27 mg/L respectively. This large drop in DO is attributed to the large increase in solids
in the MBR during this time as measured in the TSS and MLSS/MLVSS. The large
increase in solids causes a large increase in microbes that use the solids for food. The
increase in microbial activity increases the oxygen demand in the MBR tank, which
decreases the DO. This decrease in DO over the last three days of Phase 2 is not
observed in the ozone and BAF effluent. This is because the ozone supersaturates the
wastewater with oxygen. This is why the DO readings measured in the ozone effluent are
always much higher than the MBR effluent as illustrated in Figure 4-16. The DO
measurements are always lower in the BAF effluent than in the ozone effluent. The DO
in the BAF effluent is between 1 and 2 mg/L lower than the ozone effluent with an
average difference of 1.3 mg/L. This difference is caused by the microbial activity in the
BAF column and is a good indicator that biodegradation by microbes is occurring and
that the BAF is operating properly.
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Figure 4-15: MLSS and MLVSS values from September 10 to November 11, 2009 for 10 day
SRT

The pH measurements also show different values between processes as seen in
Figure 4-12. The pH increases in the range of 0.51 to 0.77 from the MBR effluent to the
ozone effluent with an average increase of 0.66. The pH also decreases an average of
0.22 from the ozone effluent to the BAF effluent. Unlike pH, the conductivity shows
little variation between processes as illustrated in Figure 4-11. This was expected
because the ozone and BAF processes are not expected to increase or decrease the
concentration of ionic species in the water unless a significant fraction of the TOC was
mineralized, which did not occur. Other parameters that show different values between
processes are TOC, SUVA, BDOC, and UV254 absorption. These will be discussed in
more detail later.
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Figure 4-16: DO values for all processes for Phase 2

Performance of Ozone Contactor
The ozone contactor was operated to produce applied ozone doses of 8, 4, and 2
mg/L for the PPCP/EDC removal experiments. The applied ozone dose was stable once
the dose was set, as illustrated in Figure 4-17. Due to the complex composition of the
wastewater, the ozone residual was more variable, as seen in Figure 4-18. This
variability could be attributed to the unstable conditions in the MBR feed that can
contribute to variations in the makeup of the wastewater. High ozone residuals correlate
with the drop in pH and spike in conductivity on October 22nd and November 1st, as
illustrated in Figures 4-9 and 4-10 respectively. These variations could include increases
or decreases in compounds that react with ozone. The large drops in ozone residual on
October 30th and November 7th are due to changing the applied ozone dose from 8 to 4
mg/L and from 4 to 2 mg/L.
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Figure 4-17: Applied ozone dose measurements for Phase 2
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Figure 4-18: Residual ozone measurements from chambers 1 and 2 for Phase 2
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To adjust the applied ozone dose, the power setting on the ozone contactor could
be adjusted. The ozone dose could also be changed by adjusting the gas or water
flowrates. The gas flowrate was set low to ensure maximum performance by the glass
ozone diffuser. When the gas flowrate was increased, larger bubbles formed in the
diffuser and the gas to liquid transfer efficiency decreased. A gas flowrate of 32 mL/min
was used because it allowed for a good ozone transfer efficiency, between 79 and 93
percent as illustrated in Figure 4-19, and because it was large enough to supply an applied
ozone dose of up to 8 mg/L. The average transfer efficiency was 91.1 percent for the 2
mg/L ozone dose, 88.2 percent for the 4 mg/L dose, and 82.3 percent for the 8 mg/L
ozone dose. The transfer efficiency decreased as the applied ozone dose increased. This
was probably due to a reduced concentration gradient between the gas and liquid streams
as the ozone concentration in solution increased. The water flowrate in the ozone
contactor was set at 100 mL/min. This flowrate was used in the design of the ozone
contactor so that each contact chamber gave 5 minutes of contact time.
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Figure 4-19: Gas transfer efficiency for ozone doses of 2, 4, and 8 mg/L from 10/21-11/13

BAF Performance
The BAF column ran continuously from October 16th, until the last day of
sampling on November 13th. The column was initially fed by MBR effluent. This was
done immediately following the seeding process that established microbial growth on the
anthracite as described in the experimental methods section. On October 21st, Phase 2 of
the experiments started and the feed for the BAF column was changed to ozone effluent.
The initial head on the column at the beginning of Phase 2 was 10 inches as shown in
Figure 4-20. By October 29th, the end of the 8 mg/L sampling event, the column had
approximately 30 inches of head, which is close to capacity. The column was
backwashed and the head decreased to approximately 9 inches. The head steadily
increased on the column during the duration of the next sampling event, from October
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30th to November 6th. At the end of the sampling event the column had approximately 31
inches of head. The column was backwashed again for the next sampling event and the
head decreased to approximately 8.5 inches. Unlike the previous two cycles, the head on
the column remained steady and never got above 9 inches.
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Figure 4-20: Head build up in the BAF during Phase 2

One of the parameters used to ensure microbial activity in the BAF column was
dissolved oxygen. As discussed earlier, there was a decrease in DO of approximately 1.3
mg/L from the ozone to the BAF effluent. This decrease is attributed to the microbial
activity in the BAF column. This was one of the parameters used to ensure the BAF
column was operating correctly.
The bulk organic analysis also showed microbial activity in the BAF column.
Decreases in TOC, SUVA, BDOC, and UV254 absorption, between the ozone contactor

89

and BAF column, show that organics are being consumed in the BAF column. These
decreases are attributed to recalcitrant compounds being partially oxidized in the ozone
contact chamber and then removed through biodegradation in the BAF column. The
decrease in organics between the ozone contactor and BAF column is further examined in
the next section.

Bulk Organic Analysis for Phase 2 Experiments
Samples for TOC, UV254 absorbance, and SUVA analysis were taken every day
during Phase 2 of the study. BDOC analysis was done three times for each applied ozone
dose examined. These analyses were used to both determine steady state conditions and
to examine whether a correlation exists between these parameters and microconstituent
removal.

Bulk Organic Analysis for 8 mg/L Ozone Dose
The first testing was done at an applied ozone dose of 8 mg/L. The system
operated for 9 days at this ozone dose, from October 21-29. Samples were collected and
analyzed daily for UV254 adsorption, TOC, SUVA, and TOC/TOC0 as shown in Figures
4-21 to 4-24. The bulk organic analysis was performed to establish that the system was
operating at steady state before sampling for PPCPs/EDCs.
The TOC values seen in Figure 4-21 were virtually the same in the MBR and
ozone effluents. This shows that even at the highest ozone dose examined, 8 mg/L,
organics are not being removed through ozonation alone. Although organic removal is
not achieved in the ozone contactor, the BAF effluent showed consistent removal of
TOC. The BAF column removed around 20 percent of the TOC for the last five days of
the 8 mg/L ozone samples as shown in Figure 4-22. This shows that recalcitrant
compounds are partially oxidized in the ozone contact chamber where they are broken
down into more biodegradable forms. These are then consumed by the microbial culture
in the BAF column.
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Figure 4-21: TOC values for 8 mg/L applied ozone dose during Phase 2 experiments

Unlike the TOC data, which shows no difference in TOC concentration between
MBR and ozone effluents, the UV254 absorbance and SUVA values show a large decrease
between the MBR and ozone effluents as illustrated in Figures 4-23 and 4-24. This
further illustrates that recalcitrant compounds are being partially oxidized in the ozone
contact chamber and then consumed in the BAF column. The UV254 absorbance values
show that there is a significant drop in UV254 absorbance after the ozone contactor but
that the values are almost the same after passing through the BAF column. This shows
that the BAF column does not increase the biodegradable fraction of organics, but instead
only consumes the newly formed biodegradable organics created in the ozone contact
chamber.
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Figure 4-22: TOC/TOCo for applied ozone dose of 8 mg/L during Phase 2 experiments
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Figure 4-23: UV254 absorption at an applied ozone dose of 8 mg/L during Phase 2
experiments
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This is also seen in the SUVA values shown in Figure 4-24. The SUVA values
are slightly higher for the BAF column though. This is because the TOC measured in the
ozone effluent is higher than the TOC measured in the BAF effluent. SUVA is a ratio of
the UV254 absorbance to the TOC concentration as detailed in Equation 1. Because the
UV254 absorbance values are the same and the TOC concentration in the ozone effluent is
higher than the BAF effluent, the SUVA value for the ozone effluent will be lower. The
large decrease in SUVA after the MBR effluent indicates a decrease in recalcitrant
compounds, especially those with a high degree of aromaticity, due to ozonation in the
ozone contact chamber and biodegradation in the BAF column.
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Figure 4-24: SUVA values for applied ozone dose of 8 mg/L during Phase 2 experiments
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All of these parameters show consistent data for several days before the
PPCP/EDC sampling date. The UV254 absorbance and the TOC concentration both
decline on the same day that there was a large spike in conductivity and drop in pH
(October 22nd). They also show that the systems quickly rebounded within a few days.
The analysis for these results, as well as the results for the 4 mg/L and 2 mg/L sampling
events, will be discussed in more detail in the next section.

Bulk Organic Analysis for 4 mg/L Ozone Dose
After sampling for PPCPs/EDCs, the column was backwashed and the applied
ozone dose was set to 4 mg/L. As with the 8 mg/L data, there was a large change in
water quality that can be seen in many of parameters measured for the 4 mg/L ozone
dose. The large spike in EC and drop in pH that occurred on November 1st caused
declines in TOC, UV254 absorbance, and SUVA values as seen in Figures 4-25, 4-27, and
4-28 respectively. The drop in SUVA values caused by the spike in conductivity and
drop in pH is really only reflected in the MBR effluent values. The UV254 absorbance
values show a clear drop in all process effluents on November 1st as do the TOC
concentrations. Although the values for the individual parameters decline, the ratio of
UV254 absorbance to TOC concentration does not decline as much. In the case of the
ozone effluent, the ratio even increases although not by much. This shows that the even
though there are changes in water quality, which can cause a drop in organics in the
wastewater, the fraction of recalcitrant compounds being oxidized in the ozone contact
chamber and consumed in the BAF column remain relatively constant.
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Figure 4-25: TOC at an applied ozone dose of 4 mg/L during Phase 2 experiments

As with the 8 mg/L ozone dose, there was no organic removal achieved through
ozonation alone. The concentration of TOC does not really change after the ozonation as
shown in Figure 4-25. This was also seen in the amount of TOC removed as illustrated in
Figure 4-26. Although there was no TOC removal in the ozone contact chamber, the
BAF column did show organic removal. TOC was removed by approximately 15 percent
in the BAF column for the last three days before sampling for PPCPs/EDCs. As
expected, this amount was smaller than what was removed at an ozone dose of 8 mg/L.
The difference in removal between applied ozone doses will be further examined in the
next section.
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Figure 4-26: TOC/TOC0 for 4 mg/L applied ozone dose during Phase 2 experiments

Like the 8 mg/L ozone dose, the UV254 absorbance values for the ozone and BAF
effluents were much lower than the MBR effluent as illustrated in Figure 4-27. This
shows that recalcitrant compounds are being oxidized into more biodegradable forms in
the ozone contact chamber. The difference in UV254 absorbance values between the
ozone and BAF effluents are larger than then 8 mg/l ozone dose. At 8 mg/L the values
were almost identical, whereas the difference between most the values during the last six
days of the 4 mg/L ozone dose experiments was approximately 0.1 cm-1. This difference
between UV254 absorbance between the ozone and BAF effluents will be examined
further in the next section.
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Figure 4-27: UV254 at an applied ozone dose of 4 mg/L during Phase 2 experiments
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Figure 4-28: SUVA values for 4 mg/L applied ozone dose during Phase 2 experiments
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As mentioned earlier, the SUVA values show little variation throughout the 4
mg/L ozone dose experiments as shown in Figure 4-28. There is the small change on
November 1st which is caused by a change in the MBR feedwater quality, but the values
quickly rebound within a day or two. The SUVA values are nearly identical for both the
ozone and BAF effluents. They are also much lower than the MBR effluent values. This
also indicates that recalcitrant compounds in the MBR effluent are being oxidized in the
ozone contact chamber to more biodegradable forms. As expected, the decrease in
SUVA in the ozone and BAF effluents are smaller at an ozone dose of 4 mg/L compared
with the 8 mg/L ozone dose. This will be further examined in the next section.
Even with this change in water quality, the UV254, TOC, SUVA, and TOC/TOC0
parameters rebound quickly to stable conditions with little variation within a few days.
Because these parameters were stable for a few days before PPCP/EDC sampling, the
system was assumed to be at steady state. After steady state conditions were confirmed,
sampling was done for microconstituents on November 6th. After sampling, the BAF
column was backwashed and the new applied ozone dose of 2 mg/L was set.

Bulk Organic Analysis for 2 mg/L Ozone Dose
The last applied ozone dose to be examined for removing microconstituents from
MBR effluent was 2 mg/L. Unlike the previous two ozone doses examined, the data
showed no large spikes in EC or drops in pH. This consistency in influent quality is
reflected in the TOC, TOC/TOC0, UV254 absorption, and SUVA values illustrated in
figures 4-29 - 4-32.
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Figure 4-29: TOC for 2 mg/L applied ozone dose during Phase 2 experiments

As with the 4 and 8 mg/L ozone dose experiments, there was no decrease in TOC
between the MBR and ozone effluents at an ozone dose of 2 mg/L as illustrated in Figure
4-29. This was expected because organic removal was not occurring at higher ozone
doses. The TOC measured in the BAF effluent did show a decrease although the
decrease was less than the 4 and 8 mg/L ozone doses. This shows that recalcitrant
compounds are being oxidized to more biodegradable forms in the ozone contactor,
where they are then consumed as food by the microbes in the BAF column. The TOC
removal at the 2 mg/L ozone dose is only around 5 percent, as seen in Figure 4-30. This
difference in organic removal at the varying ozone doses will be further examined in the
next section.
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Figure 4-30: TOC/TOC0 at an applied ozone dose of 2 mg/L during Phase 2 experiments

Like the 4 and 8 mg/L ozone doses, the UV254 absorbance and SUVA values are
lower in the ozone and BAF effluents as illustrated in Figures 4-31 and 4-32. The UV254
absorbance values are slightly different for the ozone and BAF effluents though. Like the
4 mg/L ozone dose results, the ozone effluent shows larger UV254 absorbance values than
the BAF effluent. This will be further examined in the next section. The SUVA values
were nearly the same in both the ozone and BAF effluents, which was also observed in
the 4 mg/L ozone dose results.
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Figure 4-31: UV254 absorption data for 2 mg/L applied ozone dose during Phase 2
experiments
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Figure 4-32: SUVA values for 2 mg/L applied ozone dose during Phase 2 experiments
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Although some variation is observed in the UV254 absorbance and SUVA values
on the day the PPCP/EDC samples were taken, the change is small. Little variation is
seen in any of the measured organic parameters during the 2 mg/L ozone experiments.
Because of this, the system was assumed to be at steady state for PPCP/EDC sampling.
The difference in values for the organic parameters between applied ozone doses will be
further examined in the next section.

Comparison of Bulk Organic Analysis for all Applied Ozone Doses
The results from the bulk organic analysis clearly show higher removal of
organics by the BAF column when pre-treated by higher ozone doses. The analysis also
show that although larger removal of organics is achieved with increased ozone, the 8
mg/L ozone dose only shows slight increases compared to the 2 and 4 mg/L ozone doses.
This section will examine the removal of organics between applied ozone doses.
The TOC concentrations between the MBR and ozone effluents did not change at
any applied ozone dose as illustrated in Figure 4-33. This leads to the conclusion that
little to no organics were completely mineralized even at the highest ozone dose of 8
mg/L. Although none of the organics were mineralized by ozone alone, Figure 4-34 does
show percent reductions of TOC in the BAF effluent. All values shown in Figures 4-33 4-38 are the averages of the last three days of samples during each sampling event.
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Figure 4-33: TOC concentrations for applied ozone doses of 2, 4, and 8 mg/L (Values are
averages over the last 3 days before PPCP/EDC sampling. Error bars = ± 1 Std dev)
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Figure 4-34: TOC percent reduction for applied ozone doses of 2, 4, and 8 mg/L (Values are
averages over the last 3 days before PPCP/EDC sampling. Error bars = ± 1 Std dev)
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As noted earlier, the change in TOC removal between ozone doses is much larger
from 2 to 4 mg/L than between 4 and 8 mg/L. The percent reduction nearly triples
between 2 and 4 mg/L, going from approximately 5 to 15 percent TOC reduction.
Doubling the ozone dose from 4 to 8 mg/L only reduces the TOC by an additional 5%.
This trend is also seen in the SUVA and UV254 adsorption parameters. In order to better
quantify the effectiveness of ozone in removing organics at various doses, the change in
organics per mg/L of ozone can be calculated for TOC, UV254 absorption, and SUVA, as
shown in Table 4-2. These values show the removal of organics between the MBR and
BAF effluents.
By examining the amount of TOC removed per mg/L of ozone added, a better
picture of ozone’s effectiveness in removing TOC at varying ozone doses can be
established. At 2 mg/L of ozone, the removal of TOC is 0.13 mg/L per mg/L of ozone
added as seen in Table 4-2. This increases to 0.16 mg/L of TOC removed per mg/L of
ozone added at the 4 mg/L ozone dose. This is the peak removal efficiency. At 8 mg/L
of ozone the removal of TOC drops to 0.11 mg/L per mg/L of ozone added. These values
show the increasing effectiveness of ozone in removing TOC up to an ozone dose of 4
mg/L. This also shows that TOC was removed less effectively at an ozone dose of 8
mg/L. Although these values do show the overall effectiveness of ozone at various ozone
doses, they do not take into account the amount of TOC already removed at lower ozone
doses.
The increase in organic removal between applied ozone doses can better be
understood by examining the change in organics per additional mg/L of ozone added.
This is done by subtracting the amount of organics removed at lower applied ozone
doses, then dividing by the amount of additional ozone added. For example, at an ozone
dose of 4 mg/L there was an average of 0.39 mg/L of additional TOC removed between
the ozone doses of 2 and 4 mg/L. The amount of additional ozone added between the 2
and 4 mg/L ozone doses was 2 mg/L. This gives a removal of 0.19 mg/L of TOC per
additional mg/L of ozone between the applied ozone doses of 2 and 4 mg/L. The amount
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of TOC removed per additional mg/L of ozone is shown in Table 4-3. These values give
a better understanding of the effectiveness of ozone in removing organics at various
ozone doses.
Table 4-2: Change in organic parameters per mg of ozone added

2

4

8

ΔTOC/O3 dose

0.13

0.16

0.11

ΔUV254/O3 dose

0.013

0.013

0.008

ΔSUVA/O3 dose

0.23

0.24

0.15

Ozone dose (mg/L)

The additional removal of TOC dramatically increases from 2 to 4 mg/L of ozone,
going from 0.13 to 0.19 mg/L of TOC removed per additional mg/L of ozone added, as
shown in Table 4-3. This is a 32 percent increase in removal efficiency. The ability of
ozone to remove TOC dramatically decreases after the 4 mg/L ozone dose. The
additional removal of TOC between the ozone doses of 4 and 8 mg/L is only 0.05 mg/L
of TOC per additional mg/L of ozone added. This leads to the conclusion that although
additional TOC removal is achieved at higher applied ozone doses, the effectiveness of
ozone dramatically decreases at an ozone dose of 8 mg/L. This data also shows that the 4
mg/L ozone dose was the most efficient ozone dose examined at removing TOC.

Table 4-3: Change in organic parameters between ozone doses per additional mg/L of
ozone added

0-2 mg/L

2-4 mg/L

4-8 mg/L

ΔTOC/O3 dose

0.13

0.19

0.05

ΔUV254/O3 dose

0.013

0.013

0.003

ΔSUVA/O3 dose

0.23

0.26

0.06

Ozone dose (mg/L)
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Unlike the TOC values, a noticeable difference can be seen between the MBR and
ozone effluents for UV254 absorbance as seen in Figure 4-35. This indicates that even
though the total organic concentration is not decreasing with increased ozone doses, the
biodegradable fraction is. As with the percent reduction in TOC, the percent reduction of
UV254 absorbance greatly increases from 2 to 4 mg/L with much smaller increases
between the applied ozone doses of 4 and 8 mg/L as illustrated in Figure 4-36. This is
further illustrated by examining the change in UV254 absorbance per mg/L of ozone.
The decrease in UV254 absorbance per mg/L of ozone is quantified in Table 4-2.
Similar to the TOC values, the decrease in UV254 absorbance is greatest at the applied
ozone doses of 2 and 4 mg/L with 0.013 cm-1 of UV254 absorbance removed per mg/L of
ozone. This amount decreases to 0.008 cm-1 of UV254 absorbance removed per mg/L of
ozone. This shows that the lower ozone doses are more efficient in decreasing UV254
absorbance. The effectiveness of ozone in decreasing UV254 absorbance can better be
quantified by examining the decrease in UV254 absorbance per additional mg/L of ozone
added.
The additional removal of UV254 absorbance per additional mg/L of ozone added
is the most effective at ozone doses of up to 4 mg/L. The UV254 absorbance decreases by
0.013 cm-1 for every additional mg/L of ozone for both the 0 to 2 mg/L and 2 to 4 mg/L
ozone doses as shown in Table 4-3. The additional decrease of UV254 absorbance
between the ozone doses of 4 to 8 mg/L dramatically decreases with a decrease of only
0.003 cm-1 of UV254 absorbance per additional mg/L of ozone. This is less than onefourth the decrease in UV254 absorbance per mg/L of ozone added than what was
observed between the 0 to 2 mg/L and 2 to 4 mg/L ozone doses.
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Figure 4-35: UV254 absorbance for applied ozone doses of 2, 4, and 8 mg/L (Values are
averages over the last 3 days before PPCP/EDC sampling. Error bars = ± 1 Std dev)

As discussed earlier, there is a difference in UV254 absorbance values between the
ozone and BAF effluents at the 2 and 4 mg/L ozone doses, as shown in Figure 4-35.
There is a 10% difference in UV254 absorbance between the ozone and BAF effluents at
the 2 mg/L ozone dose as shown in Figure 4-36. The difference decreases as the ozone
dose increases, and at 8 mg/L the UV254 absorbance is nearly the same for both ozone and
BAF effluents. Organics from the MBR effluent are assumed to be mostly recalcitrant.
This is because effluent from the MBR has already undergone a biological process which
consumes nearly all of the biodegradable organics. As shown by limited removal of TOC
by the BAF in the absence of ozone pretreatment, almost all of the organics in the MBR
effluent are recalcitrant, and therefore unusable as a food source for microbes in the BAF
column. The organics would first have to be broken down into a more biodegradable
form before they could be degraded in the BAF column. At the lower ozone doses of 2
and 4 mg/L, the recalcitrant compounds are partially oxidized in the ozone contactor and
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broken down into more biodegradable forms. These compounds are broken down
enough by ozone to be used as food by the microbes in the BAF column, but are still
being measured in the ozone effluent due to their structure. A portion of the
biodegradable compounds consumed in the BAF column still have double bonded carbon
groups in unsaturated or aromatic organics that are being measured as UV254 absorbance.
This is why the UV254 absorbance values are higher in the ozone effluent than the BAF
effluent at ozone doses of 2 and 4 mg/L. At an ozone dose of 8 mg/L, the organics are
broken down even more. As shown in Phase 1, the effectiveness of ozone to break down
recalcitrant compounds peaks at an ozone dose of around 8 mg/L. At this higher dose the
biodegradable fraction no longer has a chemical structure that can be measured by the
UV254 absorbance. This is why there is little to no difference in the UV254 absorbance
values between the ozone and BAF effluents at the 8 mg/L ozone dose.
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Figure 4-36: UV254 percent reduction for applied ozone doses of 2, 4, and 8 mg/L (Values
are averages over the last 3 days before PPCP/EDC sampling. Error bars = ± 1 Std dev)
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Similar to UV254 absorption, the SUVA values decrease as the applied ozone dose
increases as seen in figure 4-37. Also similar to both the percent TOC and UV254
absorbance removal, the SUVA percent removal dramatically increases between applied
ozone doses of 2 to 4 mg/L with only slight increases between 4 and 8 mg/L as illustrated
in figure 4-38. What all these values seem to indicate is that although more organic
degradation occurs at an ozone dose of 8 mg/L, the most efficient ozone dose used in this
study for treating organics is at 4 mg/L.
This is further quantified by examining the SUVA removal per mg/L of ozone
added as illustrated in Table 4-2. The amount of SUVA removed per mg/L of ozone is
similar at the 2 and 4 mg/L ozone doses with 0.23 and 0.24 L/mg-cm of SUVA removed
per mg/L of ozone. The amount of SUVA removed drops dramatically at 8 mg/L with
only 0.15 L/mg-cm of SUVA removal per mg/L of ozone. Examining the difference in
SUVA removal between applied ozone doses shows that increasing the ozone from 2 to 4
mg/L is the most effective. Going from 0 to 2 mg/L of ozone gives 0.23 L/mg-cm of
SUVA removal per additional mg/L of ozone as shown in Table 4-3. This increases to
0.26 L/mg-cm of SUVA removal per additional mg/L of ozone from 2 to 4 mg/L of
ozone. The removal of SUVA per additional mg/L of ozone dramatically decreases from
4 to 8 mg/L of ozone with only 0.06 L/mg-cm of SUVA removed per additional mg/L of
ozone. Like the TOC and UV254 absorption values, the SUVA removal per additional
mg/L of ozone is approximately 4 times greater going from 2 to 4 mg/L than going from
4 to 8 mg/L of ozone.
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Figure 4-37: SUVA values for applied ozone doses of 2, 4, and 8 mg/L (Values are averages
over the last 3 days before PPCP/EDC sampling. Error bars = ± 1 Std dev)

The TOC, UV254 absorbance, and SUVA values show that recalcitrant compounds
in the MBR effluent are being partially oxidized in the ozone contact chamber. There is a
trend of increasing organic removal with increasing ozone dose, although the efficiency
of ozone to partially oxidize recalcitrant compounds into more biodegradable forms was
not seen at the highest ozone dose examined. The most efficient ozone dose examined
for removing organics was 4 mg/L.
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Figure 4-38: SUVA percent reduction for applied ozone doses of 2, 4, and 8 mg/L (Values
are averages over the last 3 days before PPCP/EDC sampling. Error bars = ± 1 Std dev)

BDOC for Phase 2
The last of the organic analysis examined during the Phase 2 experiments was
BDOC. Three BDOC sampling events were done for each applied ozone dose examined
and measured the BDOC in the MBR, ozone, and BAF effluents. The October 25th
BDOC results, collected during the 8 mg/L ozone dose experiments, had to be discarded
due to an error with the TOC analyzer. Therefore, the 8 mg/L ozone experiments have
only two sampling dates, whereas the 4 and 2 mg/L ozone experiments have three.
BDOC samples for the 8 mg/L ozone dose experiments were collected on October
21st, 23rd, and 25th. As mentioned earlier, the October 25th results had to be discarded due
to an error with the TOC analyzer. The results for the 21st and 23rd, seen in Figure 4-39,
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show that most of the TOC in the MBR effluent is recalcitrant and therefore nonbiodegradable. The data in Table 4-4 shows that TOC is not removed in the BAF column
unless it is first oxidized by ozone. This leads to the conclusion that even though a
fraction of the organics in the MBR effluent is biodegradable, as shown in Figure 4-39,
the microbes in the BAF column are unable to degrade this fraction. This will be
discussed in more detail later.
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Figure 4-39: TOC, BDOC, and NBDOC measured in MBR, ozone, and BAF effluents for 8
mg/L ozone dose during Phase 2 experiments. TOC is the total column height
(NBDOC+BDOC)

The results also show that a portion of the NBDOC is converted to BDOC
through partial oxidation by ozone in the ozone contact chamber. The amount of BDOC
significantly increases in the ozone contact chamber as illustrated in Figure 4-40. There
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is an average of 1.41 mg/L of BDOC produced in the ozone contact chamber as shown in
Table 4-4. A portion of the newly formed biodegradable organics are then consumed in
the BAF column. An average of 0.76 mg/L of BDOC is consumed in the BAF column at
an ozone dose of 8 mg/L. This gives a ratio of 0.54 mg/L of BDOC consumed in the
BAF column to every 1 mg/L of BDOC created by ozone. This shows that not all of the
BDOC is being consumed in the BAF column. This will be discussed in greater detail
later. At the highest ozone dose examined, 8 mg/L, 58.2 percent of the initial NBDOC
from the MBR effluent was converted to BDOC in the ozone contact chamber. The
percent of NBDOC converted to BDOC per mg/L of ozone is 7.3 percent.

Table 4-4: BDOC statistics for 2, 4, and 8 mg/L ozone doses for Phase 2 experiments

BDOC statistics
Average initial TOC in MBR effluent,
mg/L
Average BDOC in MBR, mg/L
Average biodegradable fraction in
MBR effluent
Average BDOC produced in ozone
contact chamber, mg/L
Average BDOC consumed in BAF,
mg/L
Ratio of BDOC consumed in the BAF
to BDOC produced by ozone
Average BDOC produced in ozone
contact chamber (mg/L) per mg/L of
ozone
Average BDOC consumed in BAF
(mg/L) per mg/L of ozone
Percent of NBDOC converted to
BDOC
Percent of NBDOC converted to
BDOC per mg/L of ozone

Ozone dose
2 mg/L

4 mg/L

8 mg/L

4.4
1.10

4.0
0.95

3.7
0.81

24.9%

23.5%

22.0%

0.55

1.01

1.41

0.30

0.51

0.76

0.54

0.50

0.54

0.28

0.25

0.18

0.15

0.13

0.09

16.6%

33.4%

58.2%

8.3%

8.4%

7.3%
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Figure 4-40: BDOC measured in MBR, ozone, and BAF effluents for 8 mg/L ozone dose
during Phase 2 experiments

The first BDOC sampling date for the 4 mg/L ozone dose experiments was
collected on October 30th. As discussed earlier, there is a large spike in conductivity and
drop in pH on November 1st. This is reflected in the BDOC data shown in Figure 4-41,
which shows a large decrease in TOC (TOC includes NBDOC and BDOC and is the total
height of the column) on November 1st. The November 3rd BDOC data shows that the
decrease in TOC quickly rebounds. This can also be seen in Figure 4-42, which shows
the BDOC measured in all process effluents for the three sampling dates for the 4 mg/L
ozone dose. The BDOC measured in all processes sharply drops on November 1st, but
quickly rebounds by November 3rd. Even with these variations, the percent of NBDOC
in the MBR effluent that is converted to BDOC in the ozone contact chamber shows little
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variation. The October 30th results show that 32 percent of the NBDOC measured in the
MBR effluent is converted to BDOC. The November 1st and 3rd results show that 34
percent of NBDOC in the MBR effluent is converted to BDOC in the ozone contact
chamber. These results show that although the concentrations of organics in the MBR
effluent may vary, the fraction of non-biodegradable organics that can be oxidized into
more biodegradable forms is relatively constant. This consistency is also seen in the
ability of the BAF column to consume the newly formed BDOC.
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Figure 4-41: TOC, BDOC, and NBDOC measured in MBR, ozone, and BAF effluents for 4
mg/L ozone dose during Phase 2 experiments. TOC is the total column height
(NBDOC+BDOC)

Similar to the 8 mg/L ozone dose, the BAF column only consumes about half of
the newly created BDOC. At an ozone dose of 4 mg/L there is an average of 0.5 mg/L of
BDOC consumed in the BAF column for every 1 mg/L of BDOC produced in the ozone
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contact chamber. At 8 mg/L there was 0.54 mg/L of BDOC consumed in the BAF
column for every 1 mg/L of BDOC produced in the ozone contact chamber. This
consistent lack of further degradation of biodegradable organics in the BAF column will
be discussed in more detail later.
Even though not all of the newly formed biodegradable organics were consumed
in the BAF column, the 4 mg/L ozone dose shows that recalcitrant organics are being
partially oxidized in the ozone contact chamber, where they are then consumed by
microbes in the BAF column. The TOC data in Figure 4-41 shows that the total organics
are not reduced by ozone alone.

2.5

MBR
Ozone
BAF

BDOC, mg/L

2.0

1.5

1.0

0.5

0.0
Oct-30

Nov-1

Nov-3

Sample date

Figure 4-42: BDOC measured in MBR, ozone, and BAF effluents for 4 mg/L ozone dose
during Phase 2 experiments
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The BDOC results at an ozone dose of 2 mg/L show much more consistent MBR
effluent values for TOC, NBDOC, and BDOC as shown in Figure 4-43. Like the 8 and 4
mg/L ozone doses, the 2 mg/L ozone dose partially oxidizes recalcitrant compounds into
more biodegradable forms, which are then consumed in the BAF column. This can be
seen in Figure 4-44 which shows an increase in the BDOC measured in the ozone
contactor, and a decrease in the BDOC measured in the BAF column.

BDOC, mg/L
NBDOC, mg/L

5.0
4.5
4.0

TOC, mg/L

3.5
3.0
2.5
2.0
1.5
1.0
0.5
0.0
MBR
11/7

Ozone
11/7

BAF 11/7

MBR
11/9

Ozone
11/9

BAF 11/9

MBR
11/11

Ozone
11/11

BAF
11/11

Sample ID

Figure 4-43: TOC, BDOC, and NBDOC measured in MBR, ozone, and BAF effluents for 8
mg/L ozone dose during Phase 2 experiments. TOC is the total column height
(NBDOC+BDOC)
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As expected, the amount of BDOC produced in the ozone contactor at an ozone
dose of 2 mg/L is less than that produced at 4 and 8 mg/L ozone doses. The average
BDOC created in the ozone contact chamber was 0.55 mg/L for the 2 mg/L ozone dose.
At ozone doses of 4 and 8 mg/L the average concentration of BDOC created in the ozone
contact chamber was 1.01 and 1.41 mg/L respectively. Greater oxidation is expected at
higher ozone doses. This was observed in the Phase 1 BDOC results, which saw an
increase in BDOC up to an ozone dose of around 8 mg/L. The ability of ozone to
partially oxidize recalcitrant compounds greatly diminishes after this.
The concentration of TOC in the MBR effluent, as measured in the BDOC
analysis, decreased with increasing ozone dose as shown in Table 4-4. Because this
research started at an ozone dose of 8 mg/L and decreased from there, the TOC measured
in the MBR effluent actually increased as the experiment proceeded. The TOC
concentrations at ozone doses of 2, 4, and 8 mg/L are 4.4, 4.0, and 3.7 mg/L respectively.
The concentration of BDOC in the MBR effluent also decreased with increasing ozone
dose. The BDOC concentrations in the MBR effluent for ozone doses of 2, 4, and 8
mg/L are 1.10, 0.95, and 0.81 mg/L respectively. The ratio of biodegradable to nonbiodegradable organics measured in the MBR effluent increased at about the same rate.
The biodegradable fraction of organics initially present in the MBR effluent was almost
the same at all ozone doses examined. The biodegradable fraction of organics in the
three tests (ozone doses of 2, 4, and 8 mg/L) was 24.9, 23.5, and 22.0 percent
respectively. This shows a slight decrease in the biodegradable fraction of organics in the
3 tests, although the increase is almost negligible. It is important to note that the increase
in TOC and BDOC concentrations in the MBR effluent are likely the result of the varying
quality of the MBR feedwater, as discussed earlier, and not as a result of the ozone
contact chamber or BAF column. Ozone had no effect on this since this was the ozone
contactor influent.
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BAF
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Figure 4-44: BDOC measured in MBR, ozone, and BAF effluents for 2 mg/L ozone dose
during Phase 2 experiments

Even with these changes in MBR feedwater quality, the average ratio of BDOC
consumed in the BAF column to BDOC produced in the ozone contact chamber was 0.54
for the 2 mg/L ozone dose. This is nearly the same ratio as what was achieved at ozone
doses of 4 and 8 mg/L, which had ratios of 0.5 and 0.54 respectively. This leads to the
conclusion that the BAF column is only able to consume half of the biodegradable
organics produced in the ozone contact chamber regardless of the ozone dose. Half of the
recalcitrant compounds that are partially oxidized to more biodegradable forms are not
being consumed in the BAF column. The incomplete biodegradation of BDOC in the
BAF column could be attributed to drawbacks in doing pilot scale research. Unlike a
full-scale system, the pilot scale BAF column had only been operating for approximately
one month. This one month of operation included all of Phase 2. This could mean the
microbes in the column had not had enough time to assimilate to the type of organics
being fed to them. In addition, the pilot scale BAF column was exposed to both sunlight
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and changes in temperature whereas a full-scale system would be more stable in these
regards. Another factor would be that in a full-scale operation, the BAF column would
be subject to more control by higher experienced operators. The operators experience
could allow for more optimal conditions in the BAF column. Factors such as EBCT,
backwashing frequency and procedures, and better monitoring of the process could help
increase the efficiency of the BAF column. This combined with the benefits of operating
the system at full scale could greatly increase the biodegradation ability in the BAF
column. Although drawbacks of the pilot system could be the only cause of this lack of
degradation in the BAF column, further examination of the problem could be a source for
a future study if this problem is also seen in full-scale operation.
Although the ratio of BDOC produced in the ozone contact chamber to BDOC
consumed in the BAF column is relatively constant across all examined ozone doses, the
efficiency to both produce and consume BDOC decreases with increased ozone doses.
This can be quantified by examining the amount of BDOC produced and consumed per
mg/L of ozone. The average BDOC produced in the ozone contact chamber is 0.28, 0.25,
and 0.18 mg/L per mg/L of ozone at ozone doses of 2, 4, and 8 mg/L respectively, as
shown in Table 4-4. The average BDOC consumed in the BAF column is 0.15, 0.13, and
0.09 mg/L per mg/L of ozone at ozone doses of 2, 4, and 8 mg/L respectively. These
values show that although the ratio of BDOC produced to BDOC consumed remains
fairly constant at all ozone doses, the ability to convert and degrade non-biodegradable
organics is reduced at higher ozone doses. The effectiveness of ozone is nearly the same
at the 2 and 4 mg/L ozone doses.
Although the BAF is only consuming about half of the biodegradable organics
created in the ozone contact chamber at all ozone doses, the concentration of NBDOC is
virtually the same between the ozone and BAF effluents at all ozone doses examined.
This is seen in Figures 4-39, 4-41, and 4-43. This leads to the conclusion that further
degradation of recalcitrant compounds does not occur in the BAF column. If further
degradation of recalcitrant compounds were to occur in the BAF column, then the
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concentration of NBDOC would decrease in the BAF column. This is not seen, although
slight variations in TOC, BDOC, and NBDOC measurements are expected and do occur
because of the nature of the TOC analysis. These variations are well within the range of
expected errors (± 5 percent).
The fraction of non-biodegradable organics in the MBR effluent that is converted
to a more biodegradable form through partial oxidation in the ozone contact chamber
increases with applied ozone dose as shown in Table 4-4. The percent of NBDOC
converted to BDOC in the ozone contact chamber is 16.6, 33.4, and 58.2 percent at ozone
doses of 2, 4, and 8 mg/L respectively. The percent converted per mg/L of ozone is 8.3,
8.4, and 7.3 percent per mg/L of ozone at ozone doses of 2, 4, and 8 mg/L respectively.
This shows that the NBDOC is converted to BDOC more effectively at the 2 and 4 mg/L
ozone doses than at the ozone dose of 8 mg/L. The effectiveness of ozone to convert
NBDOC to BDOC is almost the same at the 2 and 4 mg/L ozone doses with 8.3 and 8.4
percent of the NBDOC being converted to BDOC per mg/L of ozone. This drops to 7.3
percent per mg/L of ozone at an ozone dose of 8 mg/L. This follows the conclusions
found in the other organic analysis previously discussed. The TOC, TOC/TOC0, UV254
absorbance, and SUVA results for Phase 2, showed that increased organic removal was
achieved with increasing ozone doses, although the effectiveness of ozone at 8 mg/L
dramatically decreased.
Following the results of the bulk organic analysis, it is expected that PPCP/EDC
removal will be achieved at all applied ozone doses examined. It is also expected that
compound removal will increase with applied ozone dose. The 8 mg/L ozone dose is
expected to show the highest removal of PPCPs/EDCs. The 4 mg/L ozone dose is
expected to remove compounds the most efficiently while the 2 mg/L ozone dose is
expected to remove some compounds well, although a majority of compounds will not be
removed to below detectable limits. The PPCP/EDC results are found in the next section.
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PPCP/EDC Results
The bulk organic analysis showed that organics are not completely mineralized by
ozone, even at higher doses, although the biodegradable fraction is increased as the
applied ozone dose is increased. The bulk organic analysis also showed that the most
effective ozone dose, in terms of percent of organics treated per mg/L of ozone, occurs at
an ozone dose of 4 mg/L for the ozone doses examined. The following section will
examine how well microconstituents were removed at the examined ozone doses and if
the removal of these compounds correlates well with what was observed in the bulk
organic analysis.

Compounds Detected in MBR Effluent
The PPCP/EDC analysis performed by MWH laboratories tested for 83 different
compounds with most having detection limits at 5 ng/L. A summary table of compounds
and detection limits was previously presented in Table 3-8. Of these 83 compounds, 52
were detected in one or more samples in the MBR effluent. These compounds as well as
average concentrations and relative standard deviation can be found in Table 4-5. Three
compounds (dehydronifedipine, meclofenamic acid, and DACT) were detected in the
ozone or BAF effluent, but not in the MBR effluent for at least one sample. All three of
these compounds were also detected in the MBR effluent in at least one of the sampling
events. The concentrations of these compounds were close to the detection limit, which
leads to the conclusion that they were not detected in the MBR effluent due to the
limitations of the analysis. This will be discussed in greater detail later.
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Table 4-5: Summary table of concentrations, average concentrations, and relative standard
deviations of compounds detected in MBR effluent (ng/L).

Analyte
1,7-Dimethylxanthine
4-Nonylphenol
4-tert-Octylphenol
Acetaminophen
Albuterol
Amoxicillin
Atenolol
BPA
Butalbital
Caffeine
Carbadox
Carbamazepine
Carisoprodol
Cimetidine
Cotinine
DACT
DEA
DEET
Dehydronifedipine
Dilantin
Erythromycin
Furosimide
Gemfibrozil
Iohexal
Iopromide
Ketoprofen
Lincomycin
Ketorolac
Lidocaine
Lopressor
Meclofenamic Acid
Meprobamate
Naproxen
Oxolinic acid
Pentoxifylline
Primidone
Propylparaben
Sucralose
Sulfadiazine
Sulfamethazine
Sulfamethoxazole
Sulfathiazole
TCEP
Theobromine
Theophylline
Triclosan
Trimethoprim
Warfarin
Atrazine
Bromacil
Diuron
Linuron

Initial sample
8 mg/L sample
Average 4 mg/L 2 mg/L sample
Relative
taken 8/18/2009 taken 10/29/2009 sample taken
taken 11/13/2009 Average std dev
(ng/L)
(ng/L)
(ng/L)
11/06/2009 (ng/L) (ng/L)
(%)
46
BDL
BDL
59
18
470
410
25
37
330
13
360
150
240
83
6.7
5.7
150
7.6
210
BDL
170
BDL
860
3400
BDL
16
BDL
BDL
230
21
230
85
BDL
5.2
110
6.3
55600
35
BDL
710
BDL
270
150
87
73
27
BDL
BDL
20
75
BDL

29
330
BDL
88
15
1200
490
BDL
80
510
BDL
440
60
110
20
BDL(1)
BDL
33
9.6
270
BDL
230
85
590
14000
BDL
BDL
11
390
230
BDL
380
260
BDL
BDL
120
BDL
37000
16
BDL
1600
BDL
41
110
62
BDL
60
7
BDL
20
23
BDL

46
270
BDL
62.5
6.2
485
380
BDL
34
300
6.05
410
48.5
100.5
32.5
BDL(1)
BDL
39
BDL(1)
350
18.5
150
43
560
5300
6.9
BDL
7.25
335
160
37.5
395
160
23
BDL
120
BDL
43000
9.15
5.1
1040
5.8
120
62.5
98
14
79.5
BDL
43
BDL
24.5
5

21
280
13
18
BDL
580
240
BDL
25
140
27
450
46
100
BDL
6.8
BDL
13
6.4
320
BDL
87
9.3
140
4100
62
BDL
BDL
300
BDL
BDL(1)
390
68
BDL
BDL
200
BDL
34000
19
BDL
470
9.2
200
36
40
14
BDL
BDL
BDL
5.6
15
BDL

36
223
11
57
11
684
380
14
44
320
13
415
76
138
36
6
5
59
7
288
12
159
36
538
6700
20
12
7
258
160
17
349
143
10
5
138
5
42400
20
5
955
6
158
90
72
28
44
6
15
13
34
5

BDL = Below detectable limit
(1) = Compound was detected in ozone or BAF effluent and not in MBR effluent

35.4%
64.8%
14.0%
50.9%
58.2%
50.8%
27.4%
54.5%
55.8%
47.4%
79.4%
9.7%
65.2%
49.7%
89.1%
17.2%
6.8%
105.3%
27.3%
21.3%
35.1%
37.0%
104.2%
55.3%
73.6%
143.0%
26.1%
40.1%
66.9%
61.9%
90.7%
22.8%
61.1%
94.7%
2.0%
30.5%
12.2%
22.6%
55.3%
1.0%
51.2%
32.0%
62.8%
56.4%
36.2%
108.9%
71.2%
18.2%
131.0%
67.1%
79.7%
0.0%
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Several compounds were not detected in all of the sampling events. To calculate
the average concentrations and relative standard deviations, compounds that were not
detected were assumed to have concentrations just below the detectable limits (5 ng/L for
most compounds). Thirty-one of the compounds tested for by MWH laboratories were
not detected in any of the 16 samples collected. A list of these compounds and their
detection limits are shown in Table 4-6.

Table 4-6: List of the 31 compounds not detected and their detection limits

Analyte
Andorostenedione
Bendroflumethiazide
Bezafibrate
Butylparaben
Chloramphenicol
Chloridazon
DIA
Diazepam
Diclofenac
Estradiol
Estrone
Ethinyl Estradiol - 17
alpha
Ethylparaben
Flumeqine
Ibuprofen
Isobutylparaben

Detection
Limit (ng/L)

Analyte

Detection
Limit (ng/L)

5
5
5
5
10
5
5
5
5
5
5

Metazachlor
Methylparaben
Nifedipine
Norethisterone
Progesterone
Sulfachloropyridazine
Sulfadimethoxine
Sulfamerazine
Sulfamethizole
Simazine
Propazine

5
20
20
5
5
5
5
5
5
5
5

5
20
10
10
5

Chlorotoluron
Cyanazine
Isoproturon
2,4-D

5
5
20
5

Quality Assurance
Several steps were taken to ensure the PPCP/EDC data was as accurate as
possible. To ensure the results were reproducible, duplicates were collected for the
MBR, ozone, and BAF effluents during the 4 mg/L ozone dose sampling event. To
ensure that the sampling process was free of contamination from outside sources, a field
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blank was collected during the 8 mg/L ozone dose sampling event. Both these additional
analyses are used to increase the confidence in the data.

MBR, Ozone, and BAF Duplicates
The duplicates collected during the 4 mg/L ozone dose sampling event were
collected in the same manner as all other PPCP/EDC samples. The duplicates for each
process were collected at the same time as the primary samples. A list of the compounds
detected, their concentrations, as well as the mean and difference/mean for the MBR,
ozone, and BAF effluents are shown in Tables 4-7, 4-8, and 4-9 respectively.
A total of 44 compounds were detected during the 4 mg/L ozone dose sampling
event. Of these compounds, only two (dehydronifedipine and DACT) were not detected
in the MBR effluent. Both dehydronifedipine and DACT were detected in the ozone and
BAF effluents in both the primary and duplicate samples at average concentrations of 14
and 11.5 ng/L respectively. Both compounds have a detection limit of 5 ng/L. Five other
compounds (ketoprofen, sulfamethazine, sulfathiazole, atrazine, and linuron) were only
detected once in either the primary or duplicate sample. Of these only atrazine was
detected at a concentration greater than 6.9 ng/L with detection limits for these
compounds at 5 ng/L. Because the concentrations were so close to the detection limits,
the lack of detection in both samples was most likely due to concentrations of compounds
being below the detection limit. Additional confidence in the data is also gained by
examining the difference in the detected concentrations in the primary and duplicate
samples and dividing it by the mean.
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Table 4-7: Concentrations of compounds detected in primary and duplicate 4 mg/L
sampling event along with mean and difference/mean
Analyte
1,7-Dimethylxanthine
4-Nonylphenol
Acetaminophen

Primary

Duplicate

Mean

Concentration, ng/L

Concentration, ng/L

Concentration, ng/L

Difference/
Mean
13%

43

49

46

270

270

270

0%

64

61

62.5

5%

Albuterol

5.5

6.9

6.2

23%

Amoxicillin

450

520

485

14%

Atenolol

350

410

380

16%

Butalbital

38

30

34

24%

Caffeine

320

280

300

13%

Carbadox

6.3

5.8

6.05

8%

Carbamazepine

460

360

410

24%

Carisoprodol
Cimetidine
Cotinine
DACT
DEET
Dehydronifedipine
Dilantin
Erythromycin
Furosimide
Gemfibrozil
Iohexal

48

49

48.5

2%

110

91

100.5

19%

19
BDL(1)

46
BDL(1)

32.5
BDL(1)

83%

38
BDL(1)

40
BDL(1)

39
BDL(1)

5%

310

390

350

23%

18

19

18.5

5%

150

150

150

0%

-

41

45

43

9%

740

380

560

64%

Iopromide

5000

5600

5300

11%

Ketoprofen

6.9

BDL

5.95

32%

Ketorolac

7.3

7.2

7.25

1%

Lidocaine

310

360

335

15%

Lopressor

150

170

160

13%

32

43

37.5

29%

Meclofenamic Acid
Meprobamate

420

370

395

13%

Naproxen

150

170

160

13%

Oxolinic acid

21

25

23

17%

Primidone

100

140

120

33%

Sucralose

47000

39000

43000

19%

Sulfadiazine

9.1

9.2

9.15

1%

Sulfamethazine

5.1

BDL

5.05

1%

Sulfamethoxazole

980

1100

1040

12%
15%

Sulfathiazole

BDL

5.8

5.4

110

130

120

17%

Theobromine

50

75

62.5

40%

Theophylline

98

98

98

0%

Triclosan

14

14

14

0%

Trimethoprim

76

83

79.5

9%

Atrazine

43

BDL

24

158%

Diuron

24

25

24.5

4%

Linuron

BDL

5

5

0%

TCEP

BDL = Below detectable limit
(1) = Compound was detected in ozone or BAF effluent and not in MBR effluent
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The difference/mean values for all compounds were low. For the MBR effluent
samples, five compounds had difference/mean values of 0, 13 had ≤ 5%, 16 compounds
had ≤ 10%, and 35 had a difference/mean value of < 25%. Only 7 compounds had a
difference/mean value of > 25%.

Table 4-8: Ozone effluent primary and duplicate concentrations, mean, and
difference/mean value for 4 mg/L sampling event

Primary
Concentration,
ng/L

Duplicate
Concentration,
ng/L

Mean
Concentration,
ng/L

Difference/
Mean

4-Nonylphenol
Atenolol
Caffeine
Carisoprodol
Cotinine

130
7.9
(2)
BDL
12
BDL

150
5.6
BDL(2)
16
12

140
6.75
BDL(2)
14
11

14%
34%
29%
18%

DACT
DEET
Dehydronifedipine
Dilantin
Iohexal
Iopromide
Meprobamate
Primidone
Sucralose
Sulfamethoxazole
TCEP
Theobromine

14(1)
4.9
(1)
14
79
390
1700
80
34
26000
13
69
(2)
BDL

9(1)
5.5
14(1)
110
220
2900
75
44
20000
12
69
BDL(2)

11.5
5.2
14
94.5
305
2300
77.5
39
23000
12.5
69
BDL(2)

43%
12%
0%
33%
56%
52%
6%
26%
26%
8%
0%
-

Analyte

BDL = Below detectable limit
(1) = Compound not detected in MBR effluent
(2) = Compound detected in BAF effluent and not in ozone effluent

A total of 17 compounds detected in the effluent from the ozone contactor or
BAF. As mentioned earlier, the compounds DACT and dehydronifedipine were not
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detected in the MBR effluent in either the primary or duplicate samples, although they
were detected in both the ozone and BAF effluents in both primary and duplicate
samples. Three compounds were detected in only one sample with two, continine (12
ng/L) and theobromine (8.6 ng/L), being detected at levels close to their detection limit.

Table 4-9: BAF effluent primary and duplicate concentrations, mean, and difference/mean
values for 4 mg/L sampling event

Analyte

Primary
Concentration,
ng/L

Duplicate
Concentration,
ng/L

4-Nonylphenol
Atenolol
Caffeine
Carisoprodol
Cotinine
DACT
DEET
Dehydronifedipine
Dilantin
Iohexal
Iopromide
Meprobamate
Primidone
Sucralose
Sulfamethoxazole
TCEP
Theobromine

140
10
24
16
12
(1)
8.9
6.2
(1)
20
85
BDL
3900
78
48
34000
13
70
BDL

120
10
15
14
11
13(1)
4.8
18(1)
98
160
2400
87
44
20000
12
51
8.6

Mean
Difference/M
Concentration,
ean
ng/L
130
10
19.5
15
11.5
10.95
5.5
19
91.5
85
3150
82.5
46
27000
12.5
60.5
6.8

15%
0%
46%
13%
9%
37%
25%
11%
14%
176%
48%
11%
9%
52%
8%
31%
53%

BDL = Below detectable limit
(1) = Compound not detected in MBR effluent

A total of 15 compounds were detected in the ozone contactor effluent as seen in
Table 4-8. Four of the compounds had a difference/mean value of ≤ 10% with two of
these at 0%. Seven compounds had a difference/mean value of < 20%. A total of 17
compounds were detected in the BAF effluent as seen in Table 4-9. Nine of the
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compounds had a difference/mean value of ≤ 15% with one compound having 0%. Eight
compounds had a difference/mean value of greater than 20% with the highest being for
iohexal at 176%. The iohexal results show inconsistency throughout the PPCP/EDC
results, as will be discussed in more detail later.

Field Blank
The other test done for quality assurance purposes was collection and analysis of
a field blank. The field blank was taken during the 8 mg/L sampling event. The field
blank was supplied by MWH laboratories and consisted of water that was free of all
compounds being tested. To sample, the water was transferred from the travel container
to the sample vials. Normal sampling protocol was followed and the sample vials were
the same ones used on all the other samples. The vials were packed and shipped with the
other samples gathered during the 8 mg/L sampling event.
Using a field blank can ensure that contamination is not the result of the sample
preparation, preservation, and shipping process. This is especially important when
measuring for contaminants at ultra-low concentrations. The field blank may also
explain if there are any discrepancies in the data. For example if an unexpected
compound is detected at high concentrations, then the field blank might help explain
why.
Two compounds, propylparaben and 4-nonylphenol, were found in the field blank
at concentrations of 42 and 200 ng/L respectively. Propylparaben is an antimicrobial
preservative that can be found in food, pharmaceuticals, creams, skin care products,
cosmetics, and shampoos [50]. Other than the field blank, propylparaben was found in
only one other sample, the 8/19/09 sample of MBR effluent. This sample was not part of
the Phase 2 experiments. Based on the presence in the field blank, the detection of
propylparaben in the 8/19/09 MBR effluent cannot be assumed to be valid.
4-nonylphenol was detected in all processes and in every sampling event except
the 8/19/09 MBR effluent sample. This compound was even detected in the RO effluent
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at concentrations of 210 and 230 ng/L for the 2 and 4 mg/L sampling events respectively.
Detecting the compound in the RO effluent at these high concentrations was unexpected,
but because this compound was detected at similar levels in the field blank (200 ng/L),
the detection is assumed to be due to contamination.
There are several possible sources of contamination for 4-nonylphenol. The
compound can be found in many different manufacturing processes as well as in
pesticides [51]. The compound is also used as a plastic stabilizer and has been reported
to be in the air at low levels [51]. Due to consistent levels of 4-nonylphenol being
detected in all process effluents for all ozone sampling events, including the field blank,
all 4-nonylphenol results were discarded. The reported concentrations for 4-nonylphenol
can be found in Table 4-10.

Table 4-10: Sampling events, processes, and concentrations for 4-Nonylphenol
Sample ID

Detection of 4-Nonylphenol in all processes (ng/L)
8/19/2009

2 mg/L

MBR effluent
BDL
Ozone effluent
NS
BAF effluent
NS
RO
NS
Field blank
NS
NS = No sample taken

280
200
140
210
NS

4 mg/L primary
270
130
140
230
NS

4 mg/L duplicate

8 mg/L

270
150
120
NS
NS

330
130
150
NS
200

BDL = Below detectable limits

PPCP/EDC Removal
A total of 48 compounds were detected during the 2, 4, and 8 mg/L sampling
events, however, propylparaben and 4-nonylphenol were not considered reliable
measurements because of their appearance in the field blank. A summary of the
remaining 46 compounds, as well as their percent removal for all 3 sampling events, can
be found in Table 4-11.
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It is important to note that even though there were a large number of PPCPs
detected in the MBR effluent, the total concentration of these compounds is only a small
fraction of the organic composition of the water. The average total concentration of
PPCPs detected in the MBR effluent is approximately 52,000 ng/L, with almost three
quarters of this total attributed to sucralose. This is approximately 1% of the total
organics in the MBR effluent. The remaining 99% of the organics in the MBR effluent is
material that is not well characterized, but will compete with the PPCPs for oxidation by
ozone and microbial populations.
Table 4-11 tabulates the percent removal of compounds from the MBR effluent
by ozonation and combined ozonation BAF processes at each applied ozone dose. For
each examined ozone dose, there are two different columns of compound percent
removal. The percent removal in BAF column lists the percent removal of compounds
between the MBR and BAF effluents. It does not take into account compound removal in
the ozone effluent and only looks at the difference in concentrations of compounds
detected in the MBR and BAF effluents. The percent removal in BAF column accounts
for the compounds initially detected in the MBR effluent, and then calculates the percent
removal based on the concentration of compounds detected in the BAF effluent. This
method looks at the total removal of compounds at the end of the treatment train. The
percent removal ozone only column examines the compound percent removal between
the MBR and ozone effluents. The values listed in this column do not take into account
the removal of compounds by the BAF process. A third category of compound percent
removal is the ozone to BAF percent removal, which examines the percent removal of
compounds between the ozone and BAF effluents. This will be further examined later.
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Table 4-11: Percent removal of PPCPs from MBR effluent by ozone oxidation and by
combined ozone oxidation and BAF, for all compounds detected in 2, 4, and 8 mg/L
sampling events
2 mg/L results
4 mg/L results
8 mg/L results
Percent removal Percent removal Percent removal Percent removal Percent removal Percent removal
in BAF
ozone only
in BAF
ozone only
in BAF
ozone only
1,7-Dimethylxanthine
BDL
BDL
BDL
BDL
BDL
BDL
BDL(2)
BDL(2)
BDL(2)
BDL(2)
4-tert-Octylphenol
BDL
BDL
BDL(2)
BDL(2)
BDL
BDL
BDL
BDL
Albuterol
Acetaminophen
BDL
BDL
BDL
BDL
BDL
BDL
94
Amoxicillin
95
BDL
BDL
BDL
BDL
29
98
Atenolol
42
97
BDL
BDL
70
Butalbital
73
BDL
BDL
BDL
BDL
55
Caffeine
42
94
BDL
BDL
BDL
BDL(2)
BDL(2)
Carbadox
19
BDL
BDL
BDL
96
Carbamazepine
95
BDL
BDL
BDL
BDL
-4
71
Carisoprodol
22
69
BDL
BDL
Cimetidine
BDL
BDL
BDL
BDL
BDL
BDL
(2)
(2)
63
BDL
BDL
Cotinine
65
BDL
BDL
18
BDL(1)
BDL(1)
BDL(1)
BDL(1)
DACT
9
8
87
DEET
8
86
BDL
BDL
-5
BDL(1)
BDL(1)
Dehydronifedipine
16
BDL
BDL
28
73
Dilantin
25
74
BDL
BDL
BDL(2)
BDL(2)
BDL(2)
BDL(2)
Erythromycin
BDL
BDL
Furosimide
BDL
BDL
BDL
BDL
BDL
BDL
Gemfibrozil
BDL
BDL
BDL
BDL
BDL
BDL
-21
46
42
Iohexal
-64
71
42
7
57
82
Iopromide
15
41
89
11
BDL(2)
BDL(2)
Ketoprofen
10
BDL
BDL
(2)
(2)
BDL
BDL
BDL
BDL
BDL
BDL
Ketorolac
75
Lidocaine
60
BDL
BDL
BDL
BDL
BDL(2)
BDL(2)
Lopressor
BDL
BDL
BDL
BDL
BDL(2)
BDL(1)
BDL(1)
BDL(2)
Meclofenamic Acid
BDL
BDL
33
80
80
Meprobamate
31
79
75
Naproxen
85
BDL
BDL
BDL
BDL
BDL
BDL(2)
BDL(2)
BDL(2)
BDL(2)
BDL
BDL
Oxolinic acid
45
68
92
Primidone
40
62
92
-6
47
57
Sucralose
0
37
57
Sulfadiazine
BDL
BDL
BDL
BDL
BDL
BDL
BDL(2)
BDL(2)
BDL(2)
BDL(2)
BDL
BDL
Sulfamethazine
47
99
Sulfamethoxazole
66
99
BDL
BDL
BDL(2)
BDL(2)
Sulfathiazole
32
BDL
BDL
BDL
10
43
-129
TCEP
20
50
-BDL
31
Theobromine
8
86
BDL
BDL
BDL
Theophylline
BDL
BDL
BDL
BDL
BDL
BDL
BDL(2)
BDL(2)
Triclosan
BDL
BDL
BDL
BDL
BDL(2)
BDL(2)
BDL
BDL
BDL
BDL
Trimethoprim
BDL(2)
BDL(2)
BDL(2)
BDL(2)
BDL
BDL
Warfarin
(2)
(2)
(2)
BDL
BDL(2)
BDL
BDL
BDL
BDL
Atrazine
(2)
(2)
BDL
BDL
BDL
BDL
Bromacil
BDL
BDL
33
Diuron
27
BDL
BDL
BDL
BDL
(2)
(2)
(2)
BDL(2)
BDL
BDL
BDL
BDL
BDL
Linuron
Analyte

BDL = Below detectable limit
(1) = Compound not detected in MBR effluent
(2) = Compound not detected during sampling event
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Because this research did not spike any compounds into the water, not all
compounds were detected in every sampling event. A total of 17 compounds were not
detected in any of the process effluents for at least one sampling event during Phase 2.
Therefore, a few assumptions are made in order to compare the removal efficiencies for
as many compounds as possible. If a compound is removed to below detectable limits
(BDL) at an ozone dose of 2 or 4 mg/L, it is assumed that the compound is also removed
to BDL at higher ozone doses even if the compound was not detected in the MBR
sample. This assumption is based on the results for 16 compounds. These compounds
were detected at all applied ozone doses and were removed to BDL at an ozone dose of 2
or 4 mg/L. All compounds that were removed to BDL at a lower ozone dose were also
removed to the same level at all higher doses. Only three compounds, iohexal,
meprobamate and TCEP were found to have a lower percent removal at a higher applied
ozone dose. The percent removal of iohexal by the BAF varies greatly from -64%, 71%,
and 42% removal at applied ozone doses of 2, 4, and 8 mg/L respectively. The ozone
only percent removals were -21%, 46%, and 42% for applied ozone doses of 2, 4, and 8
mg/L respectively. The percent removal for iohexal, as well as the concentrations
detected at each applied ozone dose, is shown in Table 4-12. This inconsistency for
iohexal was also observed in the duplicate samples taken during the 4 mg/L ozone dose
tests. The difference/mean values for iohexal were 64, 56, and 176% in the MBR, ozone,
and BAF effluents respectively. These poor duplicate results show that the iohexal data
may not be as reliable as the other compounds and that there might be another for the
observed reverse in removal with increased applied ozone dose.
Iohexal is an iodinated X-ray contrast media (ICM). The literature has shown that
ICM’s are particularly resistant to oxidation degradation [46, 52, 53] although the amount
of degradation varies depending on the compound. Iohexal has been shown to be
particularly resilient to oxidation by ozone. A recent article by Bahr et al. (2007)
reported a 35 percent removal for iohexal at an ozone dose of 1 mg O3/mg DOC0 [46].
This is equivalent to the 4 mg/L ozone dose used in this research which showed similar
removal efficiencies for iohexal.
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Table 4-12: Concentrations and percent removal for ozonation and ozonation-BAF for the
compounds iohexal, meprobamate, and TCEP
Ozone dose

MBR effluent,
mg/L

Ozone
effluent,
mg/L

140

170

560
590

305
340

BAF
effluent,
mg/L

Percent
removal ozone
only

Percent
removal in
BAF

230

-21

-64

160
340

46
42

71
42

Iohexal results
2 mg/L
4 mg/L
(average)
8 mg/L

Meprobamate results
2 mg/L
4 mg/L
(average)
8 mg/L

390

260

270

33

31

395
380

77.5
77

82.5
94

80
80

79
75

200

180

160

10

20

120
41

69
94

60.5
82

43
-129

50
-100

TCEP results
2 mg/L
4 mg/L
(average)
8 mg/L

Unlike iohexal, meprobamate had much more consistent data. The percent
removal for meprobamate in the BAF column was 31%, 79%, and 75% for applied ozone
doses of 2, 4, and 8 mg/L respectively. The ozone only results are similar with percent
removals of 33%, 80%, and 80% for ozone doses of 2, 4, and 8 mg/L respectively. The
percent removal for meprobamate, as well as the concentrations detected at each applied
ozone dose, is shown in Table 4-12. Even though the 8 mg/L ozone dose had a slightly
lower percent removal than the 4 mg/L in both the BAF and ozone only results, the
difference is small enough to assume that no additional removal was achieved at an ozone
dose of 8 mg/L. The reported result of decreased removal at higher ozone dose can be
assumed to be due to variability in the analyzer. The removal efficiency between the
ozone only and BAF column results are also close enough to assume no additional
removal occurs in the BAF column.
The last compound that showed lower removal at higher applied ozone doses was
TCEP. TCEP removal in the BAF column was 20%, 50%, and -100% at ozone doses of
2, 4, and 8 mg/L respectively, as shown in Table 4-12. The ozone only results were
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similar with percent removals of 10%, 43%, and -129% for ozone doses of 2, 4, and 8
mg/L. At applied ozone doses of 2 and 4 mg/L, there is slightly higher removal achieved
after the BAF process. There is also increased removal between the ozone doses of 2 and
4 mg/L. This follows the expected trend of increased compound removal with increasing
ozone dose. At an ozone dose of 8 mg/L though, the percent in removal does not
increase but drastically decreases and shows a large negative percent removal. It is noted
in Table 4-12 that the TECP concentration in the MBR effluent during the 8 mg/L dose
test was lower than all other results. This value may have been a bad analytical result and
may have contributed to the strange results. A study done by Snyder et al. (2006) showed
TCEP to be extremely resistant to oxidation even at higher ozone doses [43]. The results
also showed inconsistent removal between applied ozone doses, similar to what is seen in
this research.
The results have shown slight differences in PPCP removal achieved by the ozone
and BAF processes. As discussed earlier in the Phase 2 bulk organic analysis, the BAF
column is not expected to achieve additional removal of recalcitrant compounds beyond
that achieved by ozonation. The next section will further examine the effectiveness of
the BAF column in removing PPCPs/EDCs from wastewater.

Effectiveness of BAF Process in Removing Microconstituents
One of the main purposes of this research is to investigate the removal of
microconstituents by both the ozone and BAF processes. The effectiveness of the BAF
process can be seen by examining the percent removal of compounds by each process as
illustrated in Table 4-11. Many of the compounds have similar percent removals between
the ozone only and BAF processes. A majority of the compounds in all sampling events
are either removed completely by the ozone and BAF processes, or have removal
differences of <1%, although there are some compounds with larger differences,
especially in the 2 mg/L sampling event.
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The results of the previous section show that compounds are being partially
oxidized in the ozone contact chamber at all ozone doses examined. To further analyze
the effectiveness of the BAF process in removing microconstituents from wastewater, the
percent removal of compounds from the ozone to BAF process can be examined. A
summary of percent removals for 20 microconstituents between the ozone and BAF
processes is presented in Table 4-13. The other 24 compounds were not listed because
they were either not found, or were removed to below detectable limits in all three
sampling events. The data from Table 4-13 is plotted in Figure 4-45 to further illustrate
the amount of removal from the ozone to BAF process.
The data in Table 4-13 and Figure 4-45 illustrate the large range of both positive
and negative compound percent removals from the ozone to BAF processes. The
negative percent removal values show that the concentration of a compound is higher in
the BAF effluent than the ozone effluent. Out of the 20 compounds shown in Table 4-13,
10 have a negative compound percent removal from ozone to BAF in the 2 mg/L
sampling event, 8 are negative in the 4 mg/L sampling event, and only one compound has
a negative percent removal in the 8 mg/L sampling event.
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Table 4-13: Summary of percent compound removal from ozone to BAF processes

2 mg/L

4 mg/L

8 mg/L

Percent
removal OzoneBAF

Percent
removal OzoneBAF

Percent
removal OzoneBAF

Amoxicillin
Atenolol
Butalbital

12
18
9

BDL
-48
BDL

BDL
BDL
BDL

Caffeine
Carbamazepine
Carisoprodol

-29
-35
25

BDL(2)
BDL
-7

BDL
BDL
BDL

BDL(1)

4

BDL

Analyte

Cotinine

(3)

DACT
DEET

-11
0

5
-6

BDL(3)
BDL

Dehydronifedipine
Dilantin
Iopromide

19
-4
8

-36(3)
3
-37

BDL
BDL
36

Ketoprofen
Lidocaine
Meprobamate
Primidone
Sucralose
Sulfamethoxazole

-2
-62
-4
-9
6
36

BDL
BDL
-6
-18
-17
0

BDL(1)
BDL
-22
8
0
BDL

Theobromine
Diuron

-32
-10

BDL(2)
BDL

BDL
BDL

BDL = Below detectable limits
(1) = Not detected during sampling event in any process
(2) = Only detected in MBR and BAF effluent
(3) = Not detected in MBR effluent
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Figure 4-45: Percent removal of compounds from ozone to BAF processes for 2, 4, and 8
mg/L ozone doses

The difference in PPCP removal between the ozone only and BAF column is
small, as seen in Table 4-11. As mentioned earlier, many compounds show less than a
1% difference between the two processes, although there are a few compounds with
higher differences. Even though there is only a small difference in percent removals
between ozone only and BAF column measurements for most of the compounds, the
removal from ozone to BAF shows much larger differences, which can be misleading. A
large percent removal from ozone to BAF leads to the assumption that there is a large
difference in percent removals from the ozone only and BAF column. This is not the
case though. For example, the percent removals for ozone only and the BAF column for
the compound atenolol is 98.2% and 97.4% respectively for the 4 mg/L sampling event as
shown in Table 4-14. This is a difference of 0.8%. The percent removal for this
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compound from the ozone to BAF process is -48.2% for the same sampling event. The
large percent removal of atenolol from the ozone to BAF is misleading because the
concentration of atenolol in the ozone and BAF effluents is almost the same. Due to the
small difference in compound removal between the ozone and BAF for almost all the
compounds detected, the assumption is made that there is little additional removal of nonozonated, recalcitrant compounds in the BAF column. This is also seen when examining
the bulk organic analysis in Phase 2. The results of the TOC, TOC/TOC0, UV254
absorbance, SUVA, and BDOC values show that there is little to no additional removal of
recalcitrant organics in the BAF column.

Table 4-14: Percent removal of atenolol in BAF, ozone only, and from ozone to BAF
column

4 mg/L results
Analyte

Atenolol

Percent
removal in
BAF
97.4

Percent
removal ozone
only
98.2

Percent
removal OzoneBAF
-48.1

Even with the wide range of both positive and negative percent removal values,
the average percent removal from the ozone to BAF processes at 2, 4, and 8 mg/L was 4.3%, -7.4%, and 5.8% respectively. The average percent removal for all compounds
between the ozone and BAF processes over all three sampling events was -3.9%.
Because the percent removal from ozone to BAF averaged out to be close to zero, and
because the actual differences in concentrations between the two processes are extremely
close, and the detection levels are so small, the percent difference is assumed to be due to
variability in the analysis.
It is also assumed that there is little to no removal of un-oxidized, recalcitrant
compounds in the BAF process. Because the compounds have already been through a
biological process in the MBR, most of the remaining organics are assumed non-
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biodegradable. To make them more biodegradable, ozone is used, which breaks the
compound down to a more biodegradable form. The ozonation process is essential in
oxidizing recalcitrant compounds into smaller more biodegradable forms that can then be
removed through biodegradation in the BAF column. Even though the initial, recalcitrant
compounds are not removed by the BAF column, the bulk organic analysis shows that the
compounds are not completely mineralized by ozone either. Instead, they are broken
down into smaller more biodegradable compounds by the ozone, and then removed by
the BAF column. It is only through a combination of both processes that removal of
organics is attained.
Due to the observation that little to no additional removal of recalcitrant
compounds is occurring in the BAF column, and because the concentrations of
compounds detected in the ozone effluent are similar to what is being detected in the
BAF effluent, the following sections will only focus on the removal of compounds
between the MBR and BAF column.

PPCP/EDC Removal at 2, 4, and 8 mg/L Ozone Doses
Of the 52 compounds detected in the MBR effluents for the 4 sampling events, 11
were found in only one sampling event, as shown in Table 4-15. Four of these
compounds were only detected in the 8/19/09 MBR effluent sample and not during the
Phase 2 experiments. Additionally, the results for 2 compounds (4 nonylphenol and
propylparaben) were discarded due to the results from the field blank. Of the remaining
46 compounds detected and examined for percent removal, 10 compounds were removed
to BDL at an applied ozone dose of 2 mg/L. An additional 10 compounds, not detected
in the 2 mg/L sampling event, were removed to BDL at 4 mg/L. One additional
compound was removed to BDL that was not found in either the 2 or 4 mg/L samples.
The removal of PPCPs/EDCs at the various ozone doses will be examined in the next
section.
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Table 4-15: Compounds only detected in one sampling event
Analyte

Sample ID

Result

BPA
DEA

8/19/09 MBR Effluent
8/19/09 MBR Effluent

25
5.7

Lincomycin
Pentoxifylline
4-tert-Octylphenol
Erythromycin
Oxolinic acid
Sulfamethazine
Atrazine
Linuron
Warfarin

8/19/09 MBR Effluent
8/19/09 MBR Effluent
MBR Effluent 2 mg/L
MBR Effluent 4 mg/L
MBR Effluent 4 mg/L
MBR Effluent 4 mg/L
MBR Effluent 4 mg/L
MBR Effluent 4 mg/L
MBR Effluent 8 mg/L

16
5.2
13
18.5
23
5.1
43
5
7

PPCP/EDC Removal at 2 mg/L Ozone dose
A total of 36 compounds were detected during the 2 mg/L ozone dose sampling
event collected on November 13th, 2009. One of the compounds detected was 4nonylphenol. The results for this compound were discarded because of its detection in
the field blank as described earlier. The remaining 35 compounds, their concentrations in
the MBR, ozone, and BAF effluents, and their percent removal in the BAF is shown in
Table 4-16. Meclofenamic acid was the only compound not detected in the MBR
effluent during this sampling event. The compound was only detected in the BAF
effluent at a concentration of 7.4 ng/L, which is close to the detection limit of 5 ng/L.
Because meclofenamic acid was not detected in the MBR effluent, the percent removal
between the MBR and BAF cannot be determined for this compound.
Four compounds, meclofenamic acid, Sulfathiazole, naproxen, and carbadox,
were detected in the BAF effluent and not the ozone effluent. As discussed earlier,
meclofenamic acid was only detected in the BAF effluent at a concentration close to the
detection limit. The other three compounds were also detected at concentrations close to
their detection limit. Both sulfathiazole and carbadox have detection limits of 5 ng/L and
were detected in the BAF effluent at concentrations of 6.3 and 22 ng/L respectively. The
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concentration of naproxen in the BAF effluent was 10 ng/L, which is also its detection
limit. This will be further examined later.
The percent removal in the BAF column of the remaining 34 compounds for the 2
mg/L ozone dose sampling event is shown in Table 4-16. A total of 10 compounds were
removed to below detectable limits at an ozone dose of 2 mg/L. An additional 2
compounds had ≥ 90% removal, 2 had 70-90% removal, and 2 compounds had 50-70%
removal. A chart of percent removal can better illustrate the amount of compound
removal at the 2 mg/L ozone dose. The percent removal of 23 compounds is shown in
Figure 4-46. The chart does not include the 10 compounds removed to below detectable
limits, as well as the results for iohexal, which had a negative percent removal.
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Table 4-16: Concentrations of compounds detected in MBR, ozone and BAF effluents
during 2 mg/L sampling event as well as percent removal by BAF column
Analyte

Ozone
MBR effluent,
effluent, ng/L
ng/L

BAF effluent, Percent removal
in BAF
ng/L

1,7-Dimethylxanthine

21

BDL

BDL

BDL

4-tert-Octylphenol

13

BDL

BDL

BDL
BDL

Acetaminophen

18

BDL

BDL

Amoxicillin

580

34

30

95%

Atenolol

240

170

140

42%

Butalbital

25

7.4

6.7

73%

Caffeine

140

63

81

42%

Carbadox
Carbamazepine

27
450

BDL
17

22
23

19%
95%

Carisoprodol

46

48

36

22%

Cimetidine

100

BDL

BDL

BDL

DACT

6.8

5.6

6.2

9%

DEET

13

12

12

8%

Dehydronifedipine

6.4

6.7

5.4

16%

Dilantin

320

230

240

25%

Furosimide

87

BDL

BDL

BDL

Gemfibrozil

9.3

BDL

BDL

BDL

Iohexal

140

170

230

-64%

Iopromide

4100

3800

3500

15%

Ketoprofen

62

55

56

10%

300
BDL(1)

74
BDL(1)

120

60%
BDL(1)

Meprobamate

390

260

270

31%

Naproxen

68

BDL

10

85%

Primidone
Sucralose

200
34000

110
36000

120
34000

40%
0%

Sulfadiazine

19

BDL

BDL

BDL

Lidocaine
Meclofenamic Acid

7.4

Sulfamethoxazole

470

250

160

66%

Sulfathiazole

9.2

BDL

6.3

32%

TCEP

200

180

160

20%

Theobromine

36

25

33

8%

Theophylline

40

BDL

BDL

BDL

Triclosan

14

BDL

BDL

BDL

Bromacil

5.6

BDL

BDL

BDL

Diuron

15

10

11

27%

BDL = Below detectable limits
(1) = Compound not detected in MBR effluent
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Figure 4-46: Percent removal in BAF column of selected compounds at an ozone dose of 2
mg/L

Although many compounds achieved a high level of removal at the 2 mg/L ozone
dose, 18 of the 34 compounds examined did not achieve removal of ≥ 50%. The data
clearly shows that most compounds are being removed or partially removed at the lowest
applied ozone dose. From these results and the bulk organic analysis, it is expected that
higher compound removals will be achieved with increased ozone dose. Further
comparison of compound removal between applied ozone doses will be examined later.
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PPCP/EDC Removal at 4 mg/L Ozone Dose
A total of 44 compounds were detected in 4 mg/L ozone dose sampling event
collected on November 6th, 2009. Duplicate samples of the MBR, ozone, and BAF
effluents were collected for this sampling event as described earlier. One of the
compounds detected was 4-nonylphenol. The results for this compound were discarded
due to their detection in the field blank as explained earlier. The remaining 43
compounds, their average concentrations detected in the MBR, ozone, and BAF effluents,
and their average percent removal in the BAF is shown in Table 4-17. The compounds
DACT and dehydronifedipine were not detected in the MBR effluent during this
sampling event, but instead were found in both the primary and duplicate samples in both
the ozone and BAF effluents. The average concentrations of these compounds were all
close to the detection limits of 5 ng/L. The compound dehydronifedipine had the largest
average concentration at 19 ng/L. The percent removals for these compounds could not
be determined because they were not detected in the MBR effluent.
Two compounds, theobromine and caffeine, were detected in the BAF effluent
and not the ozone effluent. Both compounds had average concentrations close to their
detection limits. Theobromine had an average BAF concentration of 8.6 ng/L and has a
detection limit of 5 ng/L. Caffeine had an average BAF concentration of 19.5 ng/L and
has a detection limit of 10 ng/L. Compounds not detected in earlier processes but that are
detected in low levels later in the treatment train will be discussed later.
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Table 4-17: Concentrations of compounds detected in MBR, ozone and BAF effluents
during 4 mg/L sampling event as well as percent removal by BAF column
BAF effluent, Percent removal
in BAF
ng/L

MBR effluent,
ng/L

Ozone
effluent, ng/L

46

BDL

BDL

BDL

62.5
6.2
485
380
34
300
6.05
410
48.5
100.5
32.5
BDL(1)
39
BDL(1)
350

BDL
BDL
BDL
6.75
BDL
BDL
BDL
BDL
14
BDL
12
11.5
5.2
14
94.5

BDL
BDL
BDL
10
BDL
19.5
BDL
BDL
15
BDL
11.5
10.95
5.5
19
91.5

BDL
BDL
BDL
97%
BDL
94%
BDL
BDL
69%
BDL
65%
BDL(1)
86%
BDL(1)
74%

18.5
150

BDL
BDL

BDL
BDL

BDL
BDL

Gemfibrozil
Iohexal
Iopromide
Ketoprofen
Ketorolac
Lidocaine
Lopressor
Meclofenamic Acid
Meprobamate
Naproxen
Oxolinic acid
Primidone
Sucralose
Sulfadiazine
Sulfamethazine

43
560
5300
6.9
7.25
335
160
37.5
395
160
23
120
43000
9.15
5.1

BDL
305
2300
BDL
BDL
BDL
BDL
BDL
77.5
BDL
BDL
39
23000
BDL
BDL

BDL
160
3150
BDL
BDL
BDL
BDL
BDL
82.5
BDL
BDL
46
27000
BDL
BDL

BDL
71%
41%
BDL
BDL
BDL
BDL
BDL
79%
BDL
BDL
62%
37%
BDL
BDL

Sulfamethoxazole
Sulfathiazole
TCEP
Theobromine
Theophylline
Triclosan
Trimethoprim
Atrazine
Diuron
Linuron

1040
5.8
120
62.5
98
14
79.5
43
24.5
5

12.5
BDL
69
BDL
BDL
BDL
BDL
BDL
BDL
BDL

12.5
BDL
60.5
8.6
BDL
BDL
BDL
BDL
BDL
BDL

99%
BDL
50%
86%
BDL
BDL
BDL
BDL
BDL
BDL

Analyte
1,7-Dimethylxanthine
Acetaminophen
Albuterol
Amoxicillin
Atenolol
Butalbital
Caffeine
Carbadox
Carbamazepine
Carisoprodol
Cimetidine
Cotinine
DACT
DEET
Dehydronifedipine
Dilantin
Erythromycin
Furosimide

BDL = Below detectable limits
(1) = Compound not detected in MBR effluent
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The removal in the BAF column of the remaining 41 compounds for the 4 mg/L
ozone dose sampling event is shown in Table 4-17. A total of 27 compounds were
removed to below detectable limits at an ozone dose of 4 mg/L. An additional 3
compounds had ≥ 90% removal, 5 had 70-90% removal, and 4 compounds had 50-70%
removal. Of the 41 compounds examined, only sucralose and iopromide were found to
have percent removals of < 50%. A chart of the percent removal of 18 compounds at
ozone doses of 4 and 8 mg/L is seen in Figure 4-47. This will be examined further in the
next section.
As expected, the removal of compounds is much higher at the 4 mg/L ozone dose
than the 2 mg/L ozone dose. The data shows that most compounds were removed to
below detectable limits at the 4 mg/L ozone dose. Although it is expected that removal
will increase even more at the 8 mg/L ozone dose, the effectiveness of the ozone is
expected to decrease at the higher dose as shown by removal of TOC, SUVA, and UV254
absorbance discussed earlier. This will be further examined later.

PPCP/EDC Removal at 8 mg/L Ozone dose
A total of 37 compounds were detected during the 8 mg/L ozone dose sampling
event collected on October 29th, 2009. The compounds 4-nonylphenol and propylparaben
were detected in this sample. The results for these compounds were discarded due to
their detection in the field blank, which is explained earlier. The remaining 35
compounds, their concentrations in the MBR, ozone, and BAF effluents, and their percent
removal in the BAF is shown in Table 4-18. The compound DACT was the only
compound in the sampling event that was not detected in the MBR effluent. DACT was
only detected in the ozone effluent sample at a concentration of 5.3 ng/L, which is
slightly higher than its detection limit of 5 ng/L. Because DACT was not detected in the
MBR effluent, the percent removal between the MBR and BAF effluents cannot be
determined.
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Table 4-18: Concentrations of compounds detected in MBR, ozone and BAF effluents
during 8 mg/L sampling event as well as percent removal by BAF column

Analyte

MBR effluent,
Ozone
BAF effluent, Percent removal
in BAF
ng/L
effluent, ng/L
ng/L

1,7-Dimethylxanthine
29
BDL
88
BDL
Acetaminophen
Albuterol
15
BDL
Amoxicillin
1200
BDL
Atenolol
490
BDL
Butalbital
80
BDL
Caffeine
510
BDL
Carbamazepine
440
BDL
Carisoprodol
60
BDL
Cimetidine
110
BDL
Cotinine
20
BDL
BDL(1)
5.3
DACT
DEET
33
BDL
9.6
BDL
Dehydronifedipine
Dilantin
270
BDL
Furosimide
230
BDL
Gemfibrozil
85
BDL
Iohexal
590
340
Iopromide
14000
2500
Ketorolac
11
BDL
Lidocaine
390
BDL
Lopressor
230
BDL
Meprobamate
380
77
Naproxen
260
BDL
Primidone
120
10
Sucralose
37000
16000
Sulfadiazine
16
BDL
Sulfamethoxazole
1600
BDL
TCEP
41
94
Theobromine
110
BDL
Theophylline
62
BDL
Trimethoprim
60
BDL
Warfarin
7
BDL
Bromacil
20
BDL
Diuron
23
BDL
BDL = Below detectable limits
(1) = Compound not detected in MBR effluent

BDL
BDL
BDL
BDL
BDL
BDL
BDL
BDL
BDL
BDL
BDL
BDL(1)
BDL
BDL
BDL
BDL
BDL
340
1600
BDL
BDL
BDL
94
BDL
9.2
16000
BDL
BDL
82
BDL
BDL
BDL
BDL
BDL
BDL

BDL
BDL
BDL
BDL
BDL
BDL
BDL
BDL
BDL
BDL
BDL
BDL(1)
BDL
BDL
BDL
BDL
BDL
42%
89%
BDL
BDL
BDL
75%
BDL
92%
57%
BDL
BDL
-100%
BDL
BDL
BDL
BDL
BDL
BDL
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Out of the 34 compounds examined for percent removal in the BAF column, 28
were removed to below detectable limits. One additional compound achieved ≥ 90%
removal, 2 had 70-90% removal, and 1 compound achieved 50-70% removal at an ozone
dose of 8 mg/L. Six compounds that did not achieve 100% removal in the BAF column
at an ozone dose of 8 mg/L, and only 2 compounds did not achieve greater than 50%
removal. The six compounds that did not achieve 100% removal were sucralose,
meprobramate, primidone, iopromide, iohexal, and TCEP. Primidone was the only
compound not removed to below detectable limits that was still removed to ≥ 90%. This
compound continually showed increased removal with increased ozone dose. Primidone
had a percent removal of 40%, 62%, and 92% at ozone doses of 2, 4, and 8 mg/L
respectively. Iopromide also had increased removal with increased ozone and was
removed at 15%, 41%, and 89% for ozone doses of 2, 4, and 8 mg/L respectively. The
compound sucralose also had increased percent removal with increased ozone dose. At
an ozone dose of 2 mg/L there was no removal observed. The percent removal increased
to 37% and 57% at ozone doses of 4 mg/L and 8 mg/L. Meprobramate had increased
percent removal between the ozone doses of 4 and 8 mg/L with 31% and 79% removal
respectively. The percent removal slightly drops at the 8 mg/L ozone dose with 75%
removal. As discussed earlier, because the difference in removal between the 4 and 8
mg/L ozone dose is so small, the assumption is made that there is no additional removal
achieved at the 8 mg/L ozone dose for the compound meprobramate and that the removal
is approximately the same at both ozone doses. The only two compounds that did not
achieve greater than 50% removal were TCEP and iohexal. These two compounds were
also the only compounds to have negative percent removals in the BAF column. The
iohexal had a -64% removal at an ozone dose of 2 mg/L. The TCEP had a -100%
removal in the BAF column at an ozone dose of 8 mg/L. As discussed earlier, the
literature has shown these compounds to be extremely resistant to oxidation by ozone.
Similar inconsistencies for TCEP were shown in an article by Snyder et al. (2006), which
showed TCEP having lower percent removals at higher ozone doses [43], similar to what
was observed in this research.
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All compounds not detected in the MBR effluent and detected in another process,
or not detected in the ozone effluent and found in the BAF effluent were all detected at
levels close to the detection limit. This was found to be true for compounds in all
sampling events. This leads to the conclusion that compounds not being detected in
subsequent processes but detected later on in the treatment train is likely a result of
analytical variability associated with measurement of constituents at ultra-low
concentrations near their detection limits. The compound is most likely at concentrations
just below detectable limits. Due to slight variations in the sampling process, and that
these compounds are being detected at such low concentrations, there is expected to be
some slight fluctuations in the concentrations of the compounds detected.
A chart of the percent removal of 18 compounds detected in the 4 and 8 mg/L
ozone dose sampling events is shown in Figure 4-47. As discussed earlier the 8 mg/L
results remove 28 out of 34 compounds to below detectable limits whereas the 4 mg/L
results remove 27 out of 41 compounds to below detectable limits. Most of the
compounds not removed to below detectable limits for both the 4 and 8 mg/L ozone
doses are still removed to a relatively high degree as seen in Figure 4-47. As expected,
the 8 mg/L ozone dose achieves a higher degree of removal compared to the 4 mg/L
ozone dose. The effectiveness of the ozone at the various ozone doses will be explored
further in the next section.
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Figure 4-47: Percent removal in BAF column of selected compounds at ozone doses of 4
and 8 mg/L

Comparison of EDC/PPCP Removal Between Ozone Doses
The last section examined the removal of PPCPs/EDCs at the various ozone doses
examined. This section will examine the efficiency of the ozone doses for PPCP/EDC
removal. Similar to the last section, this section will only examine the compound
removal in the BAF column since this is ultimately the final water produced by this
combination of treatment processes.
Examination of the performance of the treatment processes at the various ozone
doses examined can be done by grouping the compounds by removal efficiencies. A list
of the number of compounds detected at the various ozone doses, as well as statistics for
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the various degrees of compound removal are shown in Table 4-19. These statistics
include compounds removed to below detectable limits, with >90%, >70%, and >50%
removal.

Table 4-19: BAF column compound removal statistics at ozone doses of 2, 4, and 8 mg/L

Compound removal statistics
Number of compounds detected
Number of compounds compared for
removal
Number of compounds removed to
below detectable limits
Number of compounds with > 90%
removal
Number of compounds with > 70%
removal
Number of compounds with > 50%
removal
Percent of compounds removed to
below detectable limit
Percent of compounds with ≥ 90%
removal
Percent of compounds with ≥ 70%
removal
Percent of compounds with ≥ 50%
removal

2 mg/L
ozone dose

4 mg/L
ozone dose

8 mg/L ozone
dose

36

44

37

34

41

34

10

27

28

12

30

29

14

35

31

16

39

32

29%

66%

82%

35%

73%

85%

41%

85%

91%

47%

95%

94%

Some of the compounds detected at each ozone dose were not included in these
statistics. The 2, 4, and 8 mg/L sampling events initially detected 36, 44, and 37
compounds respectively as seen in Table 4-19. As discussed earlier, the results for the
compounds 4-nonylphenol and propylparaben were discarded due to their detection in the
field blank. The 2, 4, and 8 mg/L sampling events all detected 4-nonylphenol in the
MBR effluent. The 8 mg/L results also detected propylparaben in the field blank. As
discussed earlier, each sampling event also had compounds that were detected in the BAF
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or ozone effluent but not in the MBR effluent. Because these compounds were not
detected in the MBR effluent, a percent removal cannot be calculated. The 2, 4, and 8
mg/L sampling events had 1, 2, and 1 compound(s) respectively that were discarded for
this reason. This leaves a total of 34, 41, and 34 compounds at ozone doses of 2, 4, and 8
mg/L respectively that were used to calculate percent removal as presented in Table 4-19.
The statistics in Table 4-19 show that 29% of the compounds detected and
compared for removal at the 2 mg/L ozone dose are removed to below detectable limits.
The percentage of compounds removed to below detectable limits sharply increases to
66% at the 4 mg/L ozone dose. As expected, the number of compounds removed to
below detectable limits increases at the 8 mg/L ozone dose to 82%. The difference in
removal between the 4 and 8 mg/L ozone doses is 16%, which is much lower than the
37% difference between the 2 and 4 mg/L ozone doses.
At an ozone dose of 2 mg/L, 35% of compounds achieved ≥ 90% removal. This
value more than doubles at the 4 mg/L ozone dose with 73% of compounds being
removed to ≥ 90%. This is a 38% difference between the 2 and 4 mg/L ozone doses. At
8 mg/L, 85% of compounds had ≥ 90 % removal. This is an increase of only 12% over
the 4 mg/L removal.
At an ozone dose of 2 mg/L, 41% of compounds achieved ≥ 70% removal. The 4
mg/L ozone dose had 85% of compounds with ≥ 70% removal, which is 44% higher than
the 2 mg/L results. The 8 mg/L ozone dose results had 91% of the compounds removed
to ≥ 70%, which is only a 6% difference over the 4 mg/L ozone dose. This trend
continues for percentage of compounds that achieved ≥ 50% removal. The 2, 4, and 8
mg/L ozone doses had 47, 95, and 94% of their compounds achieve ≥ 50% removal.
Again, the difference between the 2 and 4 mg/L ozone doses is more than double, while
the 4 mg/L ozone dose actually has a higher percentage of compounds removed to ≥ 50%
than the 8 mg/L ozone dose.
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The removal statistics presented in Table 4-19 shows that compounds are
removed to a higher degree with increasing ozone dose. These values also show that
although more compound removal is achieved at higher ozone doses, the number of
compounds that are completely removed doesn’t linearly increase with increasing ozone
dose. The amount of compounds removed greatly increases from ozone doses of 2 to 4
mg/L. At an ozone dose of 8 mg/L only slightly greater compound removal is achieved,
even though the ozone dose has doubled. This was also seen in the bulk organic analysis,
which saw a large increase in organic removal between the 2 and 4 mg/L ozone dose,
with only slight increases at the 8 mg/L ozone dose.
Examining the change in percent removals between the ozone doses can be used
to better examine how efficient the ozone doses are in removing PPCPs/EDCs. The data
presented in Figure 4-48 shows the difference in percent removals between applied ozone
doses for 20 compounds. The compounds examined were all detected in the 2 and 4
mg/L ozone dose sampling events. Three of the compounds (carbadox, ketoprofen, and
Sulfathiazole) were not detected in the 8 mg/L sampling event but were removed to
below detectable limits in the 4 mg/L sampling event. The data presented in Figure 4-48
illustrates that there is little additional removal achieved from 4 to 8 mg/L. Only two
compounds, iopromide and primidone at 48.0 and 30.7 percent removal respectively, saw
greater removal going from 4 to 8 mg/L than from 2 to 4 mg/L. Eight compounds saw
>50% removal increases going from 2 to 4 mg/L with 5 of those achieving > 70%. This
figure further illustrates the effectiveness of ozone at 4 mg/L to remove PPCPs/EDCs,
and that doubling the ozone dose to 8 mg/L only slightly increase compound removal.
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Figure 4-48: Change in compound percent removal between different applied ozone doses
for MBR-BAF

The percent removal increased with applied ozone dose for almost all compounds
detected and compared. As discussed earlier, only three compounds did not follow the
pattern of increasing percent removal with increased ozone dose. The percent removal
for the compound meprobamate was slightly lower at the 8 mg/L ozone dose than at the 4
mg/L dose. The conclusion was that the percent removal was close enough between the 4
and 8 mg/L ozone dose to assume no additional removal achieved at the 8 mg/L ozone
dose.
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Three compounds (meclofenamic acid, DACT, and dehydronifedipine) were
detected in the ozone or BAF effluent and not the MBR effluent during one of more
sampling events. These compounds were also detected in the MBR effluent for at least
one of the sampling events. Meclofenamic acid was found in the BAF effluent at a
concentration of 7.4 ng/L, and not the MBR or ozone effluents during the 2 mg/L
sampling event. The detection limit for meclofenamic acid is 5 ng/L. It is assumed that
the lack of detection of this compound in the MBR effluent is because the compound is
present at levels just below the detection limit.
The compounds DACT and dehydronifedipine were detected in the ozone and
BAF effluents and not in the MBR effluent during the 4 mg/L sampling event. DACT
was found in the ozone and BAF effluents at concentrations of 11.5 and 10.95 ng/L
respectively. Dehydronifedipine was found in the ozone and BAF effluents at
concentrations of 14 and 19 ng/L respectively. DACT was also detected in the ozone
effluent at a concentration of 5.3 ng/L during the 8 mg/L sampling event and not in the
MBR or BAF effluents. Dehydronifedipine was only detected in the MBR effluent at a
concentration of 9.6 ng/L during the 8 mg/L sampling event. Both compounds were
found in all process effluents during the 2 mg/L sampling event. DACT was detected in
concentrations of 6.8, 5.6, and 6.2 in the MBR, ozone, and BAF effluents respectively.
Dehydronifedipine was detected in concentrations of 6.4, 6.7, and 5.4 ng/L in the MBR,
ozone, and BAF effluents respectively. The compounds DACT, and dehydronifedipine
were detected at levels close their detection limits (5 ng/L) in all sampling events. This
leads to the conclusion that the lack of detection of these two compounds is due to the
concentrations in which they are present in the wastewater. It is assumed that the
concentrations at which these compounds are present in the wastewater is just below the
detectable limits. The lack of detection in the MBR effluent during some of the sampling
events, as well as the low levels at which these compounds are detected at, makes it hard
to draw a conclusion about the effectiveness of ozone in removing these compounds.
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The Phase 2 results have shown increased PPCP/EDC removal with increased
applied ozone doses. The data has also shown that compound removal is not linear to
ozone dose. Although more compounds are removed to a higher degree at an ozone dose
of 8 mg/L, the 4 mg/L dose achieves much larger differences in percent removal. This is
seen in both the PPCP/EDC data, as well as in the bulk organic analysis. The data has
also shown that the BAF column achieves little to no additional removal of recalcitrant
compounds.
Using lower ozone doses can be beneficial in several ways. First, creating ozone
is an energy intensive process, which can be very expensive. The 8 mg/L ozone dose
would actually need more than twice as much ozone than the 4 mg/L ozone dose because
the transfer efficiency is lower at the 8 mg/L ozone dose. This is seen in Figure 4-19.
The average transfer efficiency observed in this research was 82.3% for the 8 mg/L ozone
dose compared to 88.2% 4 mg/L ozone dose. The higher the ozone dose, the larger the
operating costs. Operating at an applied ozone dose of 4 mg/L instead of 8 mg/L can
greatly reduce the operating costs. Another benefit of using a lower ozone dose would be
that less ozonation by-products would be created. This is especially important in
Bromide rich waters.
The amount of compound removal desired, as well as the type of compounds
removed at the various ozone doses would better dictate the ozone dose used. For
example if a compound is known to be toxic at the levels found in the BAF effluent at the
4 mg/L ozone dose, then an increased ozone dose might be desired if this increased ozone
dose was shown to remove this compound to acceptable levels. Other factors, such as
bromide concentrations in the feedwater, should also be considered when selecting which
applied ozone dose to use.

Compounds Not Easily Oxidized by Ozone
Although a majority of PPCPs were removed to below detectable limits at applied
ozone doses of 4 and 8 mg/L, there were still some compounds that were particularly
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resistant to oxidation by ozone, even at the 8 mg/L ozone dose. A total of 14 compounds
were detected in the BAF effluent at the 4 mg/L ozone dose and 6 compounds detected in
the BAF effluent at the 8 mg/L ozone dose. The six compounds detected in the BAF
effluent at an ozone dose of 8 mg/L were iohexal, iopromide, meprobamate, primidone,
Sucralose, and TCEP. All of these compounds, with the exception of sucralose, have
been shown to be extremely resistant to oxidation by ozone [43, 46]. Sucralose was also
the most prevalent compound detected with MBR effluent concentrations in the tens of
thousands of ng/L. This was an order of magnitude higher than any other compound
detected and several orders of magnitude higher than most of the other compounds
detected during sampling. As mentioned earlier, the fraction of organics in the MBR
effluent that consisted of PPCPs was approximately 1% with most of that consisting of
sucralose. Because sucralose is being detected at these high concentrations and is not
easily oxidized, this might make it a good candidate as an indicator compound. If
sucralose is determined to be present in wastewater at these high concentrations, then a
less intensive method of determining its concentration could be developed. Current
analytical techniques are able to detect this compound in wastewater in the ng/L range.
This process is expensive though. If sucralose is prevalent in wastewater at
concentrations in the μg/L range, then a procedure could developed that would be less
intensive and costly. This research has shown that although sucralose is extremely
resistant to oxidation by ozone, the compound does show increased removal with
increased ozone dose. More research would be needed though to determine a correlation
between ozone dose and the removal of sucralose, as well as guidelines established to
determine a relationship between the amount of sucralose removed and acceptable levels
of water treatment.

RO Performance for removing PPCPs/EDCs
An RO unit was used to treat MBR effluent during the 2 and 4 mg/L sampling
events. The unit was run in parallel to the ozone and BAF processes. The same MBR
effluent water that was used in the ozone and BAF processes was also used to feed the
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RO process as described in the experimental methods section. This was done to compare
the ozone and BAF treatment train with a process that the literature has shown can
remove microconstituents to a very high degree.
As expected, the RO process removed all compounds well with most being
removed to below detectable limits. A list of the compounds detected in the RO effluent
and their percent removal is presented in Table 4-20. The 2 mg/L sampling event
detected a total of 36 compounds with 34 of these being compared for removal. The
results for the compounds 4-nonylphenol and propylparaben were discarded due to their
detection in the field blank. Removal was not calculated for compounds not detected in
the MBR effluent. The RO process removed 32 of these compounds to below detectable
limits with the other two removed to greater than 98.7%. The 4 mg/L sampling event
detected a total of 44 compounds and examined the percent removal of 41 compounds.
The RO process removed 36 compounds to below detectable limits. The remaining 5
compounds were removed to greater than 97.6% as shown in Table 4-20.

Table 4-20: Removal efficiencies of PPCPs from MBR effluent by the RO process

Analyte

Sample during 2
mg/L ozone test

Sample during 4
mg/L ozone test

Atenolol
Carbamazepine
Iopromide
Meprobamate
Sucralose
Sulfamethoxazole

ND
98.7
ND
ND
99.6
ND

98.2
97.6
99.1
98.6
99.2
98.6

ND = Not detected during sampling event

A more effective examination of the removal of PPCPs/EDCs by the RO process
can be achieved by examining the initial concentration of the detected compounds in the

159

MBR effluent as shown in Table 4-21. The concentration of the compounds detected in
the BAF effluent during the 2 mg/L sampling event, as well as the percent removal of the
detected compounds in the BAF column and RO process is also shown in Table 4-21. A
total of 14 compounds had MBR effluent concentrations of greater than 100 ng/L. Two
of these compounds had MBR effluent concentrations of greater than 1,000 ng/L with
one of those having an initial concentration of greater than 10,000 ng/L. Iopromide had
an MBR effluent concentration of 4100 ng/L and was removed to below detectable limits
by the RO process. Sucralose had an MBR effluent concentration of 34,000 ng/L and the
RO process achieved nearly complete removal with 99.6% removal. The BAF column
only achieved removals of 15% and 0% at the 2 mg/L ozone dose, 41% and 37% at an
ozone dose of 4 mg/L, and 89% and 57% at an ozone dose of 8 mg/L for iopromide and
sucralose respectively. This lack of removal by the BAF column at an ozone dose of 2
mg/L is also seen in the number of compounds removed to below detectable limits. The
BAF column removed 10 of the 34 compounds to below detectable limits at an ozone
dose of 2 mg/L, while the RO process removed 32 of the 34 compounds.
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Table 4-21: Concentrations of compounds detected in MBR, BAF, and RO effluents during
2 mg/L sampling event as well as percent removal by BAF column and RO process
Analyte

MBR effluent,
ng/L

BAF effluent,
ng/L

RO effluent, Percent removal
Percent
ng/L
in BAF
removal in RO

1,7-Dimethylxanthine

21

BDL

BDL

BDL

BDL

4-tert-Octylphenol

13

BDL

BDL

BDL

BDL

Acetaminophen

18

BDL

BDL

BDL

BDL

Amoxicillin

580

30

BDL

94.8%

BDL

Atenolol

240

140

BDL

41.7%

BDL

Butalbital

25

6.7

BDL

73.2%

BDL

Caffeine

140

81

BDL

42.1%

BDL

Carbadox
Carbamazepine

27
450

22
23

BDL
5.9

18.5%
94.9%

BDL
98.7%

Carisoprodol

46

36

BDL

21.7%

BDL

Cimetidine

100

BDL

BDL

BDL

BDL

DACT

6.8

6.2

BDL

8.8%

BDL

DEET

13

12

BDL

7.7%

BDL

Dehydronifedipine

6.4

5.4

BDL

15.6%

BDL

Dilantin

320

240

BDL

25.0%

BDL

Furosimide

87

BDL

BDL

BDL

BDL

Gemfibrozil

9.3

BDL

BDL

BDL

BDL

Iohexal

140

230

BDL

-64.3%

BDL

Iopromide

4100

3500

BDL

14.6%

BDL

Ketoprofen

62

56

BDL

9.7%

BDL

300
BDL(1)

120

BDL

7.4

BDL

60.0%
BDL(1)

BDL

Meprobamate

390

270

BDL

30.8%

BDL

Naproxen

68

10

BDL

85.3%

BDL

Primidone
Sucralose

200
34000

120
34000

BDL
150

40.0%
0.0%

BDL
99.6%

Sulfadiazine

19

BDL

BDL

BDL

BDL

Sulfamethoxazole

470

160

BDL

66.0%

BDL

Sulfathiazole

9.2

6.3

BDL

31.5%

BDL

TCEP

200

160

BDL

20.0%

BDL

Theobromine

36

33

BDL

8.3%

BDL

Theophylline

40

BDL

BDL

BDL

BDL

Triclosan

14

BDL

BDL

BDL

BDL

Bromacil

5.6

BDL

BDL

BDL

BDL

Diuron

15

11

BDL

26.7%

BDL

Lidocaine
Meclofenamic Acid

BDL = Below detectable limits
(1) = Compound not detected in MBR effluent

BDL
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The concentration of the compounds detected in the BAF effluent during the 4
mg/L sampling event, as well as the percent removal of the detected compounds in the
BAF column and RO process is shown in Table 4-22. The RO process removed 35 of the
41 compounds detected in the MBR effluent during this sampling event, while the BAF
column removed 27 compounds to below detectable limits. A total of 17 compounds had
MBR effluent concentrations of greater than 100 ng/L during the 4 mg/L ozone dose
sampling event. Similar to the 2 mg/L ozone dose sampling event results, the compounds
iopromide and sucralose were found in high concentrations in the MBR effluent. These
are two of only 5 compounds not removed to ≥ 90% by the BAF column during the 8
mg/L ozone dose sampling event and 2 of the 11 compounds not removed to ≥ 90%
during the 4 mg/L ozone dose sampling event. Two other compounds, sulfamethoxazole
and carbamazepine, achieved greater percent removals in the BAF than the RO at an
ozone dose of 4 mg/L. Another compound, atenolol, also achieved similar removal
during the 4 mg/L ozone dose.

162

Table 4-22: Concentrations of compounds detected in MBR, BAF, and RO effluents during
4 mg/L sampling event as well as percent removal by BAF column and RO process
Analyte
1,7-Dimethylxanthine
Acetaminophen
Albuterol
Amoxicillin
Atenolol
Butalbital
Caffeine
Carbadox
Carbamazepine
Carisoprodol
Cimetidine
Cotinine
DACT
DEET
Dehydronifedipine
Dilantin
Erythromycin
Furosimide
Gemfibrozil
Iohexal
Iopromide
Ketoprofen
Ketorolac
Lidocaine
Lopressor
Meclofenamic Acid
Meprobamate
Naproxen
Oxolinic acid
Primidone
Sucralose
Sulfadiazine
Sulfamethazine
Sulfamethoxazole
Sulfathiazole
TCEP
Theobromine
Theophylline
Triclosan
Trimethoprim
Atrazine
Diuron
Linuron

MBR effluent,
ng/L
46
62.5
6.2
485
380
34
300
6.05
410
48.5
100.5
32.5
BDL(1)
39
BDL(1)
350
18.5
150
43
560
5300
6.9
7.25
335
160
37.5
395
160
23
120
43000
9.15
5.1
1040
5.8
120
62.5
98
14
79.5
43
24.5
5

Percent
BAF effluent, RO effluent, Percent removal
ng/L
in BAF
removal in RO
ng/L
BDL
BDL
BDL
BDL
10
BDL
19.5
BDL
BDL
15
BDL
11.5
10.95
5.5
19
91.5
BDL
BDL
BDL
160
3150
BDL
BDL
BDL
BDL
BDL
82.5
BDL
BDL
46
27000
BDL
BDL
12.5
BDL
60.5
8.6
BDL
BDL
BDL
BDL
BDL
BDL

BDL = Below detectable limit
(1) = Compound not detected in MBR effluent

ND
ND
ND
ND
7
ND
ND
ND
10
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
47
ND
ND
ND
ND
ND
5.7
ND
ND
ND
330
ND
ND
15
ND
ND
ND
ND
ND
ND
ND
ND
ND

BDL
BDL
BDL
BDL
97.4%
BDL
93.5%
BDL
BDL
69.1%
BDL
64.6%
BDL(1)
85.9%
BDL(1)
73.9%
BDL
BDL
BDL
71.4%
40.6%
BDL
BDL
BDL
BDL
BDL
79.1%
BDL
BDL
61.7%
37.2%
BDL
BDL
98.8%
BDL
49.6%
86.2%
BDL
BDL
BDL
BDL
BDL
BDL

BDL
BDL
BDL
BDL
98.2%
BDL
BDL
BDL
97.6%
BDL
BDL
BDL
BDL(1)
BDL
BDL(1)
BDL
BDL
BDL
BDL
BDL
99.1%
BDL
BDL
BDL
BDL
BDL
98.6%
BDL
BDL
BDL
99.2%
BDL
BDL
98.6%
BDL
BDL
BDL
BDL
BDL
BDL
BDL
BDL
BDL
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These results show that although the RO process does achieve near complete
removal of all detected compounds, the compound removal in the BAF column was
shown to be comparable at ozone doses of 4 and especially 8 mg/L. The ozone doses
required depend on the amount of removal desired and the types of compounds being
detected in the wastewater. The MBR-ozone-BAF treatment train can offer an effective,
lower cost approach to removing PPCPs/EDCs from wastewater without the loss of water
and the production of a concentrated waste stream.
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Chapter 5: Conclusions
A pilot system consisting of an MBR, ozone contactor, and BAF column was
operated at the ABCWUA Southside Water Reclamation Plant (SWRP). The MBR was
continually fed primary treated wastewater and operated at an SRT of approximately 10
days throughout the duration of these experiments. The MBR effluent was used to feed
an ozone contactor, which then fed a BAF column. Three different ozone doses were
examined. Applied ozone doses of 2, 4, and 8 mg/L, were examined, which correspond
to an approximate ratio of 0.5, 1.0, and 2.0 mg ozone/mg TOC. The ozone contactor
consisted of three chambers, which provided 5 minutes of contact time in each chamber
for a total of 15 minutes of contact time. After ozone treatment, the water was pumped to
the BAF column. The BAF column used anthracite media that was initially seeded with
MLSS from the MBR and soaked in MBR feedwater for a week to establish a bio-growth
prior to the Phase 2 experiments. The system was run for at least one week between
sampling events to establish steady state conditions at each new ozone dose. Several
organic parameters were measured daily to establish steady state conditions and to predict
PPCP/EDC removal. This study also investigated the removal of PPCPs/EDCs with a
reverse osmosis (RO) system that was operated concurrent to the Ozone/BAF treatment
train for two of the ozone doses. The PPCP/EDC analysis tested for 83 compounds with
most having detection limits of 5 ng/L. The concentrations of the examined compounds
were tested in the effluents of the MBR, ozone contactor, BAF column, and RO
permeate.
The project was divided into two phases. Phase 1 of the project determined the
ozone doses used to examine the removal of PPCPs/EDCs. In Phase 1, a series of
analysis were done to examine the effects of various ozone doses on different organic
parameters. The bulk organic analysis consisted of TOC, UV254 absorption, SUVA, and
BDOC. These parameters were measured at varying ozone doses ranging from 0 to
approximately 12 mg/L. Due to the cost of each PPCP/EDC analysis and the limited
budget for testing, only three applied ozone doses could be examined for PPCP/EDC
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removal. It was determined that ozone doses of 2, 4, and 8 mg/L would be used which
corresponds to approximately 0.5, 1.0, and 2.0 mg ozone/mg TOC. Phase 1 also showed
that the effectiveness of ozone to remove organics is limited. The bulk organic analysis
showed that little to no additional organic removal was achieved after an ozone dose of
around 8 mg/L.
Phase 2 of this research can also be divided into two parts. Phase 2 examined
both the removal of organics and the removal of microconstituents at the 3 applied ozone
doses determined in Phase 1. TOC, UV254 absorbance, and SUVA were measured daily
to establish steady state conditions and to predict PPCP/EDC removal. BDOC was
measured 3 times for each applied ozone dose. The TOC analysis showed that the TOC
concentrations in the MBR and ozone effluents were approximately equal at all examined
ozone doses. The TOC/TOC0 analysis also showed that there was a decrease in TOC
concentrations between the ozone and BAF effluents at all examined ozone doses. In
contrast to the TOC values, a decrease in UV254 absorbance was observed between the
MBR and ozone effluents at all applied ozone doses examined. This indicates that even
though the TOC is not reduced by increased ozone doses, the organics become more
biodegradable and are then removed by the BAF. Similar to the UV254 absorbance
values, the SUVA values decrease after the MBR effluent and are nearly identical for
both the ozone and BAF effluents. This also indicates an increase in the biodegradable
fraction of organics due to ozonation.
The TOC, UV254 absorbance, and SUVA values show that recalcitrant compounds
in the MBR effluent are being partially oxidized in the ozone contact chamber. Although
organics are not removed by ozone alone, they are broken down into more biodegradable
forms that are then consumed by microbes in the BAF column. There is a trend of
increasing organic removal with increasing ozone dose, although the highest efficiency of
ozone to partially oxidize recalcitrant compounds into more biodegradable forms was not
seen at the highest ozone dose examined. The most effective ozone dose examined for
removing organics was 4 mg/L.
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Examining the additional removal of organics between applied ozone doses per
additional mg/L of ozone added shows a large amount of organic removal up to an ozone
dose of 4 mg/L, with the largest removal achieved at the 4 mg/L ozone dose. These
values were used to quantify the amount of organic removal per additional mg/L of ozone
added between the ozone doses of 0-2, 2-4, and 4-8 mg/L. The TOC, UV254 absorbance,
and SUVA values showed that the 4 mg/L ozone dose was the most effective at removing
organics.
The last of the organic analysis examined during the Phase 2 experiments was
BDOC. The BDOC analysis was used to examine the fraction of biodegradable and nonbiodegradable organics throughout the treatment process at all ozone doses. Three
BDOC sampling events were done for each applied ozone dose examined and measured
the BDOC in the MBR, ozone, and BAF effluents.
Similar to the other organic analysis examined during Phase 2 of these
experiments, the BDOC results showed that recalcitrant organics in the MBR effluent are
partially oxidized in the ozone contact chamber where they are further degraded by
microbes in the BAF column. The results also showed that although the amount of
BDOC created in the ozone contact chamber increases with increasing ozone doses,
ozone’s effectiveness in partially oxidizing recalcitrant organics decreases after the 4
mg/L ozone dose. These results were expected based on the results of the other organic
analysis.
The BDOC results did show that the average ratio of BDOC consumed in the
BAF column to BDOC produced in the ozone contact chamber was approximately 0.5:1
at all examined ozone doses. The ratios were 0.54, 0.5, and 0.54 at the ozone doses of 2,
4, and 8 mg/L respectively. This leads to the conclusion that the BAF column is only
able to consume half of the biodegradable organics produced in the ozone contact
chamber regardless of the ozone dose. The incomplete biodegradation of BDOC in the
BAF column may be the result of the short EBCT in the BAF column or incomplete
maturation of the biofilm on the anthracite media. It could also be attributed to
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drawbacks in doing pilot scale research and could be an issue that needs further
examination in a future study.
Following the results of the bulk organic analysis, it was expected that a certain
degree of compound removal would be achieved at all applied ozone doses examined. It
was also expected that PPCP/EDC removal would increase with applied ozone dose with
the highest removal of compounds being achieved at an ozone dose of 8 mg/L. The 4
mg/L ozone dose was expected to remove compounds the most efficiently while the 2
mg/L ozone dose was expected to remove some compounds well, although a majority of
compounds would not be removed to below detectable limits.
A total of 16 samples were collected and analyzed for PPCPs/EDCs during Phase
2 experiments. The MBR, ozone, and BAF effluent were tested for PPCPs/EDCs during
all three sampling events in Phase 2. Two samples from the RO effluent were tested as
well as an initial MBR effluent sample collected on 8/19/09 which was used to determine
what compounds were present in the wastewater. The RO effluent samples were
collected during the 2 and 4 mg/L ozone dose sampling events. In addition, some
samples were collected and analyzed for PPCPs/EDCs for quality assurance purposes.
These include one set of duplicates for the MBR, ozone, and BAF effluent, collected
during the 4 mg/L ozone dose sampling event, as well as a field blank to insure
contamination was not an issue. The results from the duplicate samples showed
consistency in the sampling process. The field blank detected two compounds, 4nonylphenol and propylparaben, consequently both were not considered in evaluating
process performance.
The PPCP/EDC analysis tested for 83 different compounds with most having
detection limits at 5 ng/L. Of these 83 compounds, 52 were detected in one or more
samples in the MBR effluent. Three compounds (dehydronifedipine, meclofenamic acid,
and DACT) were detected in the ozone or BAF effluent, but not in the MBR effluent for
at least one sample. All three of these compounds were also detected in the MBR
effluent in at least one of the sampling events. The concentrations of these compounds

168

were close to the detection limit, which leads to the conclusion that they were not
detected in the MBR effluent due to the limitations of the analysis.
As expected, the BAF column did not achieve any significant removal of
PPCPs/EDCs. Because the compounds have already been through a biological process in
the MBR, most of the remaining organics are assumed non-biodegradable or slowly
degradable. To make them more biodegradable, ozone is used, which breaks the
compound down to a more biodegradable form. The ozonation process is essential in
oxidizing recalcitrant compounds into smaller more biodegradable forms that can then be
removed through biodegradation in the BAF column. Even though the initial, recalcitrant
compounds are not removed by the BAF column, the bulk organic analysis shows that the
compounds are not completely mineralized by ozone either. Instead, they are broken
down into smaller more biodegradable compounds by the ozone, and then removed by
the BAF column. It is only through a combination of both processes that removal of
organics is attained.
All compounds that were removed to BDL at a lower ozone dose were also
removed at all higher doses. Only three compounds, iohexal, TCEP, and meprobamate,
were found to have a lower percent removal at a higher applied ozone dose. Other
studies have found both Iohexal and TCEP to be extremely resistant to oxidation by
ozone. The results of one study also had inconsistent results for TCEP with increased
concentrations detected at higher ozone doses. The meprobamate results showed
increased removal at ozone doses of 2 and 4 mg/L. The 8 mg/L ozone dose saw a
slightly lower percent removal than the 4 mg/L ozone dose. The percent differences were
small enough to be ignored and the assumption was made that no additional removal of
meprobamate is achieved at the 8 mg/L ozone dose.
Significant removal of most PPCPs/EDCs was observed at all applied ozone
doses. As expected, greater removal was achieved as the ozone dose increased.
Although the removal of PPCPs/EDCs increased with increasing ozone dose, the most
efficient ozone dose examined was at 4 mg/L. The BAF column did not dramatically
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decrease the concentrations of PPCPs/EDCs after the initial decrease due to ozonation,
although additional TOC removal was achieved in the BAF column. The data from the
bulk organic analysis was useful in predicting the effectiveness of the various ozone
doses in removing PPCPs/EDCs.
As expected, the RO process achieved very high removal of all detected
compounds. A total of 36 compounds were detected during the 2 mg/L sampling event
with 34 of these being compared for percent removal. The RO process removed 32 of
these compounds to below detectable limits with the remaining two compounds
achieving > 98% removal. A total of 44 compounds were detected during the 4 mg/L
sampling event with 41 of these being compared for percent removal. The RO process
removed 35 of these compounds to below detectable limits with the remaining 6
compounds achieving greater than 97% removal. The 2 mg/L ozone dose was not nearly
as effective at removing compounds as the RO process. At an ozone dose of 4 mg/L
though, comparable results were seen although the RO process was more effective. The
8 mg/L ozone dose results had similar compound removals in both the BAF column and
the RO process although some compounds were found to be particularly resistant to
oxidation by ozone.
These results show that although the RO process does achieve near complete
removal of all PPCPs detected, the compound removal in the BAF column was shown to
be comparable at ozone doses of 4 and especially 8 mg/L. The ozone doses required
depend on the amount of removal desired and the types of compounds being detected in
the wastewater. The MBR-ozone-BAF treatment train can offer an effective approach to
removing PPCPs/EDCs from wastewater. This process does not lose any of the treated
water and has the benefit of not having a wastestream associated with it like the RO
process does.
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